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FOREWORD
 
The Superfund Amendments and Reauthorization Act (SARA) of 1986
 
(Public Law 99-499) extended and amended the Comprehensive Environmental
 
Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund). This
 
public law directed the Agency for Toxic Substances and Disease Registry
 
(ATSDR) to prepare toxicological profiles for hazardous substances which are
 
most commonly found at facilities on the CERCLA National Priorities List and
 
which pose the most significant potential threat to human health, as
 
determined by ATSDR and the Environmental Protection Agency (EPA). The lists
 
of the 250 most significant hazardous substances were published in the Federal
 
Resister on April 17, 1987; on October 20, 1988; on October 26, 1989; and on
 
October 17, 1990. A revised list of 275 substances was published on October
 
17, 1991.
 
Section 104(i)(3) of CERCLA, as amended, directs the Administrator
 
of ATSDR to prepare a toxicological profile for each substance on the
 
lists. Each profile must include the following content:
 
(A) An examination, summary, and interpretation of available
 
toxicological information and epidemiological evaluations on the
 
hazardous substance in order to ascertain the levels of significant
 
human exposure for the substance and the associated acute, subacute, and
 
chronic health effects.
 
(B) A determination of whether adequate information on the health
 
effects of each substance is available or in the process of
 
development to determine levels of exposure which present a
 
significant risk to human health of acute, subacute, and chronic
 
health effects.
 
(C) Where appropriate, an identification of toxicological testing
 
needed to identify the types or levels of exposure that may present
 
significant risk of adverse health effects in humans.
 
This toxicological profile is prepared in accordance with
 
guidelines developed by ATSDR and EPA. The original guidelines were
 
published in the Federal Register on April 17, 1987. Each profile will
 
be revised and republished as necessary.
 
The ATSDR toxicological profile is intended to characterize
 
succinctly the toxicological and adverse health effects information for
 
the hazardous substance being described. Each profile identifies and
 
reviews the key literature (that has been peer-reviewed) that describes
 
a hazardous substance's toxicological properties. Other pertinent
 
literature is also presented but described in less detail than the key
 
studies. The profile is not intended to be an exhaustive document;
 
however, more comprehensive sources of specialty information are
 
referenced.
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1. PUBLIC HEALTH STATEMENT
 
This Statement was prepared to give you information about antimony and
 
to emphasize the human health effects that may result from exposure to it. The
 
Environmental Protection Agency (EPA) has identified 1,177 sites on its
 
National Priorities List (NPL). Antimony and its compounds have been found at
 
52 of these sites. However, we do not know how many of the 1,177 NPL sites
 
have been evaluated for antimony. As EPA evaluates more sites, the number of
 
sites at which antimony and its compounds are found may change. The
 
information is important for you because antimony may cause harmful health
 
effects and because these sites are potential or actual sources of human
 
exposure to antimony.
 
When a chemical is released from a large area, such as an industrial
 
plant, or from a container, such as a drum or bottle, it enters the
 
environment as a chemical emission. This emission, which is also called a
 
release, does not always lead to exposure. You can be exposed to a chemical
 
only when you come into contact with the chemical. You may be exposed to it in
 
the environment by breathing, eating, or drinking substances containing the
 
chemical or from skin contact with it.
 
If you are exposed to a hazardous substance such as antimony, several
 
factors will determine whether harmful health effects will occur and what the
 
type and severity of those health effects will be. These factors include the
 
dose (how much), the duration (how long), the route or pathway by which you
 
are exposed (breathing, eating, drinking, or skin contact), the other
 
chemicals to which you are exposed, and your individual characteristics such
 
as age, sex, nutritional status, family traits, life style, and state of
 
health.
 
1.1 WHAT IS ANTIMONY?
 
Antimony is a silvery white metal of medium hardness that breaks easily.
 
Small amounts of antimony are found in the earth's crust. Antimony ores are
 
mined and then either changed into antimony metal or combined with oxygen to
 
form antimony oxide.
 
Antimony oxide is a white powder that does not evaporate. Only a small
 
amount of it will dissolve in water. Most antimony oxide produced is added to
 
textiles and plastics to prevent their catching on fire.
 
Antimony metal is too easily broken to be used much by itself. To make
 
it stronger, a little antimony is usually mixed with other metals such as lead
 
and zinc to form mixtures of metals called alloys. These alloys are used in
 
lead storage batteries, solder, sheet and pipe metal, bearings, castings, type
 
metal, ammunition, and pewter.
 
Antimony enters the environment during the mining and processing of its
 
ores and in the production of antimony metal, alloys, antimony oxide, and
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combinations of antimony with other substances. Little or no antimony is mined
 
in the United States, Antimony ore and impure metals are brought into this
 
country from other countries for processing. Small amounts of antimony are
 
also released into the environment by incinerators and coal-burning power
 
plants. The antimony that comes out of the smoke stacks of these plants is
 
attached to very small particles that settle to the ground or are washed out
 
of the air by rain. It usually takes many days for antimony to be removed from
 
the air. Antimony attached to very small particles may stay in the air for
 
more than a month. Antimony cannot be destroyed in the environment. It can
 
only change its form or become attached to or separated from particles. Most
 
antimony will end up in the soil or sediment, where it attaches strongly to
 
particles that contain iron, manganese, or aluminum. For more information, see
 
Chapters 3, 4, and 5.
 
1.2 HOW HIGHT I BE EXPOSED TO ANTIMONY?
 
Antimony is found at very low levels in the environment, so low that we
 
often cannot measure it. You may be exposed to antimony by breathing air,
 
drinking water, and eating foods that contain it. You also may be exposed by
 
skin contact with soil, water, and other substances that contain antimony. The
 
analytical methods used by scientists testing for the presence of antimony in
 
the environment do not determine the specific form of antimony present.
 
Therefore, we do not always know what form of antimony persons may be exposed
 
to. Similarly, we do not know what forms of antimony are found in hazardous
 
waste sites. Much of the antimony found in sediment, soil, and rock is so
 
strongly attached to dust and dirt or buried in minerals that it cannot easily
 
affect your health. Some antimony in the environment is less tightly attached
 
to particles and may be taken up by plants and animals.
 
The concentration of antimony in air ranges from a very small part of a
 
nanogram (1 nanogram equals a billionth of a gram) in a cubic meter (m3) of
 
air (ng/m3) to about 170 ng/m3. However, near companies that change antimony
 
ores into metal or make antimony oxide, concentrations may be more than 1,000
 
ng/m3. You may breathe high levels of antimony in dust if you live or work
 
near antimony mines or processing companies.
 
The concentration of antimony that is dissolved in rivers and lakes is
 
very low, usually less than 5 parts of antimony in 1 billion parts of water
 
(ppb) . We cannot measure such small amounts without special equipment.
 
Antimony does not appear to accumulate in fish and other aquatic animals. The
 
concentration of antimony dissolved in one polluted river where wastes from
 
antimony mining and processing had been dumped was as high as 8 ppb. Most of
 
the antimony in the river, however, was not dissolved, but was attached to
 
particles of dirt. Although antimony is used in solder for water pipes, it
 
does not seem to get into the drinking water.
 
Soil usually contains very low concentrations of antimony, less than 1
 
part of antimony in a million parts of soil (ppm). However, concentrations
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close to 9 ppm have been found. The highest soil concentrations found at
 
hazardous waste sites on the NPL and at antimony-processing sites range from
 
109 to 2,550 ppm. High concentrations of antimony may be found in soil because
 
dust sent out during processing settles out from the air. Also, waste from
 
antimony-processing and other antimony-using industries is usually dumped onto
 
the soil. We do not know the form of antimony at these sites. However, we know
 
that much of the antimony in antimony-processing wastes is strongly attached
 
to soil. You may be exposed to this antimony by skin contact. Children may
 
also be exposed to this antimony by eating the dirt.
 
Food usually contains small amounts of antimony. You eat and drink
 
about 5 micrograms (5 millionths of a gram) of antimony every day. The
 
average concentration of antimony in meats, vegetables, and seafood is
 
0.2-1.1 ppb. The antimony oxide that is added to many materials for fire
 
protection is very tightly attached to these materials and does not expose
 
people to antimony.
 
You may also be exposed to antimony in the workplace. If you work in
 
industries that process antimony ore and metal or make chemicals that contain
 
antimony, such as antimony oxide, you may be exposed to antimony by breathing
 
dust or by skin contact.
 
For more information on how you may be exposed to antimony, see
 
Chapter 5.
 
1.3 HOW CAN ANTIMONY ENTER AND LEAVE MY BODY?
 
Antimony can enter your body when you drink water or eat food, soil, or
 
other substances that contain antimony. Antimony can also enter your body if
 
you breathe air or dust containing antimony. We do not know if antimony can
 
enter your body when it is placed on your skin.
 
A small amount of the antimony you eat or drink enters the blood after a
 
few hours. The amount and the form of antimony in the food or water will
 
affect how much antimony enters your blood. After you eat or drink very large
 
doses of antimony, you may vomit. This will prevent most of the antimony from
 
entering through the stomach and intestines into your blood. Antimony in your
 
lungs will enter your blood after several days or weeks. The amount of
 
antimony that will enter your blood from your lungs is not known.
 
After antimony enters your blood, it goes to many parts of your body.
 
Most of the antimony goes to the liver, lungs, intestines, and spleen.
 
Antimony will leave your body in feces and urine over several weeks. Further
 
information on how antimony enters and leaves your body is presented in
 
Chapter 2.
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1.4 HOW CAN ANTIMONY AFFECT MY HEALTH?
 
Exposure to 9 milligrams per cubic meter of air (mg/m3) of antimony for
 
a long time can irritate your eyes, skin, and lungs. Breathing 2 mg/m3 of
 
antimony for a long time can cause problems with the lungs (pneumoconiosis)
 
heart problems (altered electrocardiograms), stomach pain, diarrhea, vomiting
 
and stomach ulcers. People who drank over 19 ppm of antimony once, vomited. We
 
do not know what other health effects would occur to people who swallow
 
antimony. We do not know if antimony can cause cancer or birth defects, or
 
affect reproduction in humans. Antimony can have beneficial effects when used
 
for medical reasons, It has been used as a medicine to treat people infected
 
with parasites. Persons who have had too much of this medicine or are
 
sensitive to it when it was injected into their blood or muscle have
 
experienced adverse health effects. These health effects include diarrhea,
 
joint and/or muscle pain, vomiting, problems with the blood (anemia) and heart
 
problems (altered electrocardiograms).
 
Rats and guinea pigs that breathed very high levels of antimony for a
 
short time died. Rats breathing high levels of antimony for several days had
 
lung, heart, liver, and kidney damage. Breathing very low levels of antimony
 
for a long time has resulted in eye irritation, hair loss, and lung damage in
 
rats. Dogs and rats that breathed low levels of antimony for a long period had
 
heart problems (changes in EKGs). Problems with fertility have been observed
 
in rats that breathed very high levels of antimony for a couple of months.
 
Lung cancer has been observed in some studies of rats breathing high
 
concentrations of antimony. Antimony has not been classified for cancer
 
effects by the Department of Health and Human Services, the International
 
Agency for Research on Cancer or the Environmental Protection Agency.
 
Dogs that drank very high levels of antimony for several weeks lost
 
weight and had diarrhea. Rats that drank very low levels of antimony for most
 
of their lives died sooner than rats not drinking antimony. Rats eating high
 
levels of antimony for a long time had liver damage and fewer red blood cells.
 
Rabbits that had very small amounts of antimony placed on their skin for
 
less than 1 day had skin irritation. Small amounts of antimony placed in
 
rabbit eyes resulted in eye irritation. Large amounts of antimony placed on
 
rabbit's skin resulted in death.
 
More information on how antimony can affect your health is presented in
 
Chapter 2.
 
1.5 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN EXPOSED
 
TO ANTIMONY?
 
There are reliable and accurate ways of measuring antimony levels in the
 
body. Antimony can be measured in the urine, feces, and blood for several days
 
after exposure. High levels of antimony in these fluids will show that
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you have been exposed to high levels of antimony. However, these measurements
 
can not tell you how much antimony you have been exposed to or whether you
 
will experience any health effects. For more information, see Chapters 2 and
 
6.
 
1.6 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO
 
PROTECT HUMAN HEALTH?
 
EPA has set a limit of 145 ppb in lakes and streams to protect human
 
health from the harmful effects of antimony taken in through water and
 
contaminated fish and shellfish. EPA has also set limits on the amount of
 
antimony that industry can release.
 
The Occupational Safety and Health Administration (OSHA) has set a limit
 
of 0.5 mg/m3 of antimony in workroom air to protect workers during an 8-hour
 
work shift (40-hour workweek). The National Institute of Occupational Safety
 
and Health (NIOSH) also recommends that the concentration in workroom air be
 
limited to 0.5 mg/m3 for antimony, averaged over an 8-hour work shift. Further
 
information on regulations and guidelines pertaining to antimony is provided
 
in Chapter 7.
 
1.7 WHERE CAN I GET MORE INFORMATION?
 
If you have any more questions or concerns not covered here, please
 
contact your state health or environmental department or:
 
Agency for Toxic Substances and Disease Registry
 
Division of Toxicology
 
1600 Clifton Road, E-29
 
Atlanta, Georgia 30333
 
This agency can also provide you with information on the location of the
 
nearest occupational and environmental health clinic. Such clinics specialize
 
in recognizing, evaluating, and treating illnesses that result from exposure
 
to hazardous substances.
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2.1 INTRODUCTION
 
The primary purpose of this chapter is to provide public health
 
officials, physicians, toxicologists, and other interested individuals and
 
groups with an overall perspective of the toxicology of antimony and a
 
depiction of significant exposure levels associated with various adverse
 
health effects. It contains descriptions and evaluations of studies and
 
presents levels of significant exposure for antimony based on toxicological
 
studies and epidemiological investigations.
 
Studies in which humans or animals are exposed to various antimony
 
compounds are discussed in this chapter. The antimony compounds include
 
organic forms (potassium antimony tartrate, sodium antimony tartrate, antimony
 
acetate), inorganic trivalent antimony (antimony trioxide, antimony
 
trichloride, antimony trisulfide, stibine), pentavalent inorganic antimony
 
(antimony pentoxide, antimony pentasulfide), antimony-containing drugs
 
(stibocaptate, stibophen), and metallic antimony. No limitations were placed
 
on the selection of compounds for inclusion in this toxicological profile.
 
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE
 
To help public health professionals address the needs of persons living
 
or working near hazardous waste sites, the information in this section is
 
organized first by route of exposure--inhalation, oral, and dermal--and then
 
by health effect--death, systemic, immunological, neurological, developmental,
 
reproductive, genotoxic, and carcinogenic effects. These data are discussed in
 
terms of three exposure periods--acute (less than 15 days), intermediate (15­
364 days), and chronic (365 days or more).
 
Levels of significant exposure for each route and duration are presented
 
in tables and illustrated in figures. The points in the figures showing no­
observed-adverse-effect levels (NOAELs) or lowest-observed-adverse-effect
 
levels (LOAELS) reflect the actual doses (levels of exposure) used in the
 
studies. LOAELs have been classified into "less serious" or "serious" effects.
 
These distinctions are intended to help the users of the document identify the
 
levels of exposure at which adverse health effects start to appear. They
 
should also help to determine whether or not the effects vary with dose and/or
 
duration, and place into perspective the possible significance of these
 
effects to human health.
 
The significance of the exposure levels shown in the tables and figures
 
may differ depending on the user's perspective. For example, physicians
 
concerned with the interpretation of clinical findings in exposed persons may
 
be interested in levels of exposure associated with "serious" effects. Public
 
health officials and project managers concerned with appropriate actions to
 
take at hazardous waste sites may want information on levels of exposure
 
associated with more subtle effects in humans or animals (LOAEL) or exposure
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levels below which no adverse effects (NOAEL) have been observed. Estimates of
 
levels posing minimal risk to humans (Minimal Risk Levels, MRLs) may be of
 
interest to health professionals and citizens alike.
 
Estimates of exposure levels posing minimal risk to humans (MRLs) have
 
been made, where data were believed reliable, for the most sensitive noncancer
 
effect for each exposure duration. MRLs include adjustments to reflect human
 
variability from laboratory animal data to humans.
 
Although methods have been established to derive these levels (Barnes et
 
al. 1988; EPA 1989a), uncertainties are associated with these techniques.
 
Furthermore, ATSDR acknowledges additional uncertainties inherent in the
 
application of the procedures to derive less than lifetime MRLs. As an
 
example, acute inhalation MRLs may not be protective for health effects that
 
are delayed in development or are acquired followLng repeated acute insults,
 
such as hypersensitivity reactions, asthma, or chronic bronchitis. As these
 
kinds of health effects data become available and methods to assess levels of
 
significant human exposure improve, these MRLs will be revised.
 
2.2.1 Inhalation Exposure
 
Health effects have been observed in humans and animals following
 
inhalation exposure to several antimony compounds. Health effects following
 
exposure to airborne stibine, antimony trisulfide, antimony trioxide, antimony
 
pentoxide, antimony trichloride, antimony pentasulfide, and metallic antimony
 
are discussed below. Of these, stibine (antimony hydride) is a naturally
 
occurring gas; for ease of comparison, its concentrations will be expressed in
 
units of mg/m3 (1 ppm stibine = 5.1 mg/m3).
 
2.2.1.1 Death
 
No studies were located regarding death in humans after inhalation
 
exposure to antimony.
 
Guinea pigs exposed to approximately 37.9 mg antimony/m3 as antimony
 
trioxide dust for 52-125 days (Dernehl et al. 1945) or guinea pigs and rats
 
exposed to 1,395 mg antimony/m3 as stibine gas for 30 minutes (Price et al.
 
1979) died. In the Dernehl et al. (1945) study, four guinea pigs died, one
 
animal following each of 52, 90, 98, and 125 days of exposure. Pulmonary edema
 
was a contributing factor to the death of rats and guinea pigs exposed to
 
stibine (Price et al. 1979). None of the rats or guinea pigs exposed to 799 mg
 
antimony/m3 for 30 minutes died (Price et al. 1979). Lower concentrations of
 
antimony trisulfide or antimony trioxide did not affect the survival of rats
 
exposed for 1 year (Groth et al. 1986; Wong et al. 1979).
 
The highest NOAEL values and all reliable LOAEL values for death in each
 
species and duration are presented in Table 2-l and plotted in Figure 2-l.
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2.2.1.2 Systemic Effects
 
The highest NOAEL values and all reliable LOAEL values for each systemic
 
effect in each species and duration are presented in Table 2-l and plotted in
 
Figure 2-1.
 
Respiratory Effects. Occupational exposure to antimony trioxide and/or
 
pentoxide dust (8.87 mg antimony/m3 or greater) resulted in antimony
 
pneumoconiosis (inflammation of the lungs due to the irritation caused by the
 
inhalation of dust) (Cooper et al. 1968; Potkonjak and Pavlovich 1983; Renes
 
1953). Alterations in pulmonary function (airway obstruction, bronchospasm,
 
and hyperinflation) have been reported in workers exposed to airborne antimony
 
(Cooper et al. 1968; Potkonjak and Pavlovich 1983). Other respiratory effects
 
reported in workers include chronic bronchitis, chronic emphysema, inactive
 
tuberculosis, pleural adhesions, and irritation (Potkonjak and Pavlovich
 
1983). The respiratory irritation reported in the workers diagnosed as having
 
pneumoconiosis was characterized by chronic coughing, wheezing, and upper
 
airway inflammation. Respiratory irritation was not noted in workers exposed
 
to antimony trisulfide for 8 months to 2 years (Brieger et al. 1954). In the
 
reports of health effects associated with occupational exposure to antimony,
 
the workers inhaled a variety of compounds including antimony pentoxide,
 
arsenic oxide, iron oxide, hydrogen sulfide, and sodium hydroxide (Cooper
 
et al. 1968; Potkonjak and Pavlovich 1983; Renes 1953).
 
A variety of respiratory effects have been reported in animals exposed
 
to antimony. A majority of these effects are associated with the physiological
 
response to dust accumulation in the lung (pneumoconiosis). The effects
 
progress from pneumoconiosis and a proliferation of alveolar macrophages to
 
fibrosis.
 
Lung inflammation was noted in rabbits exposed to antimony trisulfide
 
for 5 days (Brieger et al. 1954).
 
Acute exposure to stibine gas also results in lung effects. Pulmonary
 
edema was observed in rats and guinea pigs exposed to a lethal concentration
 
of stibine for 30 minutes (Price et al. 1979).
 
A dose-related increase in the number of alveolar and/or intraalveolar
 
macrophages was observed in rats exposed to antimony trioxide for 13 weeks or
 
more (Bio/dynamics 1985, 1990). In rats exposed to 0.07 mg antimony/m3 for 1
 
year or to 0.92 mg antimony/m3 for 13 weeks, the proliferation of macrophages
 
was still present for 12 months or 28 weeks, respectively, after exposure
 
termination (Bio/dynamics 1985, 1990). Chronic interstitial inflammation was
 
also observed in rats exposed to 0.07 mg antimony/m3 for 1 year with a 1 year
 
recovery.
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The proliferation of macrophages is a normal physiological response to
 
the deposition of insoluble particulates in the lung. However, excessive
 
phagocytic activity prompted by extensive or repeated deposition of
 
particulates in the lung probably contributes to the development of fibrosis.
 
Because of the integral role the macrophages have in the progression to
 
fibrosis, nonreversible proliferation of macrophages is considered a less
 
serious adverse health effect.
 
More severe respiratory effects have also been reported in animals
 
exposed to antimony. Interstitial fibrosis and lipoid pneumonia have been
 
observed in rats exposed to antimony trisulfide or antimony trioxide for 1
 
year (Bio/dynamics 1990; Gross et al. 1952; Groth et al. 1986; Watt 1980,
 
1983; Wong et al. 1979). These effects have been reported at exposure levels
 
between 1.6 and 83.6 mg antimony/m3. No respiratory effects were reported in
 
pigs exposed to 4.2 mg antimony/m3 as antimony trioxide for 1 year (Watt
 
1983).
 
Cardiovascular Effects. Increased blood pressure (greater than 150/90)
 
and altered EKG readings were observed in workers exposed to 2.15 mg
 
antimony/m3 as antimony trisulfide for 8 months to 2 years (Brieger et al.
 
1954). Of the 75 workers examined, 37 showed changes in the EKG, mostly of the
 
T-waves; these workers had also been exposed to phenol formaldehyde resin
 
(Brieger et al. 1954). In another group of antimony workers, one out of seven
 
had altered EKG readings (Renes 1953). These limited data on cardiovascular
 
effects in humans are supported by the finding of cardiac effects following
 
parenteral administration of antimony to humans (see discussion of systemic
 
effects in Section 2.4).
 
Inhalation exposure to antimony trisulfide dust (the same dust the
 
factory workers were exposed to) resulted in degenerative changes in the
 
myocardium and related EKG abnormalities (elevation of the RS-T segments and
 
flattening of T-waves) in a variety of animal species (Brieger et al. 1954).
 
Five days of exposure to 19.94 mg antimony/m3 as antimony trisulfide resulted
 
in EKG alterations in rabbits. The effective exposure levels resulting in
 
cardiovascular effects were at least four times lower (2-4 mg antimony/m3) in
 
rats, rabbits, and dogs exposed to airborne antimony for 6-10 weeks, as
 
compared to rabbits acutely exposed (Brieger et al. 1954). Dogs exposed to
 
3.81 mg antimony/m3 as antimony trisulfide for 7 weeks (Brieger et al. 1954)
 
or pigs exposed to 4.2 mg antimony/m3 as antimony trioxide for 1 year (Watt
 
1983) did not exhibit changes in EKG readings. The degenerative changes of the
 
myocardium observed in rats, rabbits, and dogs exposed to antimony trisulfide
 
consisted of hyperemia and swelling of myocardial fibers (Brieger et al.
 
1954). Myocardial damage was not observed in rats exposed to 17.48 mg
 
antimony/m3 as antimony trioxide for 1 year (Groth et al. 1986; Watt 1980;
 
Wong et al. 1979).
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Gastrointestinal Effects. A variety of gastrointestinal disorders have
 
occurred in factory workers engaged in activities including repeated prolonged
 
exposure to airborne antimony trichloride (Taylor 1966), antimony trisulfide
 
(Brieger et al. 1954) or antimony oxide (Renes 1953). These disorders include
 
abdominal pain, diarrhea, vomiting, and ulcers. A causal relationship to
 
antimony exposure has not been definitely established because workers were
 
exposed to a variety of other agents in addition to antimony that might cause
 
or contribute to gastrointestinal effects (e.g., hydrogen chloride, sodium
 
hydroxide). Furthermore, in all likelihood, both inhalation and oral exposure
 
to antimony occur at the workplace. Assuming that gastrointestinal effects are
 
related to antimony-exposure, site monitoring data indicate that effective
 
exposure levels may range from approximately 2 to 70 mg antimony/m3.
 
Symptoms of gastrointestinal disturbances were not reported in animals,
 
and no histopathological alterations were observed in rats exposed to antimony
 
trioxide (4.2 mg antimony/m3) for 1 year (Watt 1980).
 
Hematological Effects. No studies were located regarding hematological
 
effects in humans after inhalation exposure to antimony.
 
Toxicologically significant hematological effects have not been observed
 
in rats and pigs following long-term exposure to antimony aerosols ranging
 
from 4 to 20 mg antimony/m3 as antimony trioxide (Bio/dynamics 1985, 1990;
 
Watt 1983). The only effects observed were small (but statistically
 
significant) changes in the hemoglobin concentration in the erythrocytes and
 
erythrocyte volume in rats exposed to 4.01 mg antimony/m3 as antimony trioxide
 
(Bio/dynamics 1990).
 
Musculoskeletal Effects. No studies were located regarding
 
musculoskeletal effects in humans after inhalation exposure to antimony. No
 
histopathological alterations were noted in the musculoskeletal system in rats
 
exposed to 4.2 mg antimony/m3 as antimony trioxide for 1 year (Watt 1980).
 
Hepatic Effects. No studies were located regarding hepatic effects in
 
humans after inhalation exposure to antimony.
 
Parenchymatous and fatty degeneration was observed in rabbits exposed to
 
19.94 mg antimony/m3 as antimony trisulfide for 5 days (Brieger et al. 1954)
 
and in guinea pigs exposed to 37.9 mg antimony/m3 as antimony trioxide for 30
 
weeks (Dernehl et al. 1945). The duration of exposure is unclear in the
 
Dernehl et al. (1945) study. No hepatic effects were observed in rats exposed
 
to antimony trioxide for 13 weeks (Bio/dynamics 1985) or after 1 year of
 
exposure to antimony trioxide or antimony trisulfide concentrations of 36 mg
 
antimony/m3 or lower (Bio/dynamics 1990; Groth et al. 1986; Watt 1980; Wong et
 
al. 1979).
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Renal Effects. No studies were located regarding renal effects in
 
humans after inhalation exposure to antimony.
 
Tubular dilation was observed in rats and guinea pigs exposed to stibine
 
gas for 30 minutes at a concentration of 799 mg antimony/m3 (Price et al.
 
1979). Parenchymatous degeneration was observed in rabbits exposed to 19.94 mg
 
antimony/m3 as antimony trisulfide for 5 days (Brieger et al. 1954). No renal
 
effects were noted in rats exposed to 19.6 mg antimony/m3 as antimony trioxide
 
for 13 weeks (Bio/dynamics 1985) or 17.5 mg antimony/m3 as antimony trisulfide
 
or up to 36 mg antimony/m3 as antimony trioxide for 1 year (Bio/dynamics 1990;
 
Groth et al. 1986; Wong et al. 1979).
 
Dermal/Ocular Effects. Dermal and ocular effects have been reported in
 
humans. and animals. These effects (ocular conjunctivitis and dermatosis)
 
result from airborne antimony coming into contact with the skin and/or eyes
 
(Potkonjak and Pavlovich 1983; Renes 1953; Stevenson 1965).
 
The dermatitis associated with exposure to airborne antimony is
 
characterized as epidermal cellular necrosis with associated acute
 
inflammatory cellular reactions (Stevenson 1965). The dermatitis is seen more
 
often during the summer months and in workers exposed to high temperatures
 
(Potkonjak and Pavlovich 1983; Stevenson 1965). Stevenson (1965) concluded
 
that the dermatitis resulted from the action of antimony trioxide on the
 
dermis after dissolving in sweat and penetrating the sweat glands.
 
Transferring the worker to a cooler environment often resulted in the rash
 
clearing up within 3-14 days. Antimony trioxide is not a skin sensitizer in
 
humans following topical application (see Section 2.2.3.3).
 
Eye irritation has been observed in rats and guinea pigs exposed to
 
stibine gas (Price et al. 1979) and antimony trioxide (Bio/dynamics 1985).
 
Cataracts and chromodacryorrhea have been observed in rats exposed to antimony
 
trioxide for 1 year with a 1 year recovery period (Bio/dynamics 1990). The
 
authors suggest that the chromodacryorrhea may have been secondary to dental
 
abnormality, infectious disease, or xerosis.
 
Because these dermal and ocular effects may not be the result of
 
inhalation exposure, but rather dermal contact with airborne antimony, the
 
LOAEL values were not recorded in Table 2-l or Figure 2-l. Alopecia was noted
 
in rats exposed to 0.92 mg antimony/m3 or greater as antimony trioxide for 13
 
weeks (Bio/dynamics 1985). Because high levels of antimony are measured in the
 
skin or hair of animals following nose-only exposure to antimony aerosols,
 
this effect may not be the result of dermal contact to airborne antimony
 
(Felicetti et al. 1974a, 1974b).
 
Other Systemic Effects. No studies were located regarding other
 
systemic effects in humans after inhalation exposure to antimony. Hyperplasia
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of the reticuloendothelial cells in the peribronchiolar lymph nodes was
 
observed in rats exposed to 0.07 mg antimony/m3 antimony trioxide for 1 year
 
with a 1 year recovery period (Bio/dynamic 1990).
 
2.2.1.3 Immunological Effects
 
No studies were located regarding immunological effects in humans or
 
animals after inhalation exposure to antimony.
 
2.2.1.4 Neurological Effects
 
A causal relationship between exposure to airborne antimony and
 
neurological effects in humans has not been established. Nerve tenderness and
 
a tingling sensation were reported in workers exposed to antimony oxide at a
 
concentration of 10.07 mg antimony/m3 (Renes 1953). However, the factory
 
workers were also exposed to arsenic, lead, copper, and possibly hydrogen
 
sulfide and sodium hydroxide. Thus, it is difficult to determine if this
 
effect was the result of antimony exposure.
 
No studies were located regarding neurological effects in animals after
 
inhalation exposure to antimony.
 
2.2.1.5 Developmental Effects
 
An increased incidence of spontaneous abortions, compared to a control
 
grow, were reported in women working at an antimony metallurgical plant. The
 
women were exposed to a mixture of antimony trioxide, antimony pentasulfide,
 
and metallic antimony (Belyaeva 1967). The level of airborne antimony and
 
presence of other compounds is not known. In addition, a description of the
 
control group was not given; thus, it is unclear if the controls had jobs
 
comparable to those of the exposed group.
 
A decreased number of offspring was born to rats exposed to 209 mg
 
antimony/m3 as antimony trioxide prior to conception and throughout gestation.
 
No difference in fetal body weights was observed (Belyaeva 1967). This LOAEL
 
for developmental effects in rats is presented in Table 2-l and Figure 2-1.
 
2.2.1.6 Reproductive Effects
 
Disturbances in the menstrual cycle were reported in women exposed to
 
airborne metallic antimony, antimony pentasulfide, and antimony trioxide in a
 
metallurgical plant. No other details were provided (Belyaeva 1967).
 
In rats exposed to 209 mg antimony/m3 as antimony trioxide for 63 days,
 
67% failed to conceive. Metaplasia in the uterus and disturbances in the ovum-

maturing process were obsewed in the animals that failed to conceive,. These
 
effects were not observed in the rats that conceived (Belyaeva 1967).
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This LOAEL value for reproductive effects in rats is presented in Table 2-l
 
and Figure 2-l.
 
2.2.1.7 Genotoxic Effects
 
No studies were located regarding genotoxic effects in humans or animals
 
after inhalation exposure to antimony.
 
Genotoxicity studies are discussed in Section 2.4.
 
2.2.1.8 Cancer
 
Inhalation exposure to 8.87 mg antimony/m3 as antimony oxide did not
 
affect the incidence of cancer in workers employed for 9-31 years (Potkonjak
 
and Pavlovich 1983).
 
Antimony can be carcinogenic in rats. Lung tumors were observed in rats
 
exposed to 4.2 or 36 mg antimony/m3 as antimony trioxide (Groth et al. 1986;
 
Watt 1980, 1983; Wong et al. 1979) or 17.48 mg antimony/m3 as antimony
 
trisulfide for 1 year (Groth et al. 1986; Wong et al. 1979). An increased
 
incidence of lung tumors was not observed in rats exposed to 4.01 mg
 
antimony/m3 as antimony trioxide (Bio/dynamics 1990) or in pigs exposed to 4.2
 
mg antimony/m3 as antimony trioxide (Watt 1983). The carcinogenic potential of
 
antimony may be related to the deposition and clearance of antimony from the
 
respiratory tract. Further discussion is presented in Section 2.4. The cancer
 
effect levels are recorded in Table 2-1 and
 
Figure 2-l.
 
2.2.2 Oral Exposure
 
Health effects have been observed in humans and animals following oral
 
exposure to a variety of antimony compounds. Adverse effects following
 
exposure to potassium antimony tartrate (an organic form of antimony),
 
antimony trichloride, antimony trioxide, and metallic antimony are discussed
 
below.
 
2.2.2.1 Death
 
No studies were located regarding death in humans after oral exposure to
 
antimony.
 
Mortality was not observed in rats following a single exposure to
 
188-16,714 mg antimony/kg or lower as inorganic antimony (Fleming 1982; Myers
 
et al. 1978; Smyth and Carpenter 1948; Smyth and Thompson 1945) or to a 7,000
 
mg antimony/kg dose of metallic antimony (Bradley and Frederick 1941).
 
However, a lower single dose of organic antimony (300 mg antimony/kg dose as
 
potassium antimony tartrate) resulted in death in rats (Bradley and Frederick
 
1941). Death was attributed to myocardial failure. These NOAELS and LOAELs
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for death in animals suggest that organic antimony is more lethal than the
 
inorganic compounds, probably due to increased absorption of the potassium
 
antimony tartrate.
 
Chronic administration of a low dose of potassium antimony tartrate
 
(0.262 mg antimony/kg/day) resulted in decreased lifespan in rats (Schroeder
 
et al. 1970). No effect on longevity was observed in mice exposed to 0.35 mg
 
antimony/kg/day as potassium antimony tartrate (Kanisawa and Schroeder 1969;
 
Schroeder et al. 1968).
 
The highest NOAEL values for each antimony compound and all reliable
 
LGAEL values are presented in Table 2-2 and plotted in Figure 2-2.
 
2.2.2.2 Systemic Effects
 
Cardiovascular, gastrointestinal, hematological, hepatic, and other
 
systemic effects observed following oral exposure to antimony are presented
 
below. No studies were located regarding respiratory, musculoskeletal, renal,
 
or dermal/ocular effects in human and animals after oral exposure to antimony.
 
The highest NOAEL values and all reliable LOAELs for each systemic effect in
 
each species and duration are presented in Table 2-2 and plotted in Figure 2­
2.
 
Cardiovascular Effects. No studies were located regarding
 
cardiovascular effects in humans after oral exposure to antimony.
 
No effect on blood pressure or heart rate was observed in rats exposed
 
to antimony as antimony trichloride (Marmo et al. 1987) or antimony trioxide
 
(Gross et al. 1955). Pre- and postnatal exposure or only postnatal exposure
 
alone to 0.0748 mg antimony/kg/day as antimony trichloride appears to affect
 
the development of certain cardiovascular reflexes in rats that are important
 
for regulating systemic arterial blood pressure. In rats exposed to antimony
 
trichloride pre- and postnatally or postnatally, a decreased pressor response
 
to 1-noradrenaline and a decreased hypotensive response to 1-isoprenaline and
 
acetylcholine was observed (Marmo et al. 1987). The occurrence of the effect
 
is duration related.
 
Gastrointestinal Effects. Shortly after drinking an average of
 
10 ounces of lemonade contaminated with potassium antimony tartrate
 
(equivalent to 0.53 mg antimony/kg for a 70 kg man), workers began to vomit
 
(Dunn 1928). Gastrointestinal effects have also been reported in factory
 
workers after exposure to airborne antimony dust. As discussed in Section
 
2.2.1.2, the gastrointestinal effects probably resulted from
 
swallowing the antimony dust.
 
Vomiting and diarrhea have also been observed in animals following acute
 
exposure to antimony trioxide or potassium antimony tartrate (Houpt et al.
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1984; Myers et al. 1978). Severe diarrhea was observed in dogs administered 84
 
mg antimony/kg/day as antimony trioxide for 32 days. No gastrointestinal
 
effects or gross abnormalities were noted in rats exposed to 501 mg
 
antimony/kg/day or less as antimony trioxide for 20 days (Fleming 1982).
 
Hematological Effects. No studies were located regarding hematological
 
effects in humans after oral exposure to antimony.
 
Mild hematological alterations are observed in animals exposed to
 
418 mg antimony/kg/day or greater. Increased red blood cell count was
 
observed in rats exposed to 894 mg antimony/kg/day as antimony trioxide for 30
 
days (Smyth and Thompson 1945). Exposure to metallic antimony resulted in
 
decreased hematocrit and hemoglobin levels and decreased plasma protein levels
 
in rats exposed to 500-1,000 mg antimony/kg/day for 12-24 weeks (Hiraoka 1986;
 
Sunagawa 1981). Decreased red blood cell count was observed in rats exposed to
 
418 mg antimony/kg/day as antimony trioxide for 24 weeks (Sunagawa 1981).
 
Hepatic Effects. No studies were located regarding hepatic effects in
 
humans after oral exposure to antimony.
 
Cloudy swelling of the hepatic cords has been observed in rats exposed
 
to 418 mg antimony/kg/day as antimony trioxide or 500 mg antimony/kg/day as
 
metallic antimony (Sunagawa 1981). Hepatic effects have not been observed at
 
lower concentrations of antimony trioxide or potassium antimony tartrate
 
(Fleming 1982; Schroeder et al. 1968).
 
Other Systemic Effects. No studies were located regarding other
 
systemic effects in humans after oral exposure to antimony.
 
Severe weight loss was observed in dogs administered
 
6,644 mg antimony/kg/day as antimony trioxide. Severe diarrhea and vomiting
 
were also observed in these dogs (Fleming 1982).
 
Increased serum cholesterol and decreased nonfasting serum glucose
 
levels were observed in rats exposed for a lifetime to low levels of potassium
 
antimony tartrate in drinking water (Schroeder et al. 1970). The toxicologic
 
significance of these effects is not known.
 
2.2.2.3 Immunological Effects
 
No studies were located regarding immunological effects in humans or
 
animals after oral exposure to antimony.
 
2.2.2.4 Neurological Effects
 
No studies were located regarding neurological effects in humans after
 
oral exposure to antimony.
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Muscle weakness and difficulty in moving hind limbs were observed in a
 
dog exposed to 6,644 mg antimony/kg/day as antimony trioxide for 32 days
 
(Fleming 1982). This LOAEL value for neurological effects in dogs is recorded
 
in Table 2-2 and Figure 2-2.
 
2.2.2.5 Developmental Effects
 
No studies were located regarding developmental effects in humans after
 
oral exposure to antimony.
 
No developmental effects (differences in the number of newborn pups per
 
litter and macroscopic teratogenic effects) were observed in the offspring of
 
rats treated during gestation with 0.748 mg antimony/kg/day as antimony
 
trichloride (Rossi et al. 1987). As discussed in the cardiovascular effects
 
section, pre- and postnatal or postnatal exposure impaired the development of
 
certain cardiovascular reflexes that are important in regulating systemic
 
arterial blood pressure (Angrisani et al. 1988; Marmo et al. 1987; Rossi et
 
al. 1987). Because comparisons were not made between the hypotensive response
 
in pups exposed prenatally and the response in pups exposed postnatally, the
 
potential of antimony trichloride to produce developmental
 
cardiovascular effects cannot be assessed.
 
2.2.2.6 Reproductive Effects
 
No studies were located regarding reproductive effects in humans or
 
animals after oral exposure to antimony.
 
2.2.2.7 Genotoxic Effects
 
No studies were located regarding genotoxic effects in humans or animals
 
after oral exposure to antimony.
 
Genotoxicity studies are discussed in Section 2.4.
 
2.2.2.8 Cancer
 
No studies were located regarding cancer effects in humans after oral
 
exposure to antimony.
 
No change in the incidence of cancer was observed in rats (Schroeder
 
1970) or mice (Kanisawa and Schroeder 1969; Schroeder 1968) fed 0.262 or 0.35
 
mg antimony/kg/day, respectively, as potassium antimony tartrate for a
 
lifetime. The use of these studies to assess carcinogenicity is limited
 
because only one exposure level was used, which was below the maximum
 
tolerated dose.
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2.2.3 Dermal Exposure
 
The dermal toxicity of antimony compounds is discussed below. Data were
 
located on the health effects following application of antimony trioxide,
 
antimony thioantimonate (a mixture of antimony trfsulfide, and antimony
 
pentasulfide) and antimony oxide to the skin or eye.
 
2.2.3.1 Death
 
No studies were located regarding death in humans after dermal exposure
 
to antimony.
 
Death was observed in rabbits following a single application of antimony
 
oxides at a level of 6,685 mg antimony/kg (Myers et al. 1978). The cause of
 
death was not reported. Two out of four rabbits died after 6-8 topical
 
applications of antimony trioxide paste. The antimony trioxide was combined
 
with a mixture formulated to resemble acidic sweat. The application area was
 
not occluded; thus, there is a possibility of oral ingestion of the paste
 
(Fleming 1982). Death was not reported in rabbits after 13 weeks of
 
application of a 5% solution of antimony thioantimonate (a mixture of antimony
 
trisulfide and antimony pentasulfide) (Horton et al. 1986). The highest NOAEL
 
and all reliable LOAEL values for death for rabbits for each duration are
 
recorded in Table 2-3.
 
2.2.3.2 Systemic Effects
 
Respiratory, cardiovascular, gastrointestinal, and dermal/ocular effects
 
following dermal or ocular exposure are presented below. No studies were
 
located regarding respiratory, gastrointestinal, hematological,
 
musculoskeletal, hepatic, or renal effects in humans and animals following
 
dermal exposure to antimony. The highest NOAEL for each antimony compound and
 
all reliable LOAEL values for each systemic effect for each species are
 
recorded in Table 2-3.
 
Respiratory Effects. No studies were located regarding respiratory
 
effects in humans following dermal exposure to antimony. Hyperemia in the
 
lungs was observed in two rabbits that died after 6-8 applications of an
 
antimony trioxide paste to shaven and abraded skin. The antimony trioxide
 
(concentration not reported) was combined with a mixture resembling acidic
 
sweat (Fleming, 1982). The application area was not occluded; thus, the
 
ingestion of the paste may have occurred.
 
Cardiovascular Effects. No studies were located regarding
 
cardiovascular effects in humans following dermal exposure to antimony.
 
Application of a 5% solution of antimony thioantimonate did not change EKG
 
readings or heart pathology in rabbits (Horton et al. 1986).
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Gastrointestinal Effects. No studies were located regarding
 
gastrointestinal effects in humans following dermal exposure to antimony.
 
Hemorrhages in the cardiac portion of the stomach were observed in two rabbits
 
that died after 6-8 applications of an antimony trioxide-acidic sweat paste
 
(Fleming 1982). Because the application area was not occluded, ingestion of
 
the paste is possible.
 
Dermal/Ocular Effects. No studies were located regarding dermal/ocular
 
effects in humans following dermal exposure to antimony.
 
In rabbits, edema was noted in the area where an antimony trioxide patch
 
(6,685 mg antimony/kg) was applied for 1 day (Myers et al. 1978).
 
Instillation of 79-100 mg antimony.as antimony oxide or antimony
 
thioantimonate into the eyes of rabbits resulted in eye irritation (Horton et
 
al. 1986; Wil Research Laboratories). However, instillation of antimony
 
trioxide (34.5-83.6 mg antimony) did not result in eye irritation (Gross et
 
al. 1955; Myers et al. 1978).
 
Dermal and ocular effects have been observed in humans and animals
 
exposed to airborne antimony. The effects include ocular onjunctivitis, eye
 
irritation, and dermatosis. Further information on these effects is provided
 
in Section 2.2.1.2.
 
2.2.3.3 Immunological Effects
 
No studies were located regarding immunological effects in humans and
 
animals following dermal exposure to antimony.
 
2.2.3.4 Neurological Effects
 
No studies were located regarding neurological effects in humans after
 
dermal exposure to antimony.
 
Abnormal gait was observed in rabbits following application of a lethal
 
concentration of antimony trioxide (6,685 mg antimony/kg/day) (Myers et al.
 
1978). This LOAEL value for neurotoxicity in rabbits is recorded in Table 2-3.
 
No studies were located regarding the following effects in humans or
 
animals after dermal exposure to antimony:
 
2.2.3.5 Developmental Effects
 
2.2.3.6 Reproductive Effects
 
2.2.3.7 Genotoxic Effects
 
Genotoxicity studies are discussed in Section 2.4.
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2.2.3.8 Cancer
 
No studies were located regarding cancer effects in humans or animals
 
after dermal exposure to antimony.
 
2.3 TOXICOKINETICS
 
2.3.1 Absorption
 
2.3.1.1 Inhalation Exposure
 
Quantitative data on the absorption of antimony from the lungs in humans
 
were not located. Elevated blood and urine antimony levels were observed in
 
workers exposed to antimony, suggesting that antimony is absorbed (Cooper et
 
al. 1968; Ludersdorf et al. 1987). However, there is a possibility that some
 
of the antimony detected in the urine and blood was swallowed.
 
The International Commission on Radiological Protection (ICRP 1981)
 
considers oxides, hydroxides, halides, sulfides, sulfates, and nitrates of
 
antimony to be class W chemicals. All other common compounds of antimony are
 
assigned to class D. Class W and D chemicals are considered to have
 
respiratory tract clearance rates of weeks and days, respectively. The ICRP
 
classifications are based on animal data (Felicetti et al. 1974a, 1974b;
 
Thomas et al. 1973). Data from deceased antimony smelter workers suggest that
 
the elimination half-time of some forms of antimony in the lungs may be longer
 
than weeks (Gerhardsson et al. 1982).
 
The absorption of antimony from the respiratory tract is a function of
 
particle size. Exposure to antimony tartrate with a particle size of 1.6 µm 
resulted in a greater deposition of antimony in the upper respiratory tract 
than exposure to 0.7 or 0.3 µm particles (Felicetti et al. 1974a; Thomas et 
al. 1973). Furthermore, the antimony deposited in the upper respiratory tract
 
was cleared after several hours via mucociliary clearance. Particles of the
 
two smaller sizes were relatively insoluble in the lung and were slowly
 
absorbed over several weeks (Thomas et al. 1973). No difference in the body
 
burden, 1 day after exposure to trivalent or pentavalent antimony tartrate,
 
was observed (Felicetti et al. 1974b). Although no information on differences
 
in absorption rates between antimony compounds was located, differences
 
related to solubility probably exist.
 
2.3.1.2 Oral Exposure
 
No quantitative data on the absorption of antimony from the
 
gastrointestinal tract in humans were located. However, results of studies in
 
animals suggest that at least certain forms of antimony are probably absorbed
 
from the gastrointestinal tract. Estimates of the absorption of antimony
 
tartrate and antimony trichloride in animals range from 2% to 7% (Felicetti et
 
al. 1974b; Gerber et al. 1982), suggesting that absorption of trivalent
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antimony salts in humans is probably less than 10%. Gastrointestinal
 
absorption of antimony is likely to be affected by numerous factors, including
 
chemical form of the ingested antimony, particle size and solubility, age, and
 
diet. Although quantitative information on the absorption of antimony is not
 
available for all forms, ICRP (1981) has recommended 10% for antimony tartrate
 
and 1% for all other forms of antimony as reference values for
 
gastrointestinal
 
absorption in humans.
 
2.3.1.3 Dermal Exposure
 
No studies were located regarding absorption of antimony in humans
 
following dermal exposure.
 
Exposure to high levels of antimony trioxide or a mixture of antimony
 
trioxide and pentoxide resulted in death in rabbits (Myers et al. 1978). The
 
application area was occluded, suggesting that at least some forms of antimony
 
can be absorbed through the skin.
 
2.3.2 Distribution
 
Very low levels of antimony are found in unexposed humans. Autopsy data
 
on Japanese adults (Sumino et al. 1975) and other data on selected body fluids
 
are presented in Table 2-4. The mean body burden of antimony is 0.7 mg (Sumino
 
et al. 1975). The skin and hair had the highest levels of antimony. A somewhat
 
higher estimate of 7.9 mg for total body burden is reported by ICRP (1981).
 
ICRP (1981) has recommended'reference values of 5.9 mg of antimony in soft
 
tissue and 2.0 mg in skeletal tissue.
 
2.3.2.1 Inhalation Exposure
 
Information on the distribution of antimony in humans following
 
inhalation exposure was not located. Blood is the main vehicle for the
 
transport of absorbed antimony to various tissue compartments of the body. The
 
relative partitioning between erythrocytes and plasma is a function of
 
valency. Following exposure to trivalent antimony, erythrocyte levels are
 
elevated, compared to the elevated plasma antimony levels after inhalation
 
exposure to pentavalent antimony (Felicetti et al. 1974b). The clearance of
 
antimony from the blood appears to differ among animal species. Elevated blood
 
antimony levels persist longer in rats than in mice and dogs (Felicetti
 
et al. 1974a; Thomas et al. 1973).
 
Valence-state differences also exist in the distribution of antimony to
 
the rest of the body. In hamsters, the levels of trivalent antimony increase
 
more rapidly in the liver than pentavalent antimony. Skeletal uptake is
 
greater following exposure to pentavalent antimony than trivalent antimony
 
(Felicetti et al. 1974b). Outside of the respiratory tract, antimony
 
accumulates in the liver, thyroid, skeleton, and fur; with the largest burden
 
of antimony in the fur (Felicetti et al. 1974a, 1974b).
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2.3.2.2 Oral Exposure
 
Data on the distribution of antimony in humans following oral exposure
 
to antimony were not located.
 
Following oral exposure in animals, the major sites of accumulation,
 
outside of the gastrointestinal tract, are the liver, kidney, bone, lung,
 
spleen, and thyroid. However, the rise in antimony levels in these tissues is
 
not dose-related (Sunagawa 1981). This lack of dose-responsiveness may be a
 
reflection of decreased absorption at higher antimony concentrations. Antimony
 
levels tend to reach a plateau in the livers and lungs of voles fed a diet
 
containing antimony trioxide (Ainsworth 1988).
 
Some species differences in animals exist in the elimination of antimony
 
from the tissues. In rats, antimony is cleared slowly from the thyroid, with
 
an elimination half-time of approximately 40 days (Gross et al. 1955);
 
however, more than 50% of liver, lung, and kidney antimony is removed after 15
 
days following exposure in voles (Ainsworth 1988).
 
Evidence is insufficient to determine if there are valency differences
 
in the distribution of orally administered antimony. Based on the inhalation
 
data and the fact that higher liver concentrations were found in rats fed
 
metallic antimony than those fed antimony trioxide (Sunagawa 1981), it is
 
assumed that there are differences.
 
Pregnancy results in a higher antimony body burden in mice. However,
 
transplacental transport of antimony appears limited. Exposure to antimony
 
during lactation results in high antimony levels in newborns (Gerber et al.
 
1982).
 
2.3.2.3 Dermal Exposure
 
No information on the distribution of antimony in humans or animals
 
following dermal exposure to antimony was located. However, judging from
 
studies of the distribution of antimony following inhalation, oral, and
 
parenteral exposure in animals, the major sites of accumulation are likely to
 
include the liver, kidney, skeleton, spleen, and fur.
 
2.3.2.4 Other Routes of Exposure
 
No information on the distribution of antimony in humans following
 
parenteral exposure was located. In animals, antimony is recovered primarily
 
in the liver, with smaller amounts in the spleen, heart, lungs, and muscle
 
(Gellhorn et al. 1946; Gerber et al. 1982).
 
Two hours after intraperitoneal injection of trivalent antimony, 95% of
 
the antimony in the blood is incorporated into the erythrocytes, mainly in the
 
hemoglobin fraction (Edel et al. 1983; Lippincott et al. 1947). Pentavalent
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antimony is primarily distributed into the plasma fraction of blood (Edel et
 
al. 1983).
 
Following intraperitoneal administration of trivalent antimony, a larger
 
percentage of the administered dose is recovered in the liver than in the
 
spleen. However, a smaller difference in antimony levels between the liver and
 
spleen was observed when pentavalent antimony was administered (Gellhorn and
 
van Dyke 1946).
 
2.3.3 Metabolism
 
Antimony is a metal and, therefore, does not undergo catabolism.
 
Antimony can covalently interact with sulfhydryl groups and phosphate, as well
 
as numerous reversible binding interactions with endogenous ligands (e.g.,
 
proteins). It is not known if these interactions are toxicologically
 
significant. No information was located on the in vivo interconversion of
 
trivalent and pentavalent antimony.
 
2.3.4 Excretion
 
2.3.4.1 Inhalation Exposure
 
Increased levels of urinary antimony have been noted in workers exposed
 
to antimony trioxide (Cooper et al. 1968; Ludersdorf et al. 1987). In animals,
 
antimony is excreted via the urine and feces. Some of the fecal antimony may
 
represent unabsorbed antimony that is cleared from the lung via mucociliary
 
action into the esophagus to the gastrointestinal tract. Based on studies in
 
which antimony was parenterally administered to animals, the urine/feces ratio
 
of antimony depends on valence state. Antimony is excreted predominantly in
 
the urine following pentavalent antimony injection and in the feces after
 
trivalent antimony administration (Edel et al. 1983; Felicetti et al. 1974b).
 
In animals, whole-body clearance of trivalent antimony tartrate occurs
 
in two phases. Ninety percent of the initial body burden of antimony tartrate
 
was excreted within the first 24 hours. The half-life of the slow phase was 16
 
days (Felicetti et al. 1974b).
 
2.3.4.2 Oral Exposure
 
Information on the excretion of antimony in humans following oral
 
exposure was not located. However, information obtained from human and animal
 
studies in which antimony was administered parenterally provides some insight
 
regarding the routes and rates of excretion that can be anticipated after oral
 
exposure in humans. Animal studies have shown that ingested antimony is only
 
partially absorbed from the gastrointestinal tract (Felicetti et al. 1974b;
 
Gerber et al. 1982). Assuming that this is also true for humans, fecal
 
excretion is probably an important route of excretion of ingested antimony in
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humans. Antimony absorbed from the gastrointestinal tract appears to be
 
excreted in the urine and feces to a variable degree, depending on the
 
chemical form. Pentavalent antimony injected parenterally into humans or
 
animals is excreted predominantly in the urine, whereas injected trivalent
 
antimony is excreted in the feces (Edel et al. 1983; Goodwin and Page 1943;
 
Rees et al. 1980).
 
2.3.4.3 Dermal Exposure
 
No information on the excretion of antimony following dermal exposure in
 
humans or animals was located. However, information obtained from human and
 
animal studies in which antimony was administered parenterally provides some
 
insight regarding the routes and rates of excretion that can be anticipated
 
after dermal exposure in humans. Antimony that is absorbed through the skin
 
will be excreted in urine and feces to a variable degree, depending on the
 
chemical species. Pentavalent antimony injected parenterally into humans or
 
animals is excreted predominantly in urine, whereas injected trivalent
 
antimony is excreted in feces (Edel et al. 1983; Goodwin and Page 1943; Rees
 
et al. 1980).
 
2.3.4.4 Other Routes of Exposure
 
Pentavalent antimony is rapidly excreted in humans following intravenous
 
or intramuscular administration, with greater than 50% excreted in the urine 6
 
hours after injection (Goodwin and Page 1943; Rees et al. 1980). Trivalent
 
antimony is predominantly excreted in the feces and not as rapidly excreted in
 
the urine as pentavalent antimony. Twenty-four hours after injection,
 
approximately 25% was excreted in the urine (Goodwin and Page 1943).
 
Twenty-four hours following intraperitoneal administration of trivalent
 
antimony in rats, 33% of the compound was excreted via the feces and 6% in the
 
urine. In contrast, 88% of the pentavalent antimony was excreted in the urine
 
and 1% in the feces (Edel et al. 1983j.
 
Following repeated intramuscular administration of trivalent antimony in
 
humans, approximately 15% was excreted per day at the beginning of treatment
 
and 25% at the end of treatment. Fecal antimony excretion ranged from 4% in
 
the beginning of treatment to 15.4% of the daily administered dose toward the
 
end of treatment (Lippincott et al. 1947).
 
The elimination of pentavalent antimony following intramuscular
 
injection fits into a two-compartment pharmacokinetic model. The half-life of
 
the rapid phase of elimination was 2 hours; the slower phase was 76 hours
 
(Chulay et al. 1988).
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2.4 RELEVANCE TO PUBLIC HEALTH
 
Adverse health effects have been observed in humans and animals
 
following exposure to antimony and antimony compounds. Metallic antimony,
 
organic forms, and inorganic forms of antimony were included in this profile.
 
The organic forms of antimony discussed are potassium antimony tartrate,
 
sodium antimony tartrate, and antimony acetate. Also included are the
 
antimony-containing drugs stibocaptate (sodium antimony-2,3-meso-di-mercapto
 
succinate) also referred to as astiban, and stibophen (bis[4,5-dihydroxy- 1,3­
benzenedisulfonato(4)-O4, O5]-antimonate (5-) pentasodium heptahydrate) also
 
called fuadin. Trivalent inorganic antimony compounds (antimony trioxide,
 
antimony trichloride, antimony trisulfide), pentavalent inorganic compounds
 
(antimony pentoxide, antimony pentachloride, and antimony pentasulfide), and
 
stibine are also discussed. The toxicity data for antimony and compounds have
 
been summarized across compounds; if differences in the
 
toxicity between the various antimony compounds are known, this information
 
will be presented in a compound specific discussion.
 
The toxicological effects of antimony in humans following inhalation or
 
oral exposure are pneumoconiosis, altered EKG readings, increased blood
 
pressure, abdominal distress, ulcers, dermatosis, and ocular irritation. No
 
effects were found in humans after dermal exposure to antimony. There are
 
several beneficial uses of antimony. Antimony and its compounds are among the
 
oldest known remedies in the practice of medicine. Currently, antimony
 
compounds are used to treat two parasitic diseases, schistosomiasis and
 
leishmaniasis. Toxic side effects in humans following intraperitoneal,
 
intravenous, or intramuscular injection of an antimony-containing drug have
 
been reported. These effects include altered EKG, anemia, vomiting, diarrhea,
 
joint and/or muscle pain, and death.
 
Similar toxicological effects have been reported in animals following
 
inhalation, oral, or dermal exposure to antimony. These effects include
 
fibrosis in the lung, altered EKG readings, myocardial damage, vomiting and
 
diarrhea in dogs, parenchymatous degeneration in the liver and kidney, muscle
 
weakness, difficulty in moving, developmental effects, and lung cancer. In
 
addition, degeneration of the myoneural junction has been observed in animals
 
following parenteral administration of antimony.
 
Inhalation and oral MRLs for antimony and compounds were not derived.
 
Damage to the lungs and myocardium has been observed in several species of
 
animals following acute, intermediate, and chronic inhalation exposure
 
(Brieger et al. 1954; Bio/dynamics 1985, 1990; Gross et al. 1952; Groth et al.
 
1986; Watt 1983). These effects have also been observed in humans chronically
 
exposed to airborne antimony (Brieger et al. 1954; Potkonjak and Pavlovich
 
1983). At the lowest exposure levels tested, the adversity of the effects was
 
considered to be serious. Thus, the data were inadequate for the derivation of
 
an acute-, intermediate-, and chronic-duration inhalation MKL values.
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The lowest LGAEL for acute oral exposure is from-a human report (Dunn
 
1928). Gastrointestinal disturbances were reported in workers who drank
 
lemonade contaminated with potassium antimony tartrate. If the dose was
 
administered throughout the day rather than consumed as a bolus
 
administration, it is likely that the gastrointestinal disturbances would not
 
be observed. Thus, this study would not be an appropriate basis for an
 
acuteduration oral MRL. The intermediate-duration inhalation data suggest that
 
the myocardium is a target of antimony toxicity. The intermediate oral studies
 
did not examine sensitive end points (e.g., EKG) of myocardial damage. This
 
deficiency precludes derivation of an intermediate duration oral MRL. Two
 
chronic oral studies were identified (Schroeder et al. 1968, 1970). At the
 
lowest dose tested, decreased lifespan was observed in rats; this is not an
 
appropriate basis for a chronic-duration oral MRL.
 
Acute-, intermediate-, and chronic-duration dermal MRLs were not derived
 
for antimony due to the lack of an appropriate methodology for the development
 
of dermal MRLs.
 
Death. Death has not been reported in humans following inhalation,
 
oral, or dermal exposure to antimony. However, acute exposure to
 
approximately 2 mg antimony/kg/day as stibocaptate (a drug used to treat
 
parasitic disease) administered intramuscularly resulted in the death of an
 
adult and a child (Rugemalila 1980). Therefore, antimony may be lethal at
 
sufficiently high exposure levels. Animal studies have provided some
 
information about the relative lethality of various forms of antimony. Based
 
on data from studies on parenterally administered antimony, relative lethality
 
can be ranked as follows: antimony tartrate > metallic antimony > inorganic
 
trivalent antimony (Bradley and Frederick 1941).
 
Systemic Effects
 
Respiratory Effects. The respiratory tract is a target in humans
 
following inhalation exposure to antimony. Pneumoconiosis, impaired pulmonary
 
function (airway obstruction, bronchospasm, and hyperinflation) and
 
respiratory irritation (coughing and wheezing) have been observed in factory
 
workers exposed to antimony dust (Cooper et al. 1968; Potkonjak and Pavlovich
 
1983). A relationship between exposure level and effect cannot be established
 
from this data because the workers were also exposed to other compounds,
 
including arsenic oxide, iron oxide, hydrogen chloride, and hydrogen sulfide.
 
Information on the health effects in animals following inhalation
 
exposure to antimony supports the finding in humans that the respiratory tract
 
is a target. Most of the respiratory effects observed in animals are
 
associated with the physiological response to dust accumulation in the
 
respiratory tract. Because of the large amount of antimony that is deposited
 
in the lung during chronic inhalation, the proliferation of macrophages
 
observed in rats exposed to 0.07 mg antimony/m3 or greater continues several
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months after the exposure termination (Bio/dynamics 1990). This increase in
 
the number of alveolar macrophages may contribute to the development of
 
fibrosis. Fibrosis and lipoid pneumonia have been reported in rats chronically
 
exposed to 1.6 mg antimony/m3 or higher as antimony trioxide or to 17.48 mg
 
antimony/m3 as antimony trisulfide (Bio/dynamics 1990; Gross et al. 1952;
 
Groth et al. 1986; Watt et al. 1980,1983; Wong et al. 1979). Respiratory
 
effects have not been reported in humans or animals following oral or dermal
 
exposure to antimony.
 
Although serious antimony-related lung disease has not been observed in
 
humans, antimony-induced pneumoconiosis is associated with serious lung
 
pathology in animals. Therefore, it is likely that, with sufficiently high or
 
prolonged exposures, serious lung disease would occur in humans. In addition,
 
the toxicity of inhaled antimony compounds may be greater for smaller particle
 
sizes.
 
Cardiovascular Effects. The heart is another target organ in humans.
 
Alterations in EKG readings and increased blood pressure have been reported in
 
workers exposed to airborne antimony trisulfide (Brieger et al. 1954). In
 
addition, altered EKG readings have been reported in individuals exposed to
 
repeated injections of antimony (Dancaster et al. 1966; Honey 1960; Pandey et
 
al. 1988). The antimony injections were part of a therapeutic treatment for
 
parasitic disease. In some of these individuals, the EKG did not return to
 
normal until 6 weeks after the last dose (Dancaster et al. 1966). Pentavalent
 
antimony appears to be less cardiotoxic than the trivalent form. Altered EKG
 
readings were observed after 4 days of trivalent antimony treatment (0.98 mg
 
antimony/kg/day) (Dancaster et al. 1966); however, a change in EKG readings
 
was not observed until after 3 weeks of pentavalent antimony injections (7.2
 
mg antimony/kg/day) (Pandey et al. 1988).
 
Altered EKG readings have also been observed in animals. In addition,
 
decreased blood pressure, increased heart rate, and decreased contractile
 
force have been observed following injection of trivalent antimony
 
(Bromberger-Barnea and Stephens 1965; Cotten and Logan 1966). The decreased
 
blood pressure contrasts with the increased blood pressure observed in humans
 
(Brieger et al. 1954). Studies on isolated dog hearts suggest that antimony
 
exerts its effect on the myocardium directly, and that the effect persists
 
after exposure is terminated (Bromberger-Barnea and Stephens 1965).
 
Gastrointestinal Effects. Historically, antimony has been known for its
 
emetic properties. Vomiting, diarrhea, gastric discomfort, and ulcers have
 
been reported in humans following inhalation or oral exposure to antimony.
 
Amounts as low as 0.529 mg antimony/kg have resulted in vomiting. The
 
gastrointestinal effects following inhalation exposure may have resulted from
 
antimony being swallowed. Gastrointestinal effects have also been observed in
 
humans receiving intramuscular injections of antimony (Harris 1956; Zaki et
 
al. 1964). Similar gastrointestinal effects have been reported in animals
 
following oral exposure to antimony.
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Hematological Effects. Hematological effects in humans following
 
inhalation, oral, or dermal exposure to antimony have not been reported.
 
However, hematological parameters were not measured in the human studies.
 
Hemolytic anemia was reported in one subject following repeated injections of
 
fuadin (stibophen) (Harris 1956). Fuadin is an antimony-containing compound
 
used in the treatment of schistosomiasis. Alterations in hematological
 
parameters have not been reported in animals exposed to antimony via
 
inhalation or dermal routes. Decreased hemoglobin and hematocrit and altered
 
erythrocyte count were observed in animals following oral exposure to metallic
 
antimony or antimony trioxide (Smyth and Thompson 1945; Sunagawa 1981). The
 
potential of antimony to cause hematological effects in humans is not known.
 
Musculoskeletal Effects. Musculoskeletal effects have not been reported
 
in humans or animals following inhalation, oral, or dermal exposure to
 
antimony. However, muscle and/or joint pain was reported in 30-50% of subjects
 
injected with fuadin or astiban, which were administered as part of the
 
therapeutic treatment of schistosomiasis. The joint pain was more severe in
 
subjects receiving fuadin, although' the dose was four times less than the
 
astiban dose (Zaki et al. 1964). This suggests differences in the toxicity of
 
the different antimony compounds, which might explain why musculoskeletal
 
effects have not been observed in humans by the other routes of exposure.
 
Myoneural junction swelling was observed in mice following injection with
 
potassium antimony tartrate (Mansour and Reese 1965). A more complete
 
description of the myopathy observed in these mice is given in the
 
neurological section. Because of the limited human and animal data, it is
 
difficult to determine the significance of this effect to human health.
 
Hepatic Effects. Hepatic effects have not been observed in humans
 
exposed to antimony. Parenchymatous degeneration in the liver was observed in
 
rats and guinea pigs exposed to airborne antimony trioxide for 30 weeks or to
 
antimony trisulfide for 5 days (Brieger et al. 1954; Dernehl et al. 1945).
 
However, liver effects have not been observed in more recent intermediate­
chronic-duration inhalation studies (Bio/dynamics 1985, 1990; Groth et al.
 
1986; Watt 1983; Wong et al. 1979). Swelling of the hepatic cords has been
 
observed in rats orally exposed to metallic antimony or antimony trioxide
 
(Hiraoka 1986). Since hepatic effects have not been observed in humans and
 
animal data are inconsistent, it is not known if liver damage will occur in
 
humans exposed to antimony.
 
Renal Effects. Renal effects have not been reported in humans following
 
inhalation, oral, or dermal exposure to antimony. Tubular dilation and
 
degeneration of the tubular epithelium have been observed in rats, rabbits,
 
and guinea pigs acutely exposed to airborne antimony trisulfide or stibine gas
 
(Brieger et al. 1954; Price et al. 1979). Kidney effects have not been
 
reported in animals exposed to airborne antimony for an intermediate or
 
chronic duration (Bio/dynamics 1985, 1990; Groth et al. 1986; Watt 1983; Wong
 
et al. 1979). The kidneys were not examined in the oral and dermal exposure
 
studies. The relevance of this effect to human health is not known.
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Dermal/Ocular Effects. Dermatosis and ocular irritation have been
 
reported in humans following exposure to airborne antimony and antimony via
 
injection (Potkonjak and Vishnijich 1983; R&es 1953; Stevenson 1965; Zaki et
 
al. 1964). The dermatitis associated with exposure to airborne antimony was
 
seen more often during the summer months and in workers exposed to high
 
temperatures. It is probably the result of antimony being dissolved in sweat
 
and penetrating the sweat glands (Stevenson 1965). Dermal and ocular exposure
 
to antimony has resulted in minimal skin and eye irritation in animals and the
 
formation of cataracts (Bio/dynamics 1985, 1990).
 
Other Systemic Effects. Hyperplasia of the reticuloendothelial cells in
 
the peribronchiolar lymph nodes was observed in rats chronically exposed to
 
airborne antimony (Bio/dynamics 1990). This effect is probably the result of
 
the clearance of antimony particles from the lungs, and thus it is an effect
 
that is likely to occur in humans.
 
Immunological Effects. Immunological effects have not been studied in
 
humans or animals following inhalation, oral, dermal, or parenteral exposure
 
to antimony.
 
Neurological Effects. Neurological effects have not been observed in
 
humans following inhalation, oral, dermal, or parenteral exposure to antimony.
 
Muscle weakness, difficulty in moving, and abnormal gait have been observed in
 
animals follotring oral and dermal exposure to antimony trioxide (Fleming
 
1982; Myers et al. 1978). Decreased motor efficiency and dystonic torsion of
 
the limbs were observed in mice receiving intraperitoneal injections of
 
potassium antimony tartrate (Mansour and Reese 1965). Degenerative changes in
 
the anterior horn cells of the lumbar cord, edema with hydropic degeneration
 
in the sciatic nerve, and swelling of the myoneural junction were also
 
observed in this mouse study. Because neurological effects have been observed
 
in three species of animals (dogs, rats, and mice), these effects may also
 
occur in humans exposed to high levels of antimony.
 
Developmental Effects. An increase in the number of spontaneous
 
abortions was observed in women exposed to airborne antimony in the workplace.
 
The exposure level was not reported in this study. No overt developmental
 
effects were observed in the children of these women (Belyaeva 1967). No gross
 
abnormalities were observed in the offspring of rats exposed to low levels of
 
antimony trichloride in the drinking water (Rossi et al. 1987). The likelihood
 
of antimony-induced developmental effects occurring in humans is not known.
 
Reproductive Effects. Human exposure to antimony dust in the workplace
 
has resulted in disturbances in menstruation (Belyaeva 1967). In animals, the
 
failure to conceive and metaplasia in the uterus have been observed following
 
inhalation exposure to antimony trioxide (Belyaeva 1967). No information on
 
the potential of antimony to cause reproductive effects in animals following
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oral or dermal exposure was located. These data suggest a potential for
 
antimony to cause reproductive effects in humans.
 
Genotoxic Effects. No in vivo genotoxicity studies were located. The
 
results of in vitro genotoxicity studies are presented in Table 2-5. Positive
 
results for chromosome breakage in human leukocytes were found (Paton and
 
Allison 1972). Positive results were also found for DNA damage, viral
 
transformation, and chromosomal aberrations. Gene mutation and transformation
 
tests were negative. Because of the limited in vitro genotoxicity data and the
 
lack of in vivo tests, the genotoxicity of antimony in humans cannot be
 
determined.
 
Cancer. No information on the carcinogenic potential of antimony in
 
humans was located. Inhalation exposure to antimony trioxide or antimony
 
trisulfide produced lung tumors in rats (Groth et al. 1986; Watt 1980, 1983;
 
Wong et al. 1979). Lung tumors were not observed in the Bio/dynamics (1990)
 
study. The Watt (1980, 1983) and Bio/dynamics (1990) studies used similar
 
concentrations of antimony trioxide. However, lung cancer was observed only in
 
the Watt (1980, 1983) study. A possible explanation for the conflicting
 
results is differences in the amount of antimony that was deposited in the
 
lungs. Bio/dynamics (1990) asked the pathologist who examined the
 
histopathology slides from the Watt (1980, 1983) study to also examine the
 
slides from the Bio/dynamics (1990) study. The pathologist determined that the
 
degree of pigmentation in the lungs (indicative of the amount of antimony in
 
the lungs) was greater in the lungs of rats from the Watt (1980, 1983) study
 
compared to those from the Bio/dynamics study (1990). However, why there were
 
differences in antimony deposition and/or clearance between the studies is not
 
known. The deposition and clearance of antimony depends on particle size
 
(Felicetti et al. 1979b; Thomas et al. 1973). The smaller particles are
 
deposited in the lower respiratory tract and are slowly cleared from the lung.
 
The larger particles are deposited in the upper airways and are cleared more
 
efficiently from the lung. Thus, antimony with smaller particle sizes come
 
into contact with the lung tissue for a longer period of time; this may
 
influence the carcinogenic potential. Because of differences in the methods
 
used to assess particle size distribution between these two studies, a
 
comparison of particle size distribution between the studies can not be made.
 
The carcinogenicity of inhaled antimony also may vary with the chemical form
 
of antimony, which will affect the solubility of antimony and, thereby, lung
 
retention. The carcinogenicity of inhaled antimony is probably related to its
 
deposition in the respiratory tract and the resulting reactive processes
 
induced by its presence in the lung tissue. These include macrophage
 
infiltration and fibrosis, typical of pneumoconiosis. The lung carcinogenicity
 
of inhaled antimony may not, therefore, predict carcinogenic potential for
 
other routes of exposure. Antimony has not produced cancer in rats or mice
 
exposed by the oral route (Kanisawa and Schroeder 1969; Schroeder et al. 1968,
 
1970). There may be physiological differences in the deposition and clearance
 
of antimony from the lungs between humans and rats. Thus, it is
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difficult to assess carcinogenic potential of antimony in humans. No
 
information of carcinogenic potential of antimony following dermal application
 
of antimony was located.
 
2.5 BIOMABKERS OF EXPOSURE AND EFFECT
 
Biomarkers are broadly defined as indicators signaling events in
 
biologic systems or samples. They have been classified as markers of
 
exposure, markers of effect, and markers of susceptibility (NAS/NRC 1989).
 
A biomarker of exposure is a xenobiotic substance or its metabolite(s)
 
or the product of an interaction between a xenobiotic agent and some target
 
molecule(s) or cell(s) that is measured within a compartment of an organism
 
(NAS/NRC 1989). The preferred biomarkers of exposure are generally the
 
substance itself or substance-specific metabolites in readily obtainable body
 
fluid(s) or excreta. However, several factors can confound the use and
 
interpretation of biomarkers of exposure. The body burden of a substance may
 
be the result of exposures from more than one source. The substance being
 
measured may be a metabolite of another xenobiotic substance (e.g., high
 
urinary levels of phenol can result from exposure to several different
 
aromatic compounds). Depending on the properties of the substance (e.g.,
 
biologic half-life) and environmental conditions (e.g., duration and route of
 
exposure), the substance and all of its metabolites may have left the body by
 
the time biologic samples can be taken. It may be difficult to identify
 
individuals exposed to hazardous substances that are commonly found in body
 
tissues and fluids (e.g., essential mineral nutrients such as copper, zinc,
 
and selenium). Biomarkers of exposure to antimony are discussed in Section
 
2.5.1.
 
Biomarkers of effect are defined as any measurable biochemical,
 
physiologic, or other alteration within an organism that, depending on
 
magnitude, can be recognized as an established or potential health impairment
 
or disease (NAS/NRC 1989). This definition encompasses biochemical or cellular
 
signals of tissue dysfunction (e.g., increased liver enzyme activity or
 
pathologic changes in female genital epithelial cells), as well as physiologic
 
signs of dysfunction such as increased blood pressure or decreased lung
 
capacity. Note that these markers are often not substance specific. They also
 
may not be directly adverse, but can indicate potential health impairment
 
(e.g., DNA adducts). Biomarkers of effects caused by antimony are discussed in
 
Section 2.5.2.
 
A biomarker of susceptibility is an indicator of an inherent or acquired
 
limitation of an organism's ability to respond to the challenge of exposure to
 
a specific xenobiotic substance. It can be an intrinsic genetic or other
 
characteristic or a preexisting disease that results in an increase in
 
absorbed dose, biologically effective dose, or target tissue response. If
 
biomarkers of susceptibility exist, they are discussed in Section 2.7,
 
"POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE."
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2.5.1 Biomarkers Used to Identify and/or Quantify Exposure to Antimony
 
Elevated blood, hair, urine, and fecal levels of antimony indicate high
 
exposure to antimony. A significant correlation exists between the level of
 
pentavalent antimony (N-methylglucamine antimonate) administered
 
intraperitoneally to humans and antimony levels in hair (Dorea et al. 1989).
 
However, Dorea et al. (1989) only tested two levels of antimony (10 and 20 mg
 
antimony/kg/day). Factory workers exposed to antimony trioxide (0.042-0.70 mg
 
antimony/m3) had elevated urine and blood antimony levels (Ludersdorf et al.
 
1987). Antimony levels in the urine and blood were 1.1 and 0.9-5.0 µg/L, 
respectively, compared to 0.6 µg/L urine levels and 0.4 µg/L blood levels in 
unexposed workers. Animal data suggest that urine and blood levels remain 
elevated several days after exposure (Felicetti et al. 1974b). 
No effect biomarkers that could be used to implicate exposure to
 
antimony were found.
 
2.5.2 Biomarkers Used to Characterize Effects Caused by Antimony
 
No toxic symptoms specific to antimony exposure have been identified.
 
Toxic effects that reportedly occur in humans include pneumoconiosis, altered
 
EKG readings, and gastrointestinal effects. No quantitative biomarkers
 
associated with these effects are known.
 
2.6 INTERACTIONS WITH OTHER CHEMICALS
 
No information on the influence of other compounds on the toxicity of
 
antimony was located.
 
2.7 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
 
Individuals with existing chronic respiratory or cardiovascular disease
 
or problems would probably be at special risk, since antimony probably
 
exacerbates one or both types of health problems. Because antimony is excreted
 
in the urine, individuals with kidney dysfunction may be unusually
 
susceptible.
 
2.8 MITIGATION OF EFFECTS
 
This section will describe clinical practice and research concerning
 
methods for reducing toxic effects of exposure to antimony. However, because
 
some of the treatments discussed may be experimental and unproven, this
 
section should not be used as a guide for treatment of exposures to antimony.
 
When specific exposures have occurred, poison control centers and medical
 
toxicologists should be consulted for medical advice.
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Adverse health effects in humans following antimony exposure appear to
 
target on the respiratory and cardiovascular systems. Eye and skin irritation
 
have also been noted.
 
Human exposure to antimony may occur by inhalation, ingestion, or by
 
dermal contact. Mitigation approaches to reduce absorption of antimony have
 
included general recommendations of separating contaminated food, water, air,
 
and clothing from the exposed individual. Externally, exposed eyes and skin
 
are flushed with a clean neutral solution such as water or normal saline.
 
Administration of water or milk and a cathartic such as magnesium sulfate has
 
been recommended by Stutz and Janusz (1988) for treatment following oral
 
exposure to antimony. This would reduce the concentration of antimony in the
 
stomach, but is not likely to affect its intestinal absorption.
 
Administration of activated charcoal following exposure to organic compounds
 
is thought to be effective in preventing absorption (Stutz and Janusz 1988).
 
Antimony may be found in the blood and urine several days after
 
exposure. It also can be found in the hair (Dorea et al. 1989). Pentavalent
 
antimony is rapidly excreted in humans following intravenous or intramuscular
 
administration, with greater than 50% excreted in the urine 6 hours after
 
injection (Goodwin and Page 1943; Rees et al. 1980). Trivalent antimony is not
 
as rapidly excreted in the urine and is primarily excreted in the feces over a
 
24 hour period of time as noted after intraperitoneal administration in
 
laboratory animals (Edel et al. 1983).
 
Chelation therapy with British anti-Lewisite (BAL) may be the most
 
effective mitigation approach following absorption of trivalent antimony
 
compounds into the blood stream (Ellenhorn and Barceloux 1988; Haddad and
 
Inchester 1990). Antimony can covalently bind with sulfhydryl groups. BAL, a
 
dithiol compound with two vicinal sulfur atoms, competes with the critical
 
binding sites that may possibly be responsible for the toxic effects. There is
 
no evidence that BAL is useful following stibine gas exposure (Ellenhorn and
 
Barceloux 1988).
 
Dialysis may be the most effective method for mitigation of pentavalent
 
antimony. Pentavalent antimony in the blood resides mainly in the plasma in an
 
easily dialyzable form (Edel et al. 1983); Dialysis treatment following
 
exposure to trivalent antimony may not be as effective. The majority of
 
trivalent antimony found in blood is incorporated into the red blood cell
 
fraction in a hard dialyzable form (Edel et al. 1983).
 
2.9 ADEQUACY OF THE DATABASE
 
Section 104(i)(S) of CERCLA as amended directs the Administrator of
 
ATSDR (in consultation with the Administrator of EPA and agencies and programs
 
of the Public Health Service) to assess whether adequate information on the
 
health effects of antimony is available. Where adequate information is not
 
available, ATSDR, in conjunction with the National Toxicology Program (NTP),
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is required to assure the initiation of a program of research designed to
 
determine the health effects (and techniques for developing methods to
 
determine such health effects) of antimony.
 
The following categories of possible data needs have been identified by
 
a joint team of scientists from ATSDR, NTP, and EPA. They are defined as
 
substance-specific informational needs that, if met, would reduce or eliminate
 
the uncertainties of human health assessment. In the future, the identified
 
data needs will be evaluated and prioritized, and a substance-specific
 
research agenda will be proposed.
 
2.9.1 Existing Information on Health Effects of Antimony
 
The existing data on health effects of inhalation, oral, and dermal
 
exposure of humans and animals to antimony are summarized in Figure 2-3. The
 
purpose of this figure is to illustrate the existing information concerning
 
the health effects of antimony. Each dot in the figure indicates that one or
 
more studies provide information associated with that particular effect. The
 
dot does not imply anything about the quality of the study or studies. Gaps in
 
this figure should not be interpreted as "data needs" information.
 
As seen in Figure 2-3, information on the health effects of antimony in
 
humans following inhalation, oral, or dermal exposure is limited. The
 
inhalation data consist of several reports of workers exposed to inorganic
 
forms of antimony. However, most of these studies are incomplete because the
 
workers were exposed to a variety of compounds or the exposure level was not
 
reported. One oral study involving accidental drinking of lemonade
 
contaminated with potassium antimony tartrate was located. The dermal data on
 
humans is limited to a study in which antimony was applied to the skin of
 
volunteers.
 
As compared to the human data, more complete information on the systemic
 
health effects of antimony in animals was located. Although there are several
 
reliable intermediate and chronic duration studies that examined numerous
 
toxicological end points following exposure to airborne inorganic trivalent
 
antimony (primarily antimony trioxide), most of the studies utilized rats. One
 
inhalation reproductive/developmental study was located. Several studies
 
that examined the toxicity of metallic antimony, antimony trioxide, antimony
 
trichloride, and potassium antimony tartrate via oral exposure were located.
 
Sensitive measurements of cardiovascular toxicity were not examined in most of
 
these studies. One developmental toxicity study in rats was located; internal
 
examination of pups was not located. The acute and intermediate toxicity of
 
dermally applied antimony trioxide, antimony oxide, and antimony
 
thioantimonate has been examined. However, these studies did not examine the
 
systemic toxicity of antimony; they were designed to assess the dermal and/or
 
ocular toxicity of antimony.
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2.9.2 Data Needs
 
Acute-Duration Exposure. Information on the target organs of acute
 
exposure in humans to antimony is limited. Based on one human study, the
 
gastrointestinal tract appears to be a target following inhalation exposure to
 
antimony (Taylor 1966). Animal studies have shown that the respiratory tract
 
and cardiovascular, hepatic, and renal effects occur after exposure to
 
airborne antimony (Brieger et al. 1954; Price et al. 1979). The respiratory
 
and cardiovascular effects occur at a lower exposure levels than those
 
associated with gastrointestinal effects in humans. An acute inhalation MRL
 
could not be derived from this animal data because serious myocardial effects
 
were observed at the lowest exposure level tested. The gastrointestinal tract
 
also appears to be a target in humans following oral exposure to antimony.
 
This is based on a report of workers who accidentally drank lemonade
 
contaminated with potassium antimony tartrate (Dunn 1928). An acute oral MRL
 
could not be derived from this study. Acute animal data also suggest that the
 
gastrointestinal tract is a target system (Fleming 1982; Houpt et al. 1984;
 
Myers et al. 1978). However, two of the three acute animal studies did not
 
perform complete histological examinations, thus there may be other target
 
organs that have not been identified (Fleming 1982; Houpt et al. 1984; Myers
 
et al. 1978). There is no information on the target organs in humans following
 
dermal exposure to antimony. Application of antimony to the skin or eyes of
 
animals results in mild irritation (Gross et al. 1955; Horton et al. 1986;
 
Myers et al. 1978; Wil Research Lab 1979). A majority of the animal studies
 
only examined the skin or eyes following dermal/ocular exposure to antimony.
 
Toxicokinetic data that might allow route-to-route extrapolations of health
 
effects were not found. Knowledge about the acute toxicity of antimony is
 
important because people living near hazardous waste sites might be exposed to
 
antimony for brief periods. Information about the toxicity of different
 
antimony compounds, as well as differences in valence states, was not located.
 
Additional acute-duration studies by the inhalation, oral, and dermal routes
 
would provide information on differences in the potency of various antimony
 
compounds, as well as on the thresholds for systemic toxicity due to acute-

duration exposure to antimony.
 
Intermediate-Duration Exposure. Human target organs/systems following
 
exposure to airborne antimony include the respiratory tract and
 
gastrointestinal tract and skin (Brieger et al. 1954; Renes 1953; Stevenson
 
1965). No reports of health effects in humans following oral or dermal
 
exposure were located. Animal data suggest that the heart and respiratory
 
tract may be targets following inhalation exposure (Brieger et al. 1954;
 
Bio/dynamics 1985). Developmental and reproductive effects have also been
 
reported in animals (Belyaeva 1967). There is no information on human health
 
effects following oral exposure to antimony. Oral exposure of animals to
 
antimony has resulted in adverse health effects on the liver, cardiovascular
 
system, gastrointestinal tract, and mild hematological effects (Angrisani
 
1988; Fleming 1982; Hiraoka 1986; Marmo et al. 1987; Rossi et al. 1987; Smyth
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and Thompson 1945; Sunagawa 1981). No reports of human health effects
 
following dermal exposure were located. No adverse health effects were
 
observed in animals following intermediate duration dermal exposure (Horton et
 
al. 1986). EKG readings are a sensitive indicator of myocardial damage;
 
however, in the oral and dermal intermediate-duration studies this end point
 
was not examined. Because the exposure levels tested were higher than the
 
threshold levels for respiratory tract effects, and/or because EKG readings
 
were not taken, inhalation and oral MKLs could not be derived. Toxicokinetic
 
data that might allow extrapolation of health effects across routes of
 
administration were not located. Information on the relative toxicity of the
 
different antimony compounds has not been assessed. Intermediate-duration
 
studies by inhalation, oral, and dermal routes would provide information on
 
the thresholds for systemic toxicity, as well as on the differences in the
 
potency of various antimony compounds. This information could be relevant to
 
human exposure because people living near hazardous waste sites may be exposed
 
to a variety of antimony compounds for an intermediate-duration.
 
Chronic-Duration Exposure and Cancer. There are several human and
 
animal chronic inhalation studies that indicate the targets appear to be the
 
respiratory tract, heart, eye, and skin (Brieger et al. 1954; Cooper et al
 
1968; Potkonjak and Pavlovich 1983). However, functional changes in the
 
cardiovascular system were not assessed in the animal inhalation studies
 
(Bio/dynamic 1990; Gross et al. 1952; Groth et al. 1986; Watt 1980, 1983; Wong
 
et al. 1979). A no-effect level (NOEL) for respiratory or cardiovascular
 
effects following exposure to antimony was not identified in the available
 
literature. The NOEL is an important level in evaluating the risk of exposure
 
to antimony, and it can be used along with protective uncertainty factors to
 
help determine the amount of antimony humans can be exposed to without
 
experiencing health effects. The chronic inhalation studies in animals
 
examined only the toxicologic effects in rats; thus, interspecies differences
 
could not be assessed. No target organs were identified in humans or animals
 
following oral exposure to antimony (Kanisawa and Schroeder 1989; Schroeder et
 
al. 1968, 1970). In addition, the data from the oral and inhalation studies
 
were insufficient for deriving a chronic MEL. There is no information on the
 
health effects in humans and animals following dermal exposure. Well-designed
 
oral experiments, using several exposure levels and measuring all sensitive
 
toxicological end points, would provide information on the health effects
 
associated with long-term exposure to antimony. Chronic toxicity information
 
is important because people living near hazardous waste sites might be exposed
 
to antimony for many years.
 
No studies were located regarding the carcinogenicity of antimony in
 
humans following inhalation, oral, or dermal exposure. Evidence for the
 
carcinogenicity of inhaled antimony in animals is mixed. Two studies reported
 
lung tumors in rats exposed to relatively low levels of antimony trioxide
 
(Groth et al. 1986; Watt 1983; Wong et al. 1979). A study using a similar
 
exposure level did not find evidence of carcinogenicity (Bio/dynamics 1990).
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Differences in the amount of antimony deposited and/or cleared from the lungs
 
were reported. It is not known if the conflicting results were due to
 
differences in particle sizes. A study comparing the effects of different
 
particle sizes would determine if the particle size of the inhaled antimony
 
determines the carcinogenic potential of antimony. The increased incidence of
 
lung tumors appears to be route specific. There is no evidence of increased
 
incidence of cancer in humans as a result of oral exposure to antimony. The
 
oral cancer data in animals are limited to studies that used very low levels
 
of antimony (Kanisawa and Schroeder 1989; Schroeder et al. 1968, 1970). Oral
 
studies have shown that antimony tends to accumulate in the liver and
 
gastrointestinal tract (Ainsworth 1988; Sunagawa 1981); it is not known if
 
this results in cancer. No dermal cancer studies in humans or animals was
 
located. Oral and dermal studies in rodents using several exposure levels
 
including the maximum tolerated level would provide useful information because
 
prolonged exposure to antimony in humans may occur.
 
Genotoxicity. There are no in vivo genotoxicity studies in humans or
 
animals. In vitro studies using human leukocytes were positive for chromosome
 
breakage (Paton and Allison 1972). Results were mixed in in vitro studies
 
using mammalian cells (Casto et al. 1979; Tu and Sivak 1984), and positive for
 
DNA damage in Bacillus subtilis (Kanematsu et al. 1980). Additional in vitro
 
and in vivo genotoxicity studies would enable better estimation of the actual
 
genotoxic threat posed by antimony to people exposed in the environment.
 
Reproductive Toxicity. Women exposed to antimony in the workplace have
 
reported menstrual disturbances and a higher incidence of spontaneous
 
abortions as compared to nonexposed workers (Belyaeva 1967). From this report
 
it is unclear what the exposure level was, whether the women were exposed also
 
to other compounds, and whether the controls had comparable jobs. Reproductive
 
effects (failure to conceive, uterine metaplasia) have been observed in rats
 
exposed to airborne antimony (Belaeva 1967). In addition, studies on the
 
distribution of antimony following oral administration in animals have shown
 
high levels of antimony in the testes (Sunagawa 1981). It is not known whether
 
these high levels of antimony could result in functional changes. There are no
 
data on reproductive effects following oral or dermal exposure to humans and
 
animals. There are insufficient toxicokinetic data to make route-to-route
 
extrapolation. A well-designed study to assess the effects of orally or
 
dermally administered antimony on reproductive performance would provide
 
information on possible reproductive effects that
 
might be relevant to humans.
 
Developmental Toxicity. An increased number of spontaneous abortions was
 
observed in women exposed to antimony in the workplace (Belyaeva 1967).
 
However, there are several limitations to this study, as discussed above in
 
the reproductive toxicity section. No overt developmental effects were
 
observed in the offspring of these women. Developmental effects were not
 
observed in the offspring of rats exposed orally to antimony trichloride
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(Rossi et al. 1987). An animal study has shown that antimony is not
 
efficiently transported across the placenta (Gerber et al. 1982). However,
 
there is evidence of high levels of antimony in unexposed newborn nursed by
 
exposed female mice (Gerber et al. 1982). A study in which animals are exposed
 
throughout gestation and lactation would provide information on the potential
 
of antimony to result in developmental effects in humans.
 
Immunotoxicity. Immunotoxicity following inhalation, oral, or dermal
 
exposure have not been studied in humans or animals. Immunological end points
 
should be examined in the intermediate or chronic studies, especially since
 
antimony has been shown to accumulate in the spleen (Sunagawa 1981).
 
Neurotoxicity. Neurotoxic effects have not been observed in humans
 
following inhalation, intramuscular, and intraperitoneal exposure to antimony.
 
Neuromuscular effects have been observed in animals following oral, dermal,
 
and intraperitoneal administration (Fleming 1982; Mansour and Reese 1965;
 
Myers et al. 1978). Furthermore, myopathy has been observed in mice exposed
 
via intraperitoneal injection (Mansour and Reese 1965). Although this effect
 
has not been observed by other routes of exposure there is no reason to
 
suspect that it would not occur. Sensitive tests of neurophysiological
 
function may detect early sign of neurotoxicity following inhalation, oral, or
 
dermal exposure to antimony.
 
Epidemiological and Human Dosimetry Studies. There are several
 
epidemiological occupational exposure studies (Brieger et al. 1954; Cooper et
 
al. 1968; Potkonjak and Pavlovich 1983; RBnes 1953; Stevenson 1965). However,
 
most of these studies are incomplete because the exposure level and/or
 
particle size of the airborne antimony was not reported and/or the workers
 
were often exposed to a variety of other compounds. In addition,
 
cardiovascular toxicity, a sensitive end point of antimony toxicity, was not
 
always assessed. No epidemiological or human dosimetry studies in which
 
individuals were exposed to antimony orally or dermally were located.
 
Epidemiological studies would be useful in order to determine the effects of
 
long-term exposure on humans, with particular attention paid to cardiovascular
 
and respiratory effects. If a cause/effect relationship was established
 
between antimony exposure and health effects in humans, monitoring of
 
individuals living near hazardous waste sites could be performed in order to
 
verify that exposure levels do not exceed recommended limits and that body
 
tissue and fluid levels remain below potentially hazardous levels.
 
Biomarkers of Exposure and Effect. Because antimony is not catabolized
 
in the body, metabolites could not be used as a biomarker. Thus, the only
 
biomarker of exposure would be measurement of antimony itself. Antimony levels
 
are increased in the blood, urine, and feces following exposure to antimony
 
(Cooper et al. 1968; Edel et al. 1983; Felicetti et al. 1974a, 1974b; Gerber
 
et al. 1982; Goodwin and Page 1943; Ludersdorf et al. 1987; Rees et al. 1980).
 
However, because antimony is poorly absorbed from the lung,
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measurement of antimony levels in body fluids may not reflect the exposure
 
level of airborne antimony (Felicetti et al. 1974a, 1974b; Thomas et al.
 
1973). The relationship between exposure level and concentration of antimony
 
in various body fluids has not been established. Development of a biomarker
 
with more exposure/dose data would aid in future medical surveillance that
 
could lead to better detection of exposure.
 
No antimony-specific biomarkers of effects have been identified. Future
 
studies on the toxicity of antimony should use several antimony exposure
 
levels, this may lead to the identification of subtle biochemical or
 
physiological biomarkers of effects.
 
Absorption, Distribution, Metabolism, and Excretion. There is some
 
information on the toxicokinetic properties of antimony following oral or
 
inhalation exposure in humans and animals (Ainsworth 1988; Cooper et al. 1968;
 
Edel et al. 1983; Felicetti et al. 1974a, 1974b; Gerber et al. 1982;
 
Gerhardsson et al. 1982; Goodwin and Page 1943; Ludersdorf et al. 1987; Rees
 
et al. 1980; Sumino et al. 1975; Sunagawa 1981; Thomas et al. 1973). However,
 
there is limited comparative information on the absorption, distribution, and
 
excretion of different antimony compounds. Furthermore, the site and mechanism
 
of antimony absorption from the gastrointestinal tract has not been
 
elucidated. The influence of nutritional factors as well as the presence of
 
food in the gastrointestinal tract on absorption are not known. Information on
 
the absorption, distribution, or excretion of antimony following dermal
 
application is not known. In addition, a study on the effect of oxidation
 
state on the cellular uptake of antimony and the effect of water solubility of
 
an antimony compound on lung retention/absorption would provide useful
 
information on the toxicity of different antimony compounds. A study that
 
examined these aspects of antimony would be useful in assessing the potential
 
target organs following dermal exposure to antimony.
 
Comparative Toxicokinetics. Species differences in the toxicokinetics of
 
antimony have been identified (Ainsworth 1988; Felicetti et al. 1974a; Gross
 
et al. 1955; Thomas et al. 1973). However, the absorption, distribution, and
 
excretion of antimony following oral or inhalation exposure in humans is not
 
known. Thus, it is not possible to decide which animal species is the best
 
model for assessing the toxicity of antimony. Information on the behavior of
 
antimony in humans would be useful.
 
Mitigation of Effects. Chelation therapy with BAL has been shown to
 
effectively mitigate the toxicity of trivalent antimony compounds in humans
 
(Ellenhorn and Barceloux 1988; Haddad and Winchester 1990). Although BAL has
 
been found to form stable chelates in vivo with antimony, it is not known if
 
there are adverse side effects associated with the treatment. Studies
 
examining the effectiveness of chelating agents and possible side effects
 
would be helpful in determining the most effective treatment for antimony
 
toxicity. Antimony is widely distributed throughout the body. The hair and
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skin contain the highest levels of antimony. The adrenal glands, lung, large
 
intestine, trachea, cerebellum, and kidneys also contain relatively high
 
levels of antimony (Muramatsu and Parr 1988; Sumino et al. 1975). No
 
information on methods of mitigating body stores were located. Studies that
 
examined such methods would be useful in the treatment of antimony toxicity.
 
2.9.3 On-going Studies
 
NTP (1990) has recently completed a 14-day drinking water study in which
 
groups of male and female Fischer 344 rats and B6C3Fl mice were given drinking
 
water containing potassium antimony tartrate. The doses in rats were 0, 16,
 
28, 59, 94, and 168 mg/kg/day; for mice, they were 0, 59, 98, 174, 273, and
 
407 mg/kg/day. In rats, the only effects observed were an increase in relative
 
liver and kidney (females only) weights in the high dose group. Focal areas of
 
ulceration with necrosis and inflammation of the squamous mucosa of the
 
forestomach were observed in the high dose mice. A final report
 
of this study is currently not available.
 
NTP (1990) has also completed a 13-week intraperitoneal injection study.
 
In this study, inflammation and/or fibrosis of the liver were observed in mice
 
dosed with 60 mg/kg potassium antimony tartrate every other day. Degeneration
 
was evident in the kidneys of male rats dosed with 24 mg/kg every other day. A
 
final report of this study is currently not available.
 
Genotoxicity tests were negative in Salmonella typhimurium strains
 
TAl00, TA1535, TA97, or TA98 for antimony potassium tartrate with and without
 
metabolic activation (NTP, 1990).
 
NIOSH is conducting an epidemiological study using a cohort of antimony
 
smelter workers to determine the possible association between exposure to
 
antimony and the risk of developing lung cancer (Federal Research in Progress
 
1989).
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There are many compounds, complexes, and alloys of antimony that occur
 
naturally or are man-made. The chemical identity and physical chemical
 
properties of all of these forms of antimony cannot be discussed in detail.
 
3.1 CHEMICAL IDENTITY
 
Antimony is in the fourth row of group 5A in the periodic table,
 
residing between arsenic and bismuth. It displays four oxidation states: Sb(­
3), Sb(0), Sb(+3), and Sb(+5). The +3 state is the most common and stable.
 
Antimony is sometimes referred to as a metalloid, indicating that it displays
 
both metallic and nonmetallic characteristics.
 
Metallic antimony is the only allotropic form of antimony that is stable
 
under normal conditions. Two unstable allotropes exist: yellow and black
 
amorphous forms (Herbst et al. 1985). Metallic antimony is a very brittle,
 
moderately hard metal (Herbst et al. 1985). It is occasionally found
 
uncombined in nature (Carapella 1978). Antimony has two stable isotopes with
 
mass numbers 121 and 123, with natural abundances of 57.25% and 42.75%,
 
respectively (Carapella 1978). One radioactive isotope, Sb125, is a fission
 
product released in nuclear explosions or nuclear fuel reprocessing plants and
 
has a half-life of 2.7 years (Weast 1988). Data on the chemical identity of
 
antimony, antimony pentasulfide, antimony pentoxide, antimony potassium
 
tartrate, antimony trichloride, antimony trioxide, antimony trisulfide, and
 
stibine are shown in Table 3-1.
 
3.2 PHYSICAL AND CHEMICAL PROPERTIES
 
The physical and chemical properties of antimony, antimony pentasulfide,
 
antimony pentoxide, antimony potassium tartrate, antimony trichloride,
 
antimony trioxide, antimony trisulfide, and stibine are given in Table 3-2.
 
Antimony metal is stable under ordinary conditions and is not readily attacked
 
by air or water (Herbst et al. 1985). It is a poor conductor of heat and
 
electricity (Weast 1988). Antimony is positioned after hydrogen in the
 
electrochemical series and therefore will not displace hydrogen ions from
 
dilute acids. It is not affected by cold, dilute acids (Windholz 1983). Simple
 
antimony cations (i.e., Sb+3 and Sb+5) do not occur in solution, but hydrolyzed
 
forms (e.g., Sb(OH)6
¯ ) are found. The dominant species in the pH range typical
 
of natural environments are Sb(OH)3 , in the case of trivalent antimony, and
 
Sb(OH)6
¯ for pentavalent antimony (Bodek et al. 1988). In oxidizing
 
environments, Sb(OH)6
¯
, is the dominant species for pH greater than 3, whereas
 
Sb(OH)3 is dominant under relatively reducing conditions. The concentration of
 
antimony is too low in natural water for Sb2O3 or Sb2O5 to precipitate out.
 
Antimony trioxide is dimorphic, existing as a cubic form, senarmontite,
 
and an orthorhombic form, valentinite. The cubic form is stable at
 
temperatures below 570°C (Freedman et al. 1978). Antimony trioxide is
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amphoteric; it is soluble in bases and hydrochloric and some organic acids,
 
but not dilute sulfuric or nitric acids (Cotton and Wilkinson 1966). Nitric
 
acid and other strong oxidizing agents convert antimony trioxide to antimony
 
pentoxide, Sb2O5, which is acidic (Carapella 1978; Cotton and Wilkinson 1966).
 
Antimony forms complex ions with organic and inorganic acids; one of the
 
best known is the tartrate. In the presence of sulfur, stable complexes such
 
as Sb2S4
2-
may form (Bodek et al. 1988).
 
Stibine, SbH3, is a gaseous antimony compound in which antimony is in
 
the -3 valence state. It is formed by the action of acids on metal antimonides
 
or antimony alloys, reduction of antimony compounds, or the electrolysis of
 
acidic or basic solutions where antimony is present in the cathode. As such,
 
there is a danger of stibine being liberated from overcharged lead storage
 
batteries in which antimony is alloyed into the lead. Stibine slowly
 
decomposes into metallic antimony and hydrogen. It is readily, and sometimes
 
violently, oxidized by air to form antimony trioxide and water (Freedman et
 
al. 1978).
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4.1 PRODUCTION
 
Antimony, while not abundant, occurs in over 100 minerals; the more
 
important of these are sulfides and, to a lesser extent, oxides of Sb(III),
 
and combinations with lead, copper, and silver. Stibnite (Sb2S3) is the
 
predominant ore, followed in importance by valentinite (Sb2O3), senarmontite
 
(Sb2O3), stibiconite (Sb2O4.H2O), bindheimite (Pb2Sb2O7.nH2O), kermesite (Sb2S2O),
 
tetrahedrite (Cu2Sb2O7), and jamesonite (2PbS.Sb2S3). It also occurs uncombined
 
as the metal (Herbst et al. 1985; Miller 1973). The antimony content of
 
commercial ores ranges from 5% to 60% (Carapella 1978). The world's largest
 
concentrations of antimony are found in China, Bolivia, U.S.S.R., Republic of
 
South Africa, and Mexico (Miller 1973).
 
Between 1977 and 1984, the amount of antimony mined in the United States
 
ranged from 311 to 760 metric tons (Llewellyn 1988; Plunkert 1982). The low of
 
311 metric tons occurred in 1980, and was the result of an 8-month work
 
stoppage at the Sunshine Mine in the Coeur d'Alene district of Idaho. Data for
 
1985, 1986, and 1988 were withheld to avoid disclosing proprietary company
 
data (Anonymous 1989a, 1989b; Llewellyn 1988). This reflects the fact that
 
there were two or fewer active antimony mines in the United States. In 1987,
 
the Sunshine Mine was closed, and there was no antimony mined in the United
 
States. In recent years, the principal domestic ore producers have been the
 
Sunshine Mining Company in Idaho and the United States Antimony Corporation in
 
Montana. The Sunshine Mining Company principally mines tetrahedrite in
 
conjunction with silver mining, and the United States Antimony Corporation
 
principally mines stibnite. Antimony is also produced as a byproduct of the
 
smelting of primary lead ores.
 
The primary antimony output from smelters has generally been rising in
 
recent years; smelter outputs were 14,922, 16,309, 18,795, and 18,692 metric
 
tons in 1985, 1986, 1987, and 1988, compared with 11,644 metric tons in 1977
 
(Anonymous 1989a; Llewellyn 1988; Plunkert 1982). According to the U.S. Bureau
 
of Mines, nine companies produced primary antimony metal and metal oxide
 
products in the United States in 1987. These were ASARCO Incorporated, Omaha,
 
Nebraska; Amspec Chemical Corp., Gloucester City, New Jersey; Anzon America,
 
Laredo, Texas; Chemet Co., Moscow, Tennessee; Laurel Industries Inc., La
 
Porte, Texas; McGean Chemical Co., Inc., Cleveland, Ohio; M&T Chemicals Inc.,
 
Baltimore, Maryland; Sunshine Mining Co., Kellogg, Idaho; and U.S.
 
Antimony Corp, Thompson Falls, Montana (Llewellyn 1988). Most of the primary
 
antimony generated in the United States was generated as the oxide. In 1985
 
and 1986, 13,969 and 15,898 metric tons of antimony oxide were produced,
 
compared with 855 and 343 metric tons of metal, respectively. In 1987 and
 
1988, 18,758 and 18,226 metric tons of the oxide were produced, respectively;
 
production figures for the metal were withheld to maintain business
 
confidentiality (U.S. Bureau of Mines 1989a). In 1988, U.S. primary antimony
 
consumption was 12,060 metric tons, of which 2,121 metric tons were metal,
 
9,432 metric tons were oxide, and 42 metric tons were sulfide (U.S. Bureau of
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Mines 1989a). Consumption trends have generally paralleled those of
 
production. Table 4-l lists the number of facilities in each state that
 
produced, imported, processed, or used antimony and its compounds in 1987,
 
according to reports made to EPA under requirements of Section 313 of the
 
Emergency Planning and Community Right-to-Know Act of 1986 and subsequently
 
published in the Toxic Chemical Release Inventory (TRI). Companies are
 
required to report if they produced, imported, or processed 75,000 or more
 
pounds of antimony and its compounds or used more than 10,000 pounds. Also
 
included in Table 4-l is the maximum amount of antimony and its compounds
 
these facilities have on site and whether the antimony is produced, processed,
 
or used at the site. The quality of the TRI data must be viewed with caution
 
since 1987 data represent first-time, incomplete reporting by these
 
facilities. Not all facilities that should have reported have done so.
 
Almost as much antimony is produced from scrap as from ore. Antimony
 
produced from secondary sources is primarily derived from "old scrap,"
 
generally consisting of lead battery plates, type metal, and bearing metal.
 
"New scrap," which is derived from drosses and scrap generated during
 
fabrication, constituted 8.6% of the secondary antimony in 1987 (Llewellyn
 
1988). Secondary antimony is chiefly consumed as antimonial lead; a small
 
percentage goes into the production of other lead- and tin-based alloys.
 
Secondary antimony production has stabilized and recovered slightly after a
 
long decline; it was 27,780 metric tons in 1977, 12,886 metric tons in 1983,
 
and 13,635, 14,082, 15,189, and 16,172 metric tons in 1985, 1986, 1987, and
 
1988, respectively (U.S. Bureau of Mines.1989a; Llewellyn 1988; Plunkert
 
1982).
 
The method of treating antimony ore after mining depends on the type of
 
ore and its antimony content. High grade (45-602;) sulfide ore that is free
 
from lead and arsenic can be extracted by melting, a technique known as
 
liquation. In this process, the ore is heated to 550-660°C in a crucible or
 
reverberatory furnace in a reducing atmosphere. High-grade sulfide ores can
 
also be reduced to the metal by iron precipitation, a technique in which the
 
ore is heated with iron scrap, which replaces the antimony. High-grade oxide
 
ores are reduced with charcoal in a reverberatory furnace. An alkaline flux
 
is used to reduce volatilization losses, which may be as high as 12-20X. The
 
method of choice for low-grade (less than 20%) sulfide ores is volatilizing
 
roasting. In this process, the ore is heated to about 5OO"C, and the amount of
 
oxygen is controlled, so that the antimony trioxide formed is volatilized and
 
then recondensed. Intermediate-grade sulfide or oxide ores are generally
 
handled by smelting (Carapella 1978; Herbst et al. 1985). The impure metal may
 
be refined by pyrometallurgical techniques or electrolysis. For further
 
details on antimony mining, ore processing, recovery, and refining, see
 
Carapella (1978) or Herbst et al. (1985).
 
Antimony trioxide is produced by oxidizing antimony sulfide ore or
 
antimony metal in air at 600-800°C (Avento and Touval 1980).
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4.2 IMPORT/EXPORT
 
The United States is not self-sufficient in antimony and depends heavily
 
on imports of both ore and metal. In 1987 and 1988, 24,248 and
 
30,027 metric tons of antimony, respectively, were imported into the United
 
States for consumption. Of this, 55.3% was as the metal, 31.9% as the oxide,
 
12.4% as ore and concentrate, and 0.4% as the sulfide in 1988 (U.S. Bureau of
 
Mines 1989a). The respective percentages for 1987 were 36.3, 42.4, 21.1, and
 
0.3. In 1987, China, Hong Kong, Mexico, and the Republic of South Africa
 
supplied over 72% of this antimony (U.S. Bureau of Mines 1989a). China is, by
 
far, our largest supplier of antimony, most of which is imported as antimony
 
metal. Importation of antimony has generally increased in recent years. In
 
comparison to the figures for 1987 and 1988 given above, imports ranged from
 
12,098 to 20,086 metric tons between 1977 and 1981 (Plunkert 1982). States
 
that have companies that imported more than 10,000 pounds of antimony and its
 
compounds in 1987 are indicated in Table 4-1.
 
The United States exported 624 metric tons of antimony metal, alloys,
 
and scrap and 1,227 metric tons of antimony oxide in 1988 (U.S. Bureau of
 
Mines 1989a). Canada is the largest recipient of these exports. No clear trend
 
in antimony exports was evident in the last decade (Llewellyn 1988; Plunkert
 
1982).
 
4.3 USE
 
Antimony is a brittle metal that is not readily fabricated and has no
 
significant use in its unalloyed state. It is alloyed with lead and other
 
metals to increase their hardness, mechanical strength, corrosion resistance,
 
and electrochemical stability or decrease their coefficient of friction. Some
 
antimony alloys expand slightly upon cooling, a valuable property for use in
 
type metal and other castings. Most primary antimony metal, 55% in 1988, as
 
well as most of secondary antimony, goes into antimonial lead, which is used
 
primarily in grid metal for lead acid storage batteries. In this application,
 
the antimony imparts fluidity and electrical stability, and increases the
 
fatigue strength and creep resistance of the lead (Carapella 1978). Other uses
 
in decreasing order of importance are solder, sheet and pipe, bearing metal,
 
and bearings, castings, and type metal. Antimony is also used in ammunition
 
and cable sheathing. Other uses, including nonantimonial lead alloys (e.g.,
 
pewter), accounted for 21.7% of 1988 metal consumption (U.S. Bureau of Mines
 
1989a). The level of antimony in grid metal ranges from 2.5% to 5% (Carapella
 
1978). Antimony levels in other antimony alloys range up to 23%. High-purity
 
antimony is used as a dopant in semiconductors. Intermetallic compounds of
 
antimony such as aluminum antimonide (AlSb), gallium antimonide (GaSb), and
 
indium antimonide (InSb) are used for thermoelectric devices such as infrared
 
detectors and diodes (Gudzovskij 1983; Herbst et al. 1985).
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The most common end-use of antimony compounds is antimony trioxide for
 
fire retardation. In 1985, 15,500 metric tons of antimony oxides, amounting to
 
85% of production, were consumed for this use (Sutker 1988). Antimony trioxide
 
in a suitable organic solvent is used as a fire retardant for plastics,
 
textiles, rubber, adhesives, pigments, and paper (U.S. Bureau of Mines 1989a).
 
According to Bureau of Mine estimates, 56% of the end-use consumption of
 
primary antimony in the United States was for flame retardants, as opposed to
 
23% in metal products and 21% in nonmetal products (U.S. Bureau of Mines
 
1989a). Nonmetal products include enamels for plastics, metal, and ceramics,
 
decolorizing and refining agents in special optical glass and other
 
glasses, stabilizers in plastics, pigments in paints and ceramics,
 
vulcanization agents, ammunition primers, and fireworks (U.S. Bureau of Mines
 
1989a; Herbst et al. 1985; Ludersdorf et al. 1987). The number of companies in
 
each state that used more than 10,000 pounds of antimony and its compounds in
 
1987 is included in Table 4-l. The most common general use of antimony and its
 
compounds is as a formulation or article component.
 
Some trivalent organic antimony compounds (e.g., potassium or sodium
 
antimony tartrate) are used to treat bilharziasis (schistosomiasis)
 
(Swellengrebel and Sterman 1961).
 
4.4 DISPOSAL
 
Much of the antimony used in antimonial lead, most of which comes from
 
auto batteries, is recycled. This is evident from the large amount of
 
secondary antimony production. Little information concerning the disposal of
 
antimony and its compounds has been found in the literature. Wastes from
 
mining and smelting are generally disposed of in landfills. This is evident
 
from the amounts of releases to land from companies that produce antimony and
 
its compounds (Section 5.2.1). In addition, many companies transfer their
 
antimony wastes to publicly-owned treatment works or to off-site facilities
 
for disposal. Plastics and articles of clothing that contain small amounts of
 
antimony oxide flame retardants will generally be placed in landfills or
 
incinerated along with normal industrial or municipal trash.
 
Antimony and its compounds have been designated as priority pollutants
 
by EPA (1988). As such, persons who generate, transport, treat, store, or
 
dispose of antimony-containing material must comply with regulations of the
 
federal Resource Conservation and Recovery Act (RCRA). No limitations on the
 
disposal of antimony ore from mines and mills have been promulgated in the
 
Code of Federal Regulations (EPA 1988).
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5.1 OVERVIEW
 
Antimony and its compounds are naturally present in the earth's crust.
 
Releases to the environment occur from natural discharges such as windblown
 
dust, volcanic eruption, sea spray, forest fires, and biogenic sources, as
 
well as from anthropogenic activities. Therefore, it is important to consider
 
the background levels that are due to natural sources and distinguish these
 
from higher levels that may result from anthropogenic activities. According to
 
the SARA Section 313 TRI, an estimated total of 3,061,036 pounds of antimony
 
were released to the environment from manufacturing, processing, and antimony-

using facilities in the United States in 1987 (TRI 1989). Of these releases,
 
92.9% was to land, 4.4% was to air, 2.0% was to water, and 0.6% was to
 
underground injection. Table 5-1 lists releases of antimony to air, water, and
 
land from these facilities. Companies above a minimum size are required to
 
report if they produce, import, or process over 75,000 pounds of antimony and
 
its compounds or use in excess of 10,000 pounds. The quality of the TRI data
 
must be viewed with caution since the 1987 data represent first-time,
 
incomplete reporting of estimated releases from these facilities. Not all
 
sources of chemical waste are included, and not all facilities that should
 
have reported have done so.
 
Most antimony released to the atmosphere from anthropogenic sources
 
results from metal smelting and refining, coal-fired power plants, and refuse
 
incineration. Since antimony is a fairly volatile metal, it will volatilize
 
during combustion processes and subsequently condense on suspended particulate
 
matter that is predominantly less than 1 µm in size. Such fine particles are 
less efficiently trapped by pollution control devices than are larger 
particles. In the atmosphere, they tend to settle out slowly; they are also 
removed by dry and wet deposition. A model that relates particle size to 
volatility estimates average atmospheric half-lives of 1.9 and 3.2 days for 
antimony and antimony trioxide, respectively (Mueller 1985). Submicron 
particles may have atmospheric half-lives as long as 30 days (Schroeder et al. 
1987). The long atmospheric half-life and monitoring data indicate that 
antimony can be transported far from its source (Dutkiewicz et al. 1987; 
Hillamo et al. 1988). Antimony concentrations in air particulate matter in 
remote, rural, and U.S. urban areas are 0.00045-1.19, 0.6-7, and 0.5-171 
ng/m3, respectively (Austin and Millward 1988; Schroeder et al. 1987). 
The speciation and physicochemical state of antimony are important to
 
its behavior in the environment and availability to biota. For example, the
 
antimony incorporated in mineral lattices is inert and unlikely to be
 
bioavailable. Most analytical methods for antimony do not distinguish the form
 
of antimony. While the total amount of antimony may be known, the nature of
 
the antimony compounds and whether they are adsorbed to other material are
 
not. This information, which is critical in determining antimony's lability
 
and availability, is apt to be site-specific.
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Antimony occurs in soil and rock in very low concentrations; the range
 
of concentration in soil ranges from less than 1 to 8.8 ppm, with a mean of
 
0.48 ppm (Shacklette and Boerngen 1984). This is the third lowest of 50
 
elements surveyed by the U.S. Geological Survey. The forms of antimony in
 
various soils and the transformations between these forms is poorly
 
understood. The available data indicate that the lability of antimony may vary
 
considerably according to its environment. In one study, three-quarters of the
 
soil near a smelter site was in a residual (extractible with aqua regia)
 
fraction (Ainsworth 1988). While the concentration of antimony was much lower
 
at control sites, it was in a more labile form; none of the antimony was in
 
the residual fraction. Little is known about the adsorption
 
of antimony to soil. Limited studies indicate that antimony may be fairly
 
mobile under diverse environmental conditions (Rai and Zachara 1984). Since
 
antimony forms anionic species, adsorption should be greatest under weakly
 
acidic conditions. Antimony's adsorption to soil and sediment is primarily
 
correlated with the iron, manganese, and aluminum content; it coprecipitates
 
with hydroxylated oxides of these elements.
 
As a natural constituent of soil, antimony is transported into streams
 
and waterways from natural weathering of soil as well as from anthropogenic
 
sources. Antimony has a low occurrence in ambient waters. In a survey of
 
dissolved antimony in ambient waters performed by the U.S. Geological Survey,
 
only 6% of 1,077 survey measurements were above the probable detection limit
 
of 5 ppb (Eckel and Jacobs 1989). Antimony concentrations in groundwater
 
appear to be similar to that in surface water. Mean antimony concentrations in
 
surface and groundwater at hazardous waste sites were 27 and 35 ppb,
 
respectively (CLPSD 1989). The forms of antimony and the chemical and
 
biochemical process that occur in the aquatic environment are not well
 
understood. Antimony in both aerobic freshwater and seawater is largely in the
 
+5 oxidation state, although antimony in the +3 oxidation state also occurs in
 
these waters. Trivalent antimony is the dominant oxidation state of antimony
 
in anaerobic water. Antimony can be reduced and methylated by
 
microorganisms in anaerobic sediment, releasing volatile methylated antimony
 
compounds into the water. Methylstibonic acid and dimethylstibonic acid occur
 
in natural water; the monomethyl species is the more abundant one (Andreae
 
1983; Andreae and Froelich 1984).
 
EPA has identified 1,177 NPL sites. Antimony and its compounds have been
 
found at 52 of the sites evaluated for the presence of these chemicals (View
 
1989). However, we do not know how many of the 1,177 NPL sites have been
 
evaluated for these chemicals. As more sites are evaluated by EPA, the number
 
may change. The maximum concentrations of antimony reported at these sites are
 
2,100 ppb in groundwater, 1,000 ppb in surface water, and 2,550 ppm in soil.
 
The frequency of these sites within the United States can be seen in Figure 5­
1.
 
The general population is exposed to low levels of antimony in ambient
 
air and food. The average intake of antimony from food and water is roughly
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5 µg/day (Iyengar et al. 1987). The intake from breathing air is generally a 
small fraction of that from ingestion. Exposure from antimony trioxide, which 
is used extensively in textiles and plastics as a fire retardant, is not 
expected to be significant. EPA estimates that approximately 4,000 workers may 
be exposed to antimony and antimony trioxide in production facilities and 
first-level processing facilities. These workers will have the highest levels 
of exposure to antimony. The highest air concentration of antimony reported in 
workplace surveys was 6.2 mg/m3. 
5.2 RELEASES TO THE ENVIRONMENT
 
Most analytical methods for antimony in environmental samples do not
 
distinguish between antimony metal, antimony trioxide, or other compounds of
 
antimony. More sophisticated methods are required to determine the oxidation
 
state of antimony or the nature of its binding to soil and particulate matter;
 
therefore, it is generally impossible to say with certainty what forms of
 
antimony are released from natural and anthropogenic sources, what forms are
 
deposited or occur in environmental samples, and to what form of antimony
 
people are exposed. The form of antimony will have significant consequences as
 
far as its transport, transformations, and bioavailability are concerned.
 
5.2.1 Air
 
Antimony and its compounds are natural components of the earth's crust
 
and releases to the atmosphere result from natural as well as anthropogenic
 
sources. A recent assessment of natural sources of atmospheric trace metals
 
paid special attention to biologic origins of these metals. Nriagu (1989)
 
estimated that 41% of antimony emissions to the air are from natural sources.
 
The natural sources and their median percentage contribution are: wind-borne
 
soil particles, 32.5%; volcanoes, 29.6%; sea salt spray, 23.3%; forest fires,
 
9.2%; and biogenic sources, 12.1%. Previous assessments indicated that
 
natural inputs were minor compared with anthropogenic ones; in one estimate,
 
anthropogenic sources contributed 39 times more antimony than did natural
 
sources (Lantzy and Mackenzie 1979; Yocom 1983).
 
Anthropogenic sources of antimony releases to the atmosphere include
 
nonferrous metal mining, nonferrous metal primary and secondary smelting and
 
refining (Crecelius et al. 1974; Pacyna et al. 1984), coal combustion (Gladney
 
and Gordon 1978), and refuse and sludge combustion (Greenberg et al. 1978).
 
Table 5-1 lists the air releases by state from facilities that produce,
 
process, and use antimony and its compounds according to the 1987 TRI (1989).
 
Releases to air total 135,627 pounds. The highest annual release reported by a
 
single company is 29,900 pounds. The industries that contribute the bulk of
 
releases are those that produce antimony and antimony trioxide. Since the TRI
 
does not include emissions from power plants and refuse and sludge
 
incinerators, their estimate of antimony emissions is not complete. European
 
emissions of antimony were estimated at 380 tons for 1979 (Pacyna et al.
 
1984). Volatile elements and chalcophilic elements (those elements showing an
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association with sulfur), like antimony, show large enrichment over crustal
 
abundances in particulate matter emitted from smelting, coal combustion, and
 
refuse combustion. The ranges of enrichment factors reported for these sources
 
are 10,300-l,000,000, 20-140, and 3,000-10,000, respectively (Gladney et al.
 
1978; Gordon and Sheffield 1986; Small et al. 1981). On a global basis, metal
 
smelting is estimated to make more than double the contribution to atmospheric
 
emissions as other sources, but long-term coal combustion is anticipated to be
 
a dominant factor in future tropospheric antimony levels (Austin and Millward
 
1988). The antimony that is associated with fine particles (less than 1 pm)
 
tends to result from combustion and other high temperature sources, while that
 
associated with large particles (greater than 10 pm) is likely to originate
 
from wind-blown soil and dust (Schroeder et al. 1987).
 
It is estimated that 3 g of antimony are released from copper smelters
 
for each ton of copper produced (Pacyna 1984). Typical concentrations of
 
antimony observed in plumes of five copper smelters ranged from 58 to 370
 
ng/m3 versus an average background level of 2 ng/m3 in ambient air (Small et
 
al. 1981). It was found that most of the antimony deposited close to one
 
smelter originated from ground-level emissions (e.g., fugitive emissions)
 
rather than stack emissions (Ainsworth 1988). It was determined that between
 
57% and 66% of the antimony in the stack of a plant that recycled lead storage
 
batteries was in the vapor form (Craig et al. 1981). This antimony will
 
recondense onto small particles.
 
The antimony content of 166 American coal samples ranged from
 
0.1 to 8.9 ppm, with a mean content of 1.15 ppm (Sabbioni et al. 1983).
 
Therefore, it would be expected that coal-fired power plants are a significant
 
source of antimony emissions. A typical, modem coal-fired power plant emits
 
about 31 µg of antimony per kilogram of fuel burned, compared with 3.9 µg/kg 
for an oil-fired plant (Hasanen et al. 1986). Heavy fuel oil has an antimony 
content of about 0.067 ppm. Emissions from two units of the Columbia Station 
coal-burning power plant in Portage, Wisconsin, ranged from 220 to 1,300 ng 
antimony/m3 when sampled over 1.5 years (Bauer and Andren 1988). Another 
investigator reported that a coal-fired power plant with pollution control had 
stack emissions of 6,800 ng antimony/m3 (Lee et al. 1975). Antimony in these 
emissions tends to be associated with fine particles and the surface of 
particulate matter, consistent with their formation by volatilization and 
subsequent condensation (Hansen and Fisher 1980). In a modern coal plant, 69% 
of antimony emissions were associated with particles less than 3 µm in 
diameter (Sabbioni et al. 1984). Two other studies found that 34-52% of 
emissions from coal-fired power plants were associated with particles less 
than 2 µm, and that the mass medium diameter (MMD) of particles from a plant 
with pollution control devices was 0.6 µm (Gladney et al. 1978; Lee et al. 
1975). 
A study of emissions from two municipal incinerators in
 
Washington, D.C., showed that refuse incineration can account for the major
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portion of antimony in urban aerosols (Greenburg et al. 1978). At least 90% of
 
this antimony is associated with respirable, fine particles that are less than 
or equal to 2 µm in diameter. The concentration range of antimony in suspended 
particles from these incinerators was 610-12,600 ppm, with a mean 
concentration of 2,400 ppm. In performance tests conducted under the Canadian 
National Incinerator Testing and Evaluation Program, 2.3 g antimony/ton of 
refuse was emitted under normal operating conditions. Under a range of 
operating conditions, the amounts ranged from 1.9 to 9.6 g antimony/ton (Hay 
et al. 1986). Respective stack antimony concentrations were 0.6 and 0.5-2.6 
mg/Nm3 at 12% CO2, where Nm3 indicates standard cubic meter (1 atmosphere, 
25°C). A European study gave emission factors for refuse and sewage sludge 
incinerators as 4.55 and 1.9 g antimony/ton, respectively 
(Pacyna 1984). All of the antimony from the stack of a refuse-burning plant 
was in particulate rather than gaseous form (Braun et al. 1983). 
Antimony is a component of ammunition, and therefore antimony may be
 
emitted during the discharge of firearms. This source of emission is
 
inconsequential outdoors. However, in indoor firing ranges, it is a
 
significant source of antimony emission (Dams et al. 1988; Olmez et al. 1985).
 
An air monitoring study was conducted in 1982 at three sites surrounding
 
the Anaconda Minerals Company smelter facility in Montana. This company had
 
closed 2 years earlier after 8 decades of operation. The study was performed
 
under Superfund to ascertain whether the accumulated heavy metals released
 
during the smelting operations and from tailing ponds might become reentrained
 
by wind and pose a health hazard (Ives et al. 1984). While no antimony was
 
reported to have been produced at the Anaconda Minerals Company facility, many
 
of the metals that were extracted, (e.g., copper, lead, arsenic) are found in
 
association with antimony. The atmospheric levels of heavy metals were very
 
low, indicating that there was not any significant reentrainment of heavy
 
metals from tailing ponds or smelter deposits. The particulate matter examined
 
was generally crustal or carbonaceous in character. Antimony was detected on
 
only 3 of 85 air sampling filters at the three sites.
 
Stibine may be produced in lead acid battery plants during the formation
 
process. During this process, an electric current is passed through the
 
battery plates, reducing PbO to Pb at the negative plate, and oxidizing PbO to
 
PbO2 at the positive plate. Hydrogen gas is released that can react with the
 
antimony in the grid metal to form stibine (Jones and Gamble 1984). Stibine
 
may also be formed during remelting of mixed lead-calcium and lead-antimony
 
battery scrap, the former being used for starter batteries. In this process,
 
the intermetallic compound calcium antimonide may be produced in the dross or
 
scum. This compound releases stibine when it comes in contact with water
 
(Ayhan et al. 1982).
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5.2.2 Water
 
Antimony is a natural constituent of soil and is transported into
 
streams and waterways in runoff either due to natural weathering or disturbed
 
soil. Much of this antimony is associated with particulate matter. In the EPA-

sponsored National Urban Runoff Program in which 86 samples of runoff from 19
 
cities throughout the United States were analyzed, antimony was found in 14%
 
of runoff samples at concentrations ranging from 2.6 to 23 ppb (Cole et al.
 
1984).
 
Estimated releases of antimony to water from facilities in the United
 
States that produced, processed, and used antimony in 1987 according to the
 
TRI are found in Table 5-1. These releases totaling 62,328 pounds are much
 
lower than those to air or land. A survey of raw and treated waste water from
 
20 industrial categories indicates that antimony is commonly found in some
 
waste waters. Those industries with mean effluent levels exceeding 1 ppm in
 
raw waste water were (industry [mean level in ppm]): foundries (l.l),
 
porcelain enameling (1.4), and nonferrous metal manufacturing (5.7) (EPA
 
1981). The maximum levels in discharges from these industries were 3.4, 22,
 
and 80 ppm, respectively. Additionally, four other industrial categories had
 
maximum concentrations exceeding 1 ppm. These were laundries (2.4 ppm),
 
inorganic chemical manufacturing (1.4 ppm), ore mining and dressing (3.8 ppm),
 
and paint and ink formulation (2.2 ppm). For treated waste water, only
 
porcelain enameling had mean antimony levels in excess of 1 ppm. The levels
 
reached 4.3 ppm.
 
Domestic waste water is a potential source of antimony in waterways.
 
Concentrations of antimony in influents to 11 municipal waste water treatment
 
plants (POTWs) (155 observations) ranged from 0.0003 to 2.1 ppm; the median
 
value was approximately 0.1 ppm (Minear et al. 1981). Antimony is not well
 
removed in POTWs, and releases from these facilities may contribute to
 
releases of antimony to water (Aulenbach et al. 1987; EPA 1981). The outfall
 
of a sewage treatment plant in Seattle, however, did not appear to make a
 
significant contribution to the antimony levels in the sediment of Puget Sound
 
(Crecelius et al. 1975).
 
Waste water generated from mining and smelting operations comes from
 
seepage, runoff from tailing piles, or utility water used for mine operation.
 
In addition to liquid effluent from smelting operations, slag may be dumped
 
directly into receiving waters (Crecelius et al. 1975). These discharges
 
largely contain insoluble silicates and sulfides which readily settle out.
 
Total antimony in effluent from a primary aluminum production facility was 40
 
ppb (Rawlings 1980). Sixty percent of this antimony was subsequently removed
 
by lime coagulation.
 
One of the potentially dangerous sources of chemical release at waste
 
sites is from leachate. Leachate from three municipal landfills in New
 
Brunswick, Canada, each contained 0.01 ppm of antimony (Cyr et al. 1987).
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The antimony concentration in sediment at two sites below the leachate
 
outfalls was 23.9 ppm (dry weight) and nondetectable, respectively.
 
5.2.3 Soil
 
Most of the antimony released to the environment is released to land.
 
According to Table 5-1, which shows the estimated releases in 1987 of domestic
 
industries that produce, process, or use antimony, 2,845,131 pounds of
 
antimony are released to land, constituting 93% of environmental releases
 
reported to TRI (TRI 1989). The industries that release the largest amount of
 
antimony are the smelters that produce antimony and antimony trioxide. Much of
 
this release is slag, which is the residue from smelting operations. Other
 
releases to land include sludge from POTWs and municipal refuse.
 
An analysis of the concentration of antimony at hazardous waste sites at
 
the Contract Laboratory Program Statistical Database (CLPSD) shows that
 
antimony was reported in 153 of 1,307 soil samples, with geometric mean and
 
maximum levels in positive samples of 8.0 and 330 ppm, respectively (Eckel and
 
Langley 1988). An analysis of these data indicates that 7.3% of the CLPSD
 
samples exceed the number expected to be above the 95% upper confidence limit
 
for background U.S. soils (Eckel and Langley 1988). The CLPSD includes both
 
NPL and non-NPL data. A more recent update of the CLPSD reports a 12.8%
 
occurrence of antimony and a geometric mean concentration of 16.86 ppm (CLPSD
 
1989). No analysis was performed on these results to indicate what percentage
 
exceed the background levels of antimony normally found in soil.
 
5.3 ENVIRONMENTAL FATE
 
It is not always possible to separate the environmental fate processes
 
relating to transport and partitioning from those relating to transformation
 
for a metal and its various compounds and complexes. Part of this problem is
 
that the form of a metal is rarely identified. A change of mobility may result
 
from a transformation of a metal to a more or less soluble form. Adsorption
 
may be the result of the formation of strong bonds (transformation) as well as
 
weak bonds. Information regarding the deposition and general adsorption of
 
antimony is in Section 5.3.1 and information regarding the areas of
 
environmental fate where speciation is discussed is in Section 5.3.2.
 
5.3.1 Transport and Partitioning
 
Antimony is released to the atmosphere in the form of particulate matter
 
or adsorbed to particulate matter. It is dispersed by wind and removed by
 
gravitational settling and dry and wet deposition (Schroeder et al. 1987). The
 
removal rate and distance traveled from the source will depend on source
 
characteristics (e.g., stack height), particle size and density, and
 
meteorological conditions.
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Gravitational settling governs the removal of large particles (greater 
than 5 µm), whereas smaller particles are removed by the other forms of dry 
and wet deposition. Removal of coarse particles may occur in a matter of 
hours. Very small particles may have an atmospheric half-life as long as 30 
days (Schroeder et al. 1987). Antimony is predominantly associated with small, 
submicron particles (Stoessel and Michaelis 1986). This is frequently the case 
with the more volatile metals, such as antimony, that may volatilize during 
combustion and condense when cooled. A model which relates particle size to 
volatility estimates an average atmospheric half-life for antimony of 1.9 
days; for the more volatile antimony trioxide (see Table 3-2), the 
estimated half-life is 3.2 days (Mueller 1985). With such an atmospheric half-
life, antimony may be transported far from its source. Evidence of this was 
reported by Animoto and Duce (1987), who stated that the antimony levels in 
aerosols at the Enewatak Atoll in the tropical North Pacific were higher than 
those expected from seawater or crustal material. 
Metal deposition is characterized by large temporal and spatial
 
variability. Estimated antimony deposition rates in urban areas are
 
0.006 and 0.004 kg/hectare/year (60 and 40 ng/cm2/year) for dry and wet
 
deposition, respectively (Schroeder et al. 1987). For remote areas, bulk (wet
 
plus dry) deposition may be as little as 0.00016 kg/hectare/year (1.6
 
ng/cm2/year). Rates of air-sea transfer of antimony are similar to the rates
 
of accumulation of antimony in sediment (Arimoto and Duce 1987).
 
The partitioning between dry and wet deposition depends on the intensity
 
and duration of precipitation, the element in question, its form in the
 
particulate matter, and its particle size. The ratio of wet to dry deposition
 
generally increases with decreasing particle size; therefore, a larger
 
proportion of antimony will be found in rain compared with most other metals.
 
A study of the wet and dry deposition over an 8-week period on an island in
 
the German Bight, which was presumably far from sources, found 87% of
 
deposited antimony dissolved in rain, 11% in particulate matter in rain, and
 
only 2% as dry deposition (Stoessel and Michaelis 1986). In other studies
 
conducted in areas removed from sources of antimony emissions, half of the
 
antimony deposition was in the form of wet deposition (Ainsworth 1988). The
 
total antimony deposition annualized from a B-month study in an industrial
 
area of England where a number of ferrous and nonferrous metal smelting and
 
manufacturing works were concentrated was 1,000 ng/cm2-year (a factor of 20-40
 
above nonurban deposition rates) (Pattenden et al. 1982). Of this, 42%
 
represented wet deposition, of which 58% was dissolved antimony.
 
Antimony released into waterways is generally associated with
 
particulate matter; it is transported to and settles out in areas of active
 
sedimentation such as where a river empties into a lake or bay (Beijer and
 
Jernolov 1986). Similarities in the composition of suspended river sediment
 
and the sediment in bays indicate that the rivers transport the suspended
 
sediment and deposit it in the bottom sediment (Crecelius et al. 1975).
 
Additionally, when a river feeds into an estuary, the salinity changes that
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are encountered may affect adsorption to sediment and particulate matter,
 
complexation, and coprecipitation.
 
Little is known of the adsorptive behavior of antimony, its compounds,
 
and ions. The binding of antimony to soil is determined by the nature of the
 
soil and the form of antimony deposited on the soil. Some forms of antimony
 
may bind to inorganic and organic ligands. On the other hand, a mineral form
 
would be unavailable for binding. Some studies suggest that antimony is fairly
 
mobile under diverse environmental conditions (Rai and Zachara 1984), while
 
others suggest that it is strongly adsorbed to soil (Ainsworth 1988; Foster
 
1989; King 1988). Since antimony has an anionic character (e.g., Sb(OH)i), it
 
is expected to have little affinity for organic carbon. No information could
 
be found about antimony's adsorption to clay minerals. It is not expected that
 
cation exchange, which generally dominates adsorption to clay, would be
 
important for anionic antimony. Antimony is known to form coprecipitates with
 
hydrous iron, manganese, and aluminum oxides in soil and sediment (Callahan et
 
al. 1978).
 
The capacity of soil to adsorb antimony and the nature of the bound
 
antimony were evaluated by incubating 200 ppm of antimony potassium tartrate
 
with 5 g samples of soils for 6 days (King 1988). Thirteen soils and subsoils
 
(21 samples) from the southeastern United States (10 mineral and 3 organic)
 
were included in the study. Antimony adsorbed strongly to most soils. The
 
amount of adsorbed antimony ranged from 50% in Lakeland surface soil to 100%
 
in several soils; the median percent adsorption was 93%. The percentage of
 
nonexchangeable (i.e., that not removed with KCl) antimony adsorbed paralleled
 
that of total antimony and ranged from 57% to 99%. Both sorbed and
 
nonexchangeable antimony were negatively correlated to sand content in mineral
 
soil. The soil/water partition coefficient (mmol/kg soil)/(mol/m3) was 81 and
 
greater than 185 for organic and mineral soils, respectively. Several mineral
 
soils adsorbed 100% of the antimony and were excluded from the averaging. It
 
is not clear what species of antimony was adsorbed in this study. If it was
 
the antimony tartrate ion, the study may not be particularly relevant to other
 
forms of antimony. The mobility of antimony in clay, sandy loam, silt loam,
 
and sand soils was investigated using soil thin-layer chromatography (TLC)
 
(Foster 1989). The antimony was applied as antimony trioxide in a water or 1%
 
HCl suspension and developed with water in 8 hours or less. Despite
 
experimental difficulties, the results demonstrated that there is no general
 
mobility of antimony in any soil. The experimental problems and the fact that
 
small amounts of antimony were found in all zones is possibly due to an
 
unsuitable soil digestion (Ainsworth 1988).
 
A Superfund site study at a battery reclamation plant showed that while
 
soil and sediment contained high levels of antimony, an aquifer 3 m below the
 
surface contained 0.1 ppm of antimony; no antimony was detected in two deeper
 
aquifers (Trnovsky et al. 1988). Antimony adsorbs strongly to colloidal
 
material in soil. The partition coefficient of antimony to 0.05-0.003 µm 
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colloids was 1,300. Antimony adsorbed to such material can be transported with
 
the colloids in groundwater (Buddenmeier and Hunt 1988).
 
Leaching experiments performed with river sediment samples from a mintng
 
district in Idaho indicated that Sb(V) was the major species released during
 
leaching (Mok and Wai 1990). The fraction of antimony leached from sediment
 
with deionized water after 10 days was highly correlated with the free iron
 
and manganese oxide content of the sediment (correlation coefficients of 0.90
 
and 0.75). Experiments were also performed in which the pH dependence of
 
leaching was determined. The release of antimony from the sediment increased
 
at low pH and increased sharply at high pH. The form of released antimony was
 
also sensitive to pH. At pH 2.7, the bulk of antimony released was as
 
Sb(II1); at pH 4.3, the concentrations of tri- and pentavalent antimony were
 
comparable; and at pH 6.3 and above, Sb(V) was the predominant species.
 
In order to evaluate the potential for leaching of elements from
 
landspread sewage sludge, Gerritse et al. (1982) studied the adsorption of
 
elements from water, salt solutions, and sludge solutions to sandy and sandy
 
loam top soils. They used metal levels that occur in the solution phase of
 
sewage sludge, lo-100 ppb in the case of antimony. The results indicate that
 
antimony is fairly mobile in these soils. The adsorption constants were
 
approximately 2-16 in the sandy soil and 20 in the sandy loam soil. Although
 
the presence of sludge increases the mobility of many trace elements because
 
of complexation with dissolved organic compounds or increased ionic strength,
 
this did not appear to be the case with antimony (Gerritse et al. 1982). It is
 
not easy to reconcile these results with those of Foster (1989), Ainsworth
 
(1988), Trnovsky et al. (1988), or Van der Sloot et al. (1982). These studies
 
indicated that antimony deposited on the soil surface accumulates primarily in
 
the surface layer, and that aquifers beneath antimony waste piles are not
 
grossly contaminated.
 
Mobilization of elements deposited on soil in fly ash is a potential
 
source of terrestrial and aquatic pollution. When the alkaline fly ash from a
 
coal-fired power plant was packed in a column and subject to leaching with
 
dilute sulfuric acid, antimony was partially dissolved and removed from the
 
upper layers of ash and deposited and retained on lower sections of ash in the
 
column (Warren and Dudas 1988). It was thought that extractable,
 
surfaceadsorbed antimony in the upper layers of ash was removed by the acid,
 
subsequently precipitated by iron oxyhydroxides, and retained lower down in
 
the column. Other column leaching and shake-flask experiments with coal ash
 
are too complex to summarize; they basically indicate that leaching of
 
antimony is low. Low concentrations of antimony found in groundwater beneath
 
precipitator ash ponds lend field confirmation to the laboratory results (Van
 
der Sloot et al. 1982).
 
When saline sediment is oxidized, such as when dredged sediment is
 
exposed to oxygen, the pH can become very low (pH 3.1 in a lab experiment),
 
and antimony and other toxic metals may be released (DeLaune and Smith 1985).
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This occurs because sediments in estuaries often contain pyrite and other
 
readily oxidizable sulfur compounds; sulfuric acid may be produced and
 
overwhelm the buffering capacity of the sediment. An analogous pH decrease
 
following oxidation was not observed in a freshwater sediment.
 
Antimony does not appear to bioconcentrate appreciably in fish and
 
aquatic organisms. No detectable bioconcentration occurred during a 28-day
 
test in bluegills (EPA 1980). Only low levels of antimony have been reported
 
in fish and aquatic organisms collected off the coast of Africa, Australia,
 
and the Danube River in Austria (Callahan et al. 1978; Maher 1986).
 
Bioconcentration factors for antimony ranged from 0.15 to 390 (Acquire 1989;
 
Callahan 1978). A study of the distribution of antimony around a smelter site
 
indicated that antimony occurring in plants results from surface deposition.
 
Uptake from soil is minor and appears to be correlated with the amount of
 
available antimony (that which is soluble or easily exchangeable) (Ainsworth
 
1988). Antimony bioconcentration was measured in voles, shrews, rabbits, and
 
invertebrates around a smelter. Analysis of antimony in organs of the small
 
mammals, compared with estimates of their antimony intake from food, showed
 
that, although the amount of antimony in the organs was elevated, it was low
 
compared to the amount ingested. The results suggest that antimony does not
 
biomagnify from lower to higher trophic levels in the food chain.
 
5.3.2 Transformation and Degradation
 
5.3.2.1 Air
 
Little is known about the chemical forms and physical and chemical
 
transformations of trace elements in the atmosphere. This is primarily
 
because analytical methods provide information concerning the metal content
 
rather than the specific compounds or species. Studies at an antimony smelter
 
suggest that emissions consist of antimony oxide (Ainsworth 1988). In the
 
absence of specific information, it is generally assumed that elements of
 
anthropogenic origin, especially those emanating from combustion sources, are
 
present as the oxide. Windblown dust particles may contain antimony in mineral
 
species, such as sulfides and oxides, and are associated with silicates.
 
When released into the atmosphere as an aerosol, antimony is believed to
 
be oxidized to antimony trioxide by reaction with atmospheric oxidants.
 
Antimony trioxide particles do not undergo changes in chemical composition,
 
particle size, or morphology after emission; however, a surface coating of
 
sulfate may form (Ainsworth 1988).
 
5.3.2.2 Water
 
There is relatively little information available regarding the behavior
 
of antimony in the aquatic environment. Since the dissolved state is the phase
 
in which transfers to suspended matter, organisms, and sediment occur,
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it is especially important to know the oxidation state and forms of the
 
antimony that is dissolved. This is particularly difficult for antimony
 
because the levels of total antimony in water are so low. Thermodynamically,
 
most dissolved antimony in natural waters under aerobic conditions should be
 
present in the +5 oxidation state as antimonate species. At 0.001 M total
 
antimony, the dominant species were Sb(OH)6¯ and Sb(OH)5 
0
 (Rai et al. 1984). A
 
small quantity of polymeric hydroxy species were found, but these will be less
 
significant when the total antimony concentration is low, such as in natural
 
water. While industrial inputs will commonly contain antimony in the +3
 
oxidation state (e.g., antimony trioxide), it is not known how fast antimonite
 
would oxidize to antimonate under natural conditions. Under reducing
 
conditions, trivalent species such as Sb(OH) 0, Sb(OH) ¯ , and Sb S 4- may be
3 4 2 4
 
significant (Andreae and Froelich 1984; Rai et al. 1984).
 
Antimony compounds may undergo photochemical reactions, but these do not
 
appear to be significant in determining their aquatic fate (Callahan et al.
 
1978). Antimony trioxide suspensions strongly absorb ultraviolet radiation
 
below 325 nm and darken. The process is reversible, and when the light is
 
removed, the white color slowly returns (Markham et al. 1958). The effect is
 
believed to be due to peroxide radical formation on the crystal surface. Both
 
water and oxygen seem to be necessary for the reoxidation of the reduced
 
antimony.
 
Antimony can be reduced and methylated by microorganisms in the aquatic
 
environment, similar to arsenic, and become mobilized (Andreae et al. 1983;
 
Austin and Millward 1988). This reaction is most likely to occur in reducing
 
environments, such as in bed sediment. In the case of arsenic, this reaction
 
may be mediated by fungi and bacteria (Beijer and Jernelov 1986), but it is
 
not known whether this is the case with antimony. The resulting
 
trimethylstibine is initially oxidized by atmospheric oxygen to a mixture of
 
trimethylstilbine oxide ((CH ) SbOH) and trimethylstibinic acid ((CH ) SbO H),
3 3 3 2 3

and then to antimony oxides and insoluble polymers (Parris and Brinckman
 
1976). The rate constant is estimated to be of the order of 0.1 to 0.2 L/mol­
sec. Trimethylstibine has a high vapor pressure, 103 mmHg at 25ºC, and might
 
volatilize before it is completely oxidized. The oxidation product, (CH3)3SbO,
 
is much more soluble than trimethylstibine; therefore, oxidation will reduce
 
volatilization (Callahan et al. 1978). Oxidation of
 
trimethylstibine in the gas phase is very rapid; the rate is 0.11/mmHg-sec or
 
2000 L/mol-sec. Trimethylstibine has been shown to react with alkyl iodides
 
and bromides; this results in the formation of quaternary salts (Parris and
 
Brinckman 1975). Should antimony occur in a landfill with alkyl halides, the
 
formation of quaternary salts should greatly enhance antimony's mobility.
 
The chemical and biochemical transformations of antimony in natural
 
waters are not well understood. There are only a few studies that describe the
 
antimony species present in various systems and their transformations. A study
 
of the waters of the Ochlockonee River estuary revealed the presence of
 
Sb(III), Sb(V), methylstibonic acid, and dimethylstibonic acid (Andreae 1983).
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The concentration of all four species increased with the salinity of the
 
water. For freshwater, the concentrations were about 18, 3.3, and 1 ng
 
antimony/L (ppt) for Sb(V), Sb(III), and methylstibonic acid, respectively;
 
dimethylstibonic acid was not detectable. The concentration of Sb(V) and
 
Sb(II1) increased linearly with salinity, reaching 135 and 11 ppt,
 
respectively, in the ocean. An analogous increase in the level of the
 
methylated forms with salinity was nonlinear, suggesting that these forms are
 
consumed in the estuary. In seawater, levels of methylstibonic acid and
 
dimethylstibonic acid were 12.5 and 1.5 ng antimony/L (ppt), respectively. It
 
was reported that the Sb(III) levels were approximately 2% that of Sb(V) in
 
samples of sea water and river water (Mok and Wai 1987). In a sample of river
 
water from the Kellogg mining district in Idaho, the contribution of Sb(III)
 
was only 0.4% (0.03 ppb compared with 7.03 ppb of Sb(V)). More recent studies
 
in Idaho indicated that 1-4% of antimony was in the trivalent form in a river
 
receiving mining leachate, while at a site on an unpolluted fork of the same
 
river, the fraction was 17% (Mok and Wai 1990).
 
The depth profile of antimony species in the Baltic sea showed that
 
Sb(V) was the most abundant species in the oxic zone, although Sb(III) was
 
detectable throughout the water column (Andreae and Froelich 1984). A maximum
 
for Sb(III) in the oxic zone was sometimes noted in the surface layer and is
 
believed to result from biological activity. There is evidence that
 
phytoplankton can reduce Sb(V) to the Sb(III). Sb(III) decreases to very low
 
levels at the base of the seasonal thermocline and remains low down to the
 
sediment where increasing levels are again observed. Sb(III) only accounts
 
for 44% of the inorganic antimony in the anoxic zone, and speciation in this
 
region is unclear. Thermodynamically, the antimony should be in the trivalent
 
state. Thiocomplexes are thought to account for some of the antimony in this
 
zone. Methylated antimony species existed throughout the water column and made
 
up 10% of total antimony. Monomethyl antimony species were more abundant in
 
surface waters and in the anoxic zone. There was no sharp increase in methyl
 
antimony near the sediment, which would be expected if these species were
 
formed biosynthetically. Since the highest antimony concentration is at
 
the surface, it is unlikely that antimony is taken up by phytoplankton, as is
 
the case with arsenic. A decrease in antimony concentration with depth
 
suggests scavenging by particulate matter and, at lower depths, by iron
 
hydroxyoxides.
 
Sea water samples off the Belgian coast were analyzed using oxidation,
 
UV irradiation, and anodic stripping voltammetry to distinguish bound antimony
 
and to identify its oxidation state (Gillian and Brihaye 1985). The
 
concentration of total antimony ranged from 0.05 to 0.38 ppb. The study showed
 
that antimony was mainly present as Sb(V), and the percentage complexed to
 
organic matter varied between 20% and 60%. This results is surprising because
 
antimony occurs as anionic species in water and these are not expected to
 
complex with organic matter. These results have not been confirmed by other
 
investigators. The concentration of Sb(II1) was below the detection
 
limit (0.005 ppb) at almost all sites. The exception was the coastal sites
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where it ranged up to 0.039 ppb. Antimony found in rain and snow is
 
predominantly in the +5 oxidation state (Metzger and Braun 1986).
 
Information concerning the behavior of antimony in sediment is extremely
 
limited. Investigators would like to know how strongly antimony is bound in
 
sediment and what the potential is for long-term mobilization. A study was
 
conducted of sediments in Puget Sound, Washington, where a copper smelter
 
discharges large amounts of antimony (Crecelius et al. 1975). In 23
 
noncontaminated sediment samples, antimony concentrations correlated with
 
organic carbon and fine-grained particles; however, since these sediments are
 
also associated with hydrous-iron oxides, further investigations on the
 
association of antimony in sediment were conducted and showed that less than
 
10% of the antimony in both contaminated and uncontaminated sediment was bound
 
to readily oxidizable organic matter. Extraction with oxalate and
 
citratedithionite-bicarbonate suggested that roughly half of the antimony in
 
uncontaminated sediment and less than 20% of that in contaminated sediment was
 
bound to extractable iron or aluminum compounds. Most of the antimony in the
 
polluted water was bound to chemically stable slag.
 
Experiments were performed in which the forms of antimony in sediment
 
were evaluated after the sediment was incubated under anaerobic conditions for
 
45 days (Brannon and Patrick 1985). Ten dredged, contaminated sediments that
 
were obtained from various locations in the United States were used as is or
 
amended with 75 ppm antimony potassium tartrate. An extraction procedure was
 
used that identified the antimony in interstitial water and in "exchangeable,"
 
"easily reducible," and "moderately reducible" sediment fractions. Essentially
 
all antimony in the unamended sediment was in a "moderately reducible" phase
 
(oxalate extraction). The same was generally true for 7 of the 10 sediments
 
that were amended with potassium antimony tartrate. In the other three
 
sediments, the greatest proportion of antimony was in the "easily reducible"
 
fraction. A small fraction of the antimony-amended sediment (but none of the
 
unamended sediment) was contained in the more potentially mobile interstitial
 
water and "exchangeable" fraction. It should be stressed that since the
 
amended samples had higher antimony levels, small percentages in
 
different fractions were more readily detectable than for the unaziended
 
sediment. The high correlation of antimony with the "moderately reducible"
 
fraction indicates that hydrous iron and aluminum oxides were affecting the
 
fixation of antimony. These hydrous oxides are positively charged under
 
environmental conditions and bind the anionic antimony. The samples were
 
subjected to 6 months of aerobic leaching. Unamended samples released antimony
 
very slowly, compared with amended samples, indicating the higher amounts of
 
mobile antimony in the latter samples. Antimony-amended sediments lost from
 
3.6% to 32% of their antimony during leaching; unamended sediments lost from
 
0% to 23% of their antimony. The sediment/water distribution coefficient
 
ranged from 3.3 to 27.5 in amended sediments, compared with values
 
up to 1,183 in unamended sediments. The distribution coefficient correlated
 
with iron in both amended and unamended sediment; additionally, it correlated
 
with calcium carbonate in amended sediment. After aerobic leaching, there was
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an increase in antimony in the "moderately reducible" phase and a decrease in
 
the "easily reducible" phase that paralleled changes in iron concentrations.
 
Volatile antimony compounds were formed in seven of the amended sediments but
 
in none of the unamended sediments; they escaped through the overlying water
 
independently of the redox state of the water (i.e., aerobic or anaerobic).
 
When 10 and 100 ppm antimony trioxide with added nutrients was incubated
 
with natural bottom sediment from Puget Sound under aerobic or anaerobic
 
conditions for up to 120 days, three organoantimony biotransformation products
 
were found in solution after 60 days (Martinson 1988). Two of these were
 
identified as methylstibonic acid and dimethylstibonic acid. No determination
 
of rate or conditions affecting the transformation was made. However, it was
 
estimated that much less than 0.1% of the antimony present was transformed.
 
Few data are available on the removal of antimony in the activated
 
sludge process used in water treatment plants. In one laboratory simulation,
 
mixture of metals at levels considered typical of industrial/domestic sewage
 
(0.1 ppm antimony) was continuously added to the influent of the treatment
 
system. No antimony removal was observed (Kempton et al. 1983).
 
5.3.2.3 Soil
 
Little is known about the behavior of antimony on soil during
 
weathering. In aerobic surface soils, oxidation generally occurs. Antimony
 
trisulfide in ore deposits is known to be oxidized by soil bacteria (Ainsworth
 
1988). Methylated antimony compounds, similar to those formed in sediment, may
 
be formed in waterlogged soil.
 
The form and availability of antimony in soil is determined by measuring
 
antimony's extractability with different solvents. A sequential extraction
 
procedure was used to determine the form of antimony in soil around a stibnite
 
smelter and to compare it with that found at a control site (Ainsworth 1988).
 
The extraction procedure used could identify the following fractions of
 
antimony: soluble or bound to ion-exchange sites and, therefore, available;
 
bound to carbonates; bound to manganese oxides that are easily reduced; bound
 
to iron oxides that are less easily reduced; bound to organic matter; and
 
residual antimony that was not incorporated into silicates (Ainsworth 1988).
 
Results of the study showed that the distribution pattern among the various
 
fractions was different at the smelter and control sites. Three quarters of
 
the total extracted antimony in surface (0-5 cm) soil near the smelter was in
 
the residual fraction; none of the antimony in the control site was in this
 
fraction. The remainder of antimony in soil from the smelter site was more or
 
less equally distributed among the other fractions. Higher proportions of the
 
antimony at the control site were in the readily available fraction, bound to
 
manganese oxides, or complexed with organic matter, compared to the smelter
 
site. Because of the low concentration of antimony in the control-site soil,
 
fractional determinations are less accurate than for sites near the smelter.
 
For subsoil (greater than 15 cm depth) from the smelter site, less antimony
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was found in the residual fraction (62%), and more antimony was in the
 
available fraction, bound to carbonates, or bound to iron oxides than in the
 
surface sample. The factors determining the distribution of antimony between
 
fractions is unclear. The absence of any residual fraction at the control site
 
has been explained by assuming that antimony-containing mineral has been
 
completely broken down.
 
Near the smelter, antimony deposits have a different character than
 
further away since they are derived from fugitive emissions rather than stack
 
deposition. In a 3-month study of deposition of antimony from the smelter,
 
about one-third to one-half of the deposited antimony at the smelter site was
 
soluble, compared with about one-half to two-thirds at other sites. Since
 
antimony in rain near the smelter site was soluble, it appears that once
 
deposited on soil, antimony rapidly converts to more insoluble forms.
 
5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT
 
5.4.1 Air
 
There are insufficient data regarding antimony concentrations in the
 
atmosphere for representative general mean or median concentrations to be
 
reported. Antimony concentrations in air particulate matter in remote, rural,
 
and U.S. urban areas are 0.00045-1.19, 0.6-7, and 0.5-171 ng/m3, respectively
 
(Austin and Millward 1988; Schroeder et al. 1987). No vapor-phase antimony has
 
been reported. Antimony concentrations over the North Atlantic and North
 
Pacific are 0.086 and 0.0037 ng/m3, respectively (Arimoto and Duce 1987;
 
Austin and Millward 1988). Two values reported for antimony in aerosols in
 
clean continental and marine environments are 0.2 ng/m3 at the Jungfraujoch in
 
the Swiss Alps and 0.00045 ng/m3 at American Samoa (Austin and Millward 1988).
 
The mass median aerodynamic diameter of antimony-containing aerosols from a
 
range of areas remote from anthropogenic sources was 0.86 µm (Milford and 
Davidson 1985). The mass size distribution is bimodal, with the larger peak at 
about 0.6 µm and a smaller one at about 3 µm. An example of the size 
distribution of antimony-containing particles removed from anthropogenic 
sources was obtained in an 8-week study on an island in the German Bight. The 
concentration of antimony in a size fraction increased as the size decreased. 
The antimony concentration ranged from 0.03 ng/m3 for particles greater than 
7.2 µm to 0.3 ng/m3 for particles less than 0.5 µm (Stoessel and Michaelis 
1986). 
Several studies show that antimony can travel long distances, and that
 
ambient levels may reflect the origin of the air masses. The geometric mean
 
antimony concentration in aerosols at three rural/remote locations in New York
 
state was 1.0, 0.72, and 0.33 ng/m3 (Dutkiewicz et al. 1987), and the
 
enrichment over crustal abundance ranged from 920 to 1,650. The enrichment
 
factor is smaller but similar to the mean enrichment factor of 1,880 for
 
antimony in 29 cities (Gladney et al. 1984). The high enrichment indicates
 
that the antimony is of anthropogenic origin. An analysis of the New York
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State data using backward-in-time air trajectories is consistent for the
 
Midwest being the dominant source of antimony. An analysis of European sources
 
and wind trajectories further illustrate that antimony may be transmitted over
 
long distances. The average concentration at a city in southern Norway was
 
0.54 ng/m3 when the air masses came from the United Kingdom, and 0.07 ng/m3
 
when they came from over the Atlantic (Hillamo et al. 1988).
 
Twenty-four-hour samples collected at 10 locations in Washington, D.C.,
 
yielded average antimony concentrations ranging from 1.1 to 3.0 ng/m3
 
(Kowalczyk et al. 1982). As a result of a chemical element balance analysis,
 
the three major contributing sources in order of decreasing significance are
 
believed to be refuse incineration, motor vehicles, and coal combustion. In a
 
Houston study, the range of antimony concentrations in fine (0.1-2.5 µm) 
aerosols was 0-12 ng/m3, whereas that in particles greater than 2.5 µm was 0-4 
ng/m3 (Johnson et al. 1984). Median, mean, and maximum concentrations of 
antimony in aerosols at three sites in Quebec, Ontario, and Nova Scotia were 
0.05-0.10, 0.11-0.23, and 0.37-2.17 ng/m3, respectively (Hopper and Barrie 
1988). According to the Texas Air Control Board, the first- and secondhighest 
annual average antimony concentration in Texas between 1978 and 1982 was 452 
and 50 ng/m3 at Laredo and Dallas, respectively. The statewide 1978-1982 
average was below the minimum detectible mean of 90 mg/m3 (Wiersema et al. 
1984). 
Concentrations of antimony in 24-hour air samples at Kellogg, Idaho,
 
which is the site of a large and active nonferrous metal industry, ranged from
 
5.21 to 1,210 ng/m3 with a mean of 146 ng/m3 (Ragaini et al. 1977). Air
 
particulate matter in Tacoma, Washington, 40 km downwind of a copper smelter
 
often have antimony concentrations in excess of 300 ppm (Crecelius et al.
 
1974). The 6-month average concentration of antimony in air in an industrial
 
area of England where a number of ferrous and nonferrous metal smelting and
 
manufacturing works were concentrated was 40 ng/m3. This is a factor of 50
 
higher than that found in rural areas (Pattenden et al. 1982). Antimony was
 
reported in air at one site on the NPL (View 1989). The maximum concentration
 
at the site was 69 ng/m3.
 
The mean monthly concentration of antimony in precipitation at Birkenes
 
in southern Norway ranged from 0.2 to 2.3 ppb with a mean of 0.6 ppb (Pacyna
 
et al. 1984). During the same period, the respective air concentrations were
 
0.19-0.80 and 0.43 ng/m3. Rain samples were collected during two storms upwind
 
and downwind of a copper smelter in Tacoma, Washington. Antimony in rainwater
 
originated primarily from the smelter. The mean total antimony concentration
 
in rainwater downwind from the smelter was 1.3 ppb; the concentration upwind
 
was 0.03 ppb (Vong et al. 1988). Eighty percent of the antimony in rainwater
 
was dissolved (i.e., passed through a 0.45 µm filter). 
Antimony is almost entirely found in the particulate, as opposed to the
 
dissolved fraction of snow (Landsberger et al. 1983). The antimony content of
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snow particulate matter in samples from Montreal, Canada, ranged from
 
4 to 145 ppm. A more recent sampling of snow around Montreal found total
 
antimony concentrations of l-8.7 ppb and enrichment factors of 39-590
 
(Zikovsky and Badillo 1987).
 
Antimony is a component of ammunition, and studies have been performed
 
to ascertain the elemental concentrations of antimony in the air of indoor
 
shooting ranges. Antimony might be expected in such situations because it is
 
alloyed with lead in bullets, and lead stibnite and antimony sulfides are used
 
as primers (Dams et al. 1988). After an intensive 3-hour shooting exercise,
 
levels of antimony reached 119 µg/m3 or four orders of magnitude over ambient 
levels (Vandecasteele et al. 1988). An instructor at the shooting range had a 
time-weighted average (TWA) inhalable antimony concentration of 12.0 µg/m3, 
compared with the threshold limit value (TLV) of 500 µg/m3. An American study 
conducted at the National Guard Armory in Washington, D.C., during 
routine daytime and gun club use, had antimony concentrations ranging from 57 
to 216 µg/m3 versus background air ranging from 1.5 to 2.3 µg/m3, an enrichment 
of 9,900 over District of Columbia air) (Olmez et al. 1985). More than 60% of 
the antimony was associated with respirable particles with an aerodynamic 
diameter less than 3.5 pm. 
5.4.2 Water
 
Antimony has a low occurrence in ambient waters, and there are few
 
monitoring data with which one can establish a mean value of antimony in
 
surface waters. Eckel and Jacob (1989) gathered water monitoring data from the
 
Water Resources Division of the U.S. Geological Survey covering the period
 
from about 1960 to September, 1988, and found that all but 70 of 1,077 entries
 
for dissolved antimony were below 5 ppb, which was the probable detection
 
limit. The geometric mean and standard deviation of the 70 values above 5 ppb
 
were 12 and 1.93 ppb, respectively. By applying a technique known as
 
censoring, and assuming a log normal distribution for the monitoring data,
 
these investigators determined the population geometric mean and standard
 
deviation for antimony to be 0.25 and 7.16 ppb, respectively. The
 
concentration of dissolved antimony in other rivers reported in the literature
 
include: St. Lawrence River at Massena, New York, 1.62 nM (0.197 ppb); Yukon
 
River 2.73 nM (0.332 ppb); and European rivers less than 0.03-4.43 nM (0.004­
0.539 ppb) (Andreae and Froelich 1984). Few rivers have dissolved antimony
 
concentrations below 1 nM (0.120 ppb) (Andreae and Froelich 1984).
 
The major antimony mining area in the United States was the Kellogg
 
district in northern Idaho, and mining and smelting wastes have been dumped
 
into the South Fork of the Coeur d'Alene River for over 80 years (Mok and Wai
 
1990). The South Fork joins with the North Fork of the river to form the Main
 
Stem of the Coeur d'hlene River somewhat below Kellogg. Mean and maximum total
 
dissolved antimony concentrations at two sites on the South Fork are 4.3 and
 
8.2 ppb, respectively. Mean and maximum concentration at six stations on the
 
Main Stem ranged from 0.6 to 1.0 and 0.8 to 1.9 ppb, respectively.
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Those at a station on the unpolluted North Fork were 0.09 and 0.2 ppb,
 
respectively.
 
The concentration of dissolved antimony in a polluted estuary in
 
Portugal was found to increase with salinity up to 30 parts per thousand and
 
then rapidly decrease (Andreae et al. 1983). The total antimony content of
 
seawater samples off the Belgian coast ranged from 0.05 to 0.38 ppb (Gillain
 
and Brihaye 1985). Filtered and unfiltered coastal marine waters from the
 
North Adriatic contained 0.31 and 45 ppb, respectively (Strohal et al. 1975).
 
Little information is available concerning the concentration of antimony
 
in groundwater. The range of antimony concentrations reported for antimony in
 
groundwater in Switzerland (0.3-1.0 ppb) was essentially the same as that
 
reported for the nearby Glatt River (0.5-1.2 ppb) (von Gunten and Ku11 1986).
 
The concentration of antimony in groundwater under four retention-recharge
 
basins receiving urban runoff water in Fresno, California, were all less than
 
the 1 ppb detection limit (Nightingale 1987).
 
Antimony was found in 5.7% and 8.5% of surface waters and groundwaters
 
at hazardous waste sites on the CLPSD (CLPSD 1989). The geometric means of
 
antimony found in positive samples of these media were 40 and 50 ppb,
 
respectively (CLPSD 1989). The CLPSD includes both NPL and non-NPL sites.
 
Since antimony is used in solder, there has been interest as to whether
 
antimony will leach from pipes soldered with antimony-containing solder into
 
drinking water. Leaching of antimony from tin/antimony (Sn/Sb) solder when it
 
comes in contact with water with pH of 5.2-8.6 was evaluated using loops of
 
pipe containing 20 solder joints (Murrell 1987). Antimony was undetectable
 
(less than 4 ppb) in the water at first, but rose to 10 ppb after 4 days and
 
68 ppb (at pH 7.4) after 4 weeks. A study was conducted at the University of
 
Washington to evaluate the potential for leaching of metals into drinking
 
water from 95/5 Sn/Sb solder (Herrera et al. 1982). After a series of static
 
and continuous-flow laboratory tests and evaluation of field samples from
 
university buildings, it was concluded that increases in antimony
 
concentration as a result of corrosion and leaching were minimal and would not
 
contribute significantly to dietary antimony intake. Only one of the field
 
samples of standing water from university buildings containing Sn/Sb solder
 
joints was above the detection limit of 0.6 ppb. The sample contained 2 ppb of
 
antimony, one-half of which was dissolved. Examination of the solder joints
 
indicated that a double passivation film of tin monoxide (SnO) and tin dioxide
 
(SnO2) forms and inhibits leaching.
 
Sediment is a significant sink for antimony. No information was found on
 
the levels of antimony in pristine sediment. Background antimony
 
concentrations in sediment cores from open water of Lake St. Clair ranged from
 
0.032 to 0.098 ppm with a mean concentration of 0.061 and 0.068 ppm in sand
 
and silty-clay sediment, respectively (Rossmann 1988). The range of antimony
 
levels in 10 sediments obtained from all over the United States by workers
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engaged in research on contaminated, dredged sediment was 0.5-17.5 ppm, and
 
the median concentration was 2.9 ppm (Brannon and Patrick 1985). Sediment
 
samples taken from Puget Sound in Washington (the site of a copper smelter)
 
were analyzed for antimony. This was the only known anthropogenic source of
 
antimony in the area. While the antimony concentration in sediment from
 
noncontaminated areas ranged from 0.3 to 1.0 ppm, these levels rose to 2-3
 
times background within 8-15 km of the smelter, and up to 12,500 ppm within 1
 
km of the smelter where considerable amounts of slag were dumped (Crecelius et
 
al. 1975). One hundred and seven core samples of sediment were collected in
 
the delta area of the Coeur d'Alene river in northern Idaho, a primary
 
antimony mining and smelting area in the United States. The sediment was
 
mostly fine silt, which is typical of mine tailings. The top layer of sediment
 
contained 270-900 ppm of antimony with a mean of 512 ppm (Maxfield et al.
 
1974). More recent monitoring data reported antimony concentrations in
 
sediment of 137, 49-72, and 1.9 ppm on the South Fork, Main Stem, and North
 
Fork of the Coeur d'Alene River, respectively (Mok and Wai 1990). The South
 
Fork receives mining and smelting wastes, and the North Fork is essentially
 
uncontaminated. A sediment profile on one sample showed that the antimony
 
concentration decreased with depth and was between 2 and 3 ppm between 8.5 and
 
21.5 cm depth.
 
5.4.3 Soil
 
A survey of soils throughout the conterminous United States conducted by
 
the U.S. Geological Survey showed that antimony concentrations ranged from
 
less than 1 to 8.8 ppm with an average concentration of 0.48 ppm. This was the
 
third lowest concentration of the 50 elements surveyed (Shacklette and
 
Boerngen 1984). In this survey, samples were taken at a depth of 20 cm at
 
1,318 sampling sites. Soils not derived from ore-bearing rock or close to
 
industrial sources do not generally contain more than 1 ppm of antimony.
 
Antimony concentrations in igneous rock, shales, limestone, and sandstone have
 
been reported to be 0.2, 1.5, 0.2, and 0.05 ppm, respectively (Ainsworth
 
1988). Antimony concentrations in 57 sludge-treated soils in an agricultural
 
area west of Toronto in Ontario, Canada, ranged from 0.16 to 0.37 ppm (dry
 
weight) (Webber and Shamess 1987).
 
A study of the effects of an antimony smelter on soil found that
 
antimony levels exceeding 50 ppm were found only within 2 km of the smelter
 
(Ainsworth 1988); the background antimony concentration was 6.9 ppm. Antimony
 
concentrations in surface soil near the Kellogg Valley, Idaho, the site of one
 
of the nation's largest and richest mining districts, were considerably
 
elevated at seven contaminated sites, with mean and maximum levels of 111 and
 
260 ppm, respectively (Ragaini et al. 1977). These values represent an
 
enrichment of 1,000 or more over crustal antimony levels. The concentration
 
profiles in core samples sharply decreased with depth. This indicates that the
 
antimony contamination resulted from air deposition. Soil samples taken in
 
Tacoma, Washington, 40 km downwind of a copper smelter, often
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had antimony concentrations in the range of 11-109 ppm (dry weight). Natural
 
levels are believed to be 3-5 ppm (Crecelius et al. 1974).
 
The range of maximum antimony concentration in soil at sites on the NPL
 
was 0.084-2,550 ppm (View 1989). The geometric mean and the maximum
 
concentration of antimony found in soil at hazardous waste sites on the CLPSD
 
is 8.0 and 330 ppm, respectively (Eckel and Langley 1988). Thirteen percent of
 
sites on an updated version of CLPSD contain antimony in soil (CLPSD 1989).
 
The geometric mean of positive samples is 17 ppm. The CLPSD includes both NPL
 
and non-NPL sites. The concentration of antimony in surface soil at the Sapp
 
Battery Superfund site in northern Florida, which housed a facility for
 
recovering lead from auto batteries from 1970 to 1980, ranged from 0.46 to
 
857.0 ppm (Trnovsky et al. 1988).
 
A New Zealand study showed that the mean level of antimony in street
 
dust was comparable to that in soil (4.69 ppm versus 5.94 ppm) (Fergusson et
 
al. 1986). The antimony content of household dust, however, was enriched
 
approximately two-fold to 10.0 ppm.
 
5.4.4 Other Environmental Media
 
A determination of nutrients in a human diet was conducted by the U.S.
 
Food and Drug Administration (FDA) using mixed diet composites representative
 
of the intake of a 25- to 30-year-old U.S. male. The average concentration of
 
antimony in the diet was 9.3 ppb (dry weight). This corresponds to a daily
 
dietary intake of 4.6 µg of antimony assuming a 3,075 g diet/day (wet weight 
with a total dry matter of 16.2%) (Iyengar et al. 1987). Another study of 
antimony in food using a highly sensitive neutron activation procedure found 
that the average antimony concentration in 12 table-ready foods ranged from 
0.22 to 2.81 ppb (Cunningham 1987). The food items used in the study were
 
primarily prepared for FDA's Total Diet Studies program in Kansas City and
 
included meats, vegetables, and seafood. The mean concentration ranges of
 
antimony in meats, seafoods, and vegetables were 0.46-1.15, 0.22-1.81, and
 
1.09-2.81 ppb, respectively. The results of an earlier investigation of trace
 
elements in food in an FDA basket survey reported that median levels of
 
antimony in eight food groups were less than 10 ppb (wet weight) (Tanner and
 
Friedman 1977). In a separate study, the concentration of antimony in pooled
 
human milk was 13 ppb (dry weight) (Iyengar et al. 1982).
 
In a comprehensive survey of the presence of heavy metals in sewage
 
sludge, 30 sludge samples from 23 American cities were analyzed (Mumma et al.
 
1984). The antimony concentration in the sludge samples ranged from 1.3 to
 
55.7 ppm (dry weight) and had a median value of 7.35 ppm. The highest
 
concentration of antimony was in a sludge sample from Baltimore. This level
 
was more than double that of the second highest sludge sample analyzed. In
 
comparison with the above values, the concentration of antimony in cow manure
 
was 0.43 ppm.
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The concentration of antimony in grass from representative sites in the
 
Kellogg Valley, Idaho (the site of the heavy-metal industry), ranged from 6.2
 
to 111 ppm. Grass from background sites in the valley that were located 3.3
 
and 7.8 miles from a smelter contained from 3.5 to 4.5 ppm of antimony
 
(Ragaini et al. 1977). Similar results were found around an antimony smelter
 
in England. The antimony content of grass close to the smelter was 50-300 ppm.
 
The content at control sites ranged from 0.1 to 0.3 ppm (Ainsworth 1988). In
 
comparison with the above values, the concentration of antimony in forage
 
crops was about 0.1 ppm (Ragaini et al. 1977).
 
Concentrations of antimony in selected species of algae, mollusc tissue,
 
crustacean tissue, and fish muscle from southeastern Australia were 0.094­
0.193, 0.031-0.060, 0.018-0.116, and less than 0.009-0.010 ppm (dry weight),
 
respectively. The water collected at the site contained 0.17 ppm of antimony
 
(Maher 1986).
 
A French study of the metallic content in soaps, shampoos, body oils,
 
and cosmetics found that of all products tested only lacquer contained
 
significant amounts of antimony (1.7 ppm) (Demanze et al. 1984). Antimony was
 
found in high concentrations in certain composite resins used in dentistry.
 
Two materials analyzed in England had mean antimony levels of 288 and 403 ppm
 
(Molokhia and Lilley 1986).
 
5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE
 
Antimony occurs naturally in the earth's crust, and the general
 
population is exposed to low levels of antimony in ambient air and food. The
 
average daily intake of antimony from food or water was estimated at 100
 
µg/day (Wiersema et al. 1984). According to the recent results of Iyengar 
(1987), the average daily dietary intake is 4.6 µg, ,and, because of the low 
antimony levels in water, the average daily intake of antimony (by ingestion) 
is probably not much greater than 5 pg. Laredo, Texas, has the highest annual 
average concentration of antimony in ambient air (452 ng/m3). If a person is 
assumed to inhale 20 m3 of air/day, this would amount to an average antimony 
intake of 9.0 µg/day. For a city such as Washington, D.C. (average antimony 
concentration about 2 ng/m3), the inhalation intake would be 0.04 µg/day. Only 
in an extreme situation would the amount of antimony inhaled compare to the
 
amount that is ingested; the amount inhaled is generally much less. Those
 
people who reside near industrial sources of antimony such as smelters,
 
coalfired power plants, and refuse incinerators are exposed to higher levels
 
of atmospheric antimony. People who spend time in shooting galleries are also
 
exposed to higher antimony levels.
 
EPA does not believe that the antimony found in such consumer products
 
as car batteries and flame retardants in plastics and textiles results in
 
significant consumer exposure (EPA 1983a). When antimony oxide is used as a
 
fire retardant, it is tightly bound into the material; release and subsequent
 
exposure during use is unlikely (EPA 1983a). No antimony leached from several
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glass containers used for injectable solutions into distilled water, saline,
 
sodium bicarbonate solution, or hydrochloric acid (Pradeau et al. 1988). This
 
glass contained up to 5 ppm of antimony, and the detection limit for the
 
analytical procedure was 10 ppb. In another study, no antimony was detected in
 
water (pH 3, 7, or 10) kept in a canteen for 24 hours (Augustson 1976).
 
A National Occupational Exposure Survey (NOES) conducted by NIOSH from
 
1981 to 1983 estimated that 373,460 workers were potentially exposed to
 
antimony (molecular formula unknown) in the United States in 1981-1983 (NIOSH
 
1989). The number of workers exposed to antimony trioxide, antimony sulfide,
 
antimony oxide, antimony pentoxide, antimony dialkyldithiocarbamate, and other
 
antimony compounds is estimated to be 226,645. The total estimated number of
 
workers exposed to antimony and all of its compounds is 486,347. Since all of
 
the data for trade-name products that may contain antimony have not been
 
analyzed, this estimate is preliminary. The NOES was based on field surveys of
 
4,490 facilities. It was designed as a nationwide survey based on a
 
statistical sample of virtually all workplace environments in the United
 
States where eight or more persons are employed in all standard industrial
 
codes (SIC) except mining and agriculture. The NOES database does not contain
 
information on the frequency, concentration, or duration of exposure of
 
workers to any of the chemicals listed therein. These surveys provide only
 
estimates of the number of workers potentially exposed to chemicals in the
 
workplace. EPA states that the NOES figures substantially overestimate
 
occupational exposure to antimony and compounds (EPA 1983a). Most antimony in
 
this country is either smelted from imported ore or impure metallic antimony
 
or recycled from antimony scrap. According to EPA, "mining, hauling, and
 
crushing of ore will be of minor consequence," because ore crushing is done in
 
closed systems, and ore processing is done under wet conditions to minimize
 
dust (EPA 1983a). Following a membership survey, the Antimony Oxide Industry
 
Association (AOIA) reported that 230-240 production workers and l,000-2,000
 
workers using antimony were exposed to antimony (EPA 1983a). This represented
 
the entire population.of workers potentially exposed to antimonial substances.
 
An independent survey of the three facilities producing and processing
 
antimony metal in 1979 estimated that 2,249 workers were exposed to antimony
 
(EPA 1983a). This estimate included producers and first-level processors of
 
antimony metal into products such as batteries and alloys. Alloys usually
 
contain small amounts of antimony that are most often combined with much
 
larger amounts of lead. Occupational exposure controls that are employed to
 
mitigate lead exposure also protect workers from antimony. Much of the
 
estimated exposure to antimony metal may actually be to antimony oxide; fumes
 
formed when heating the metal (e.g., for carting) are oxidized. The survey
 
also estimated that 1,710-1,880 workers were employed at facilities that
 
manufacture and process antimony trioxide. EPA believes that 200-2,000 workers
 
may be exposed to stibnite, which is used in small quantities in smokes and in
 
priming mixtures for igniting explosives (EPA 1983a). This stibnite is
 
expected to form antimony trioxide during use, and exposure will be primarily
 
to the oxide.
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There have not been any systematic and representative surveys of
 
occupational exposure levels to antimony in industry; however, some data are
 
available from walk-through surveys of selected companies conducted by NIOSH
 
and other investigators. In some of these surveys, only a few samples were
 
analyzed. In a facility where antimony oxide was produced from the sulfide
 
ore, breathing-zone samples from five antimony oxide production workers ranged
 
from 0.21 to 3.2 mg antimony/m3; four of these samples were above 0.5 mg
 
antimony/m3. Air samples from the bagging area ranged from 0.43 to 0.83 mg
 
antimony/m3 (Cassady and Etchison 1976). In another facility that produced
 
antimony and antimony oxide from ore, breathing-zone samples from 55 employees
 
ranged from 0.05 to 6.21 mg antimony/m3, and area air samples ranged from 0.14
 
to 2.12 mg antimony/m3 (Donaldson 1976). The mean exposure for the antimony
 
oxide operation was 2.23 mg/m3, and this was the highest in the plant. Two
 
personal air samples in a third antimony oxide production facility were 2.7
 
and 5.0 mg antimony/m3, and general area samples ranged from 1.8 to 5.6 mg
 
antimony/m3 (Donaldson and Gentry 1975). In a secondary lead smelter where
 
scrap batteries were reclaimed, breathing zone samples in 2 of 21 workers
 
were quantifiable; these TWAs were 0.037 and 0.051 mg/m3 (Craig et al. 1981).
 
TWA antimony concentrations in the compounding area of a rubber company ranged
 
from 0.01 to 0.15 mg/m3, and the mean in an iron foundry was 0.00015 mg/m3
 
(Salisbury 1980; Zhang et al. 1985). Antimony levels in a glass production
 
facility were 0.005 mg/m3, and this represents 1% of the NIOSH-recommended
 
maximum level (Burroughs and Horan 1985). Antimony may also be released during
 
injection molding of ignitionresistant polystyrene in which fire retardant
 
additives that contain antimony are used. In one such study, antimony levels
 
ranged from less than the detection limit of 0.0003 to 0.2 mg/m3 (Willetts et
 
al. 1982).
 
Since antimony trioxide is used in many materials as a fire retardant,
 
it is likely that antimony will be released during fires. Antimony was present
 
in soot and in tracheal specimens of people who perished in fires (Willetts et
 
al. 1982). In 18 cases that were analyzed, soot antimony concentrations ranged
 
from 0.1 to 543 ppm, and 50% of tracheal antimony concentrations exceeded the
 
normal range of 0.1-124.0 ppm. These results indicate that firemen and other
 
people at fires may be exposed to increased antimony levels in smoke.
 
Stibine may be produced in lead-acid battery plants during the formation
 
process (Jones and Gamble 1984). In a study involving five battery plants,
 
stibine concentrations ranged from not detectable to 2.5 mg/m3. In three other
 
surveys of battery plants, stibine concentrations ranged from not detectable
 
to 0.35 mg/m3 (Young 1979a), 0.007 mg/m3 (Young 1979b), and 0.031 mg/m3 (Young
 
et al. 1979). Stibine was also reported in a company that manufactured glass
 
for hypodermic syringes at levels up to 0.5 mg/m3 (Burroughs and Horan 1985).
 
Antimony trioxide is used in the glass industry as a refining agent and
 
colorant. In an exposure assessment in the German glass industry, TWA
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antimony levels were as high as 0.351 mg/m3 (Ludersdorf et al. 1987). Urine 
and blood antimony levels of exposed workers were enhanced. The median and 
maximum urine antimony levels in spot urine samples were 1.9 and 15.7 µg/L, 
respectively, compared with 0.4 and 0.7 µg/L for controls. Median and maximum 
blood levels for workers were 1.0 and 3.1 µg/L, respectively, versus 0.3 and 
1.7 µg/L, respectively, for unexposed persons. 
Nail samples from 71 Americans contained an average of 0.41 ppm of
 
antimony. Averages for residents of four other countries ranged from
 
0.28 to 0.70 ppm (Takagi et al. 1988). In an analogous study, the mean
 
concentration of antimony in hair samples from 55 men and women from Scranton,
 
Pennsylvania, contained 0.096 ppm of antimony. The hair samples of populations
 
from cities in four other countries contained mean antimony levels between
 
0.11 and 0.86 ppm (Takagi et al. 1986). These hair levels can also be compared
 
to those in a Japanese national study in which the geometric mean
 
concentration and standard deviation of antimony in washed hair samples from
 
234 healthy individuals were 0.078 and 2.5 ppm, respectively. No significant
 
differences between different sexes or age groups were noted (Ohmori et al.
 
1981). In another Japanese study, hair and nail samples taken from workers at
 
an antimony refinery, nearby residents, and a control group were analyzed
 
before and after washing with a nonionic, surface-active agent in an
 
ultrasonic cleaner (Katayama and Ishide 1987). The concentration of antimony
 
in the nails of the three groups before and after washing was 730, 2.46, 0.19
 
ppm and 230, 0.63, and 0.09 ppm, respectively. The concentration of antimony
 
in the hair of workers before and after washing was 222 and 196 ppm, compared
 
with 0.21 and 0.15 ppm for controls. Exposure to antimony, therefore, greatly
 
increases the antimony levels in nails and hair. The concentration in nails in
 
exposed people is largely surficial.
 
A group of 21 workers from northern Sweden who were employed in
 
nonferrous metal smelting and refining industries had median antimony
 
concentrations‘ in their lungs of 0.30 ppm (wet weight). Controls from an
 
unpolluted area had 0.029 ppm in their lungs (Hewitt 1988). Antimony
 
concentrations in the lung tissues of eight British coal miners ranged from
 
0.19 to 0.59 ppm (dry weight); the levels in two controls were
 
0.47 and 0.62 ppm (Hewitt 1988).
 
5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES
 
In discussing exposure to antimony, it is important to consider what
 
form of antimony a person is exposed to and what is its availability. Such
 
information is seldom available. Although high concentrations of antimony may
 
be found in contaminated soil and sediment, the few studies that have been
 
conducted indicate that much of the antimony may be embedded in a crystalline
 
matrix or bound to hydrated iron, aluminum, and manganese oxides. In water,
 
the pentavalent state is predominant, although significant levels of trivalent
 
antimony and methylated antimony compounds exist. People who live or work near
 
sources of antimony such as smelters, coal-fired power plants, and refuse
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incinerators may be exposed to high levels of antimony in airborne dust, soil,
 
and vegetation. People who live near or work at waste sites that receive slag
 
from smelters or fly ash from power plants and refuse incinerators may also be
 
exposed to higher than background levels. Exposure routes would include either
 
inhalation of contaminated air or ingestion of contaminated soil or
 
vegetation. Similarly, people who are exposed to soot and smoke in fires, such
 
as firemen, may be exposed to high levels of antimony. Occupational exposure
 
to antimony appears to be highest for those involved in the production and
 
processing of antimony and antimony oxide. Workers in battery-forming areas of
 
lead-storage battery plants may be exposed to high levels of stibine.
 
5.7 ADEQUACY OF THE DATABASE
 
Section 104(i)(5) of CERCLA as amended directs the Administrator of
 
ATSDR (in consultation with the Administrator of EPA and agencies and programs
 
of the Public Health Service) to assess whether adequate information on the
 
health effects of antimony is available. Where adequate information is not
 
available, ATSDR, in conjunction with the National Toxicology Program (NTP),
 
is required to assure the initiation of a program of research designed to
 
determine the health effects (and techniques for developing methods to
 
determine such health effects) of antimony.
 
The following categories of possible data needs have been identified by
 
a joint team of scientists from ATSDR, NTP, and EPA. They are defined as
 
substance-specific informational needs that, if met, would reduce or eliminate
 
the uncertainties of human health assessment. In the future, the identified
 
data needs will be evaluated and prioritized, and a substance-specific
 
research agenda will be proposed.
 
5.7.1 Data Needs
 
Physical and Chemical Properties. It is apparent from the physical and
 
chemical properties of antimony and antimony trioxide shown in Table 3-2, that
 
there are discrepancies in the literature values for the boiling points of
 
antimony, antimony trichloride, and antimony trioxide (Freedman et al. 1978;
 
Herbst et al. 1985; Weast 1988; Windholz 1983). This may be due to different
 
levels of impurities in the samples tested. The fact that no numerical value
 
exists for the water solubility of antimony trioxide, antimony pentoxide, and
 
antimony pentasulfide is of no special significance. For inorganic salts, the
 
solubility product coupled with stability constants for the ionic species in
 
solution are the factors determining how much of the compound.goes into
 
solution; the solubility in terms of the number of milligrams of the parent
 
compound in solution, as used for organic compounds, is not meaningful. We do
 
not know whether all the solubility products and stability constants for
 
antimony and its compounds, required for determining the antimony species in
 
natural water and their concentrations, are available. Other physical and
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chemical properties in Table 3-2 for which there are no data are generally not
 
well defined for antimony and its compounds or are not useful in determining
 
their environmental fate.
 
Production, Import/Export, Use, and Disposal. Information on the
 
production, import, and use of antimony and antimony trioxide is readily
 
available (Carapella 1978; Llewellyn 1988; Plunkert 1982; U.S. Bureau of Mines
 
1989a). However, information on the production, import, and use patterns of
 
other antimony compounds is not available, and is needed to assess human
 
exposure to these compounds. Except for the recycling of batteries, little
 
information is available concerning the disposal of antimony and its
 
compounds.
 
Much of the antimony released to the environment is transferred to
 
offsite locations for disposal (probably landfills) (TRI 1989). Most of the
 
waste products from mining and smelting operations are discarded on land in
 
large tailing piles; many of these are now abandoned (TRI 1989). Acid
 
conditions are often created in these tailing piles by the oxidation of
 
pyrites contained in the tailings that increase the potential for leaching
 
(DeLaune and Smith 1985). Information concerning antimony leaching from slag
 
heaps is important in assessing antimony releases to the environment. More
 
detailed information regarding the form of antimony that is disposed of and
 
the disposal methods is necessary to assess the potential exposure to these
 
compounds.
 
According to the Emergency Planning and Community Right-to-Know Act of
 
1986, 42 U.S.C. Section 11023, industries are required to submit chemical
 
release and off-site transfer information to the EPA. The Toxic Release
 
Inventory (TRI), which contains this information for 1987, became available in
 
May of 1989 (TRI 1989). This database will be updated yearly and should
 
provide a list of industrial production facilities and emissions. Releases
 
according to this database are shown in Table 5-l.
 
Environmental Fate. In assessing human exposure, the form (valence
 
state, compound, adsorption, coprecipitation, particle size) of antimony and
 
its availability must be considered. This information is apt to be
 
sitespecific. Data concerning the forms of antimony in air, soil, water, and
 
sediment are limited. Information regarding the transformations that may
 
occur, the rates of transformation, and the conditions that facilitate the
 
transformations is also lacking. For example, we do not know whether antimony
 
is methylated in soil as is arsenic and as antimony itself may be methylated
 
in the aquatic environment (Andreae et al. 1983; Austin and Millward 1988).
 
Information relating to the adsorption of antimony and its compounds by soil
 
and sediment is limited. This information should cover a range of soil types,
 
soil components (e.g., clay), and conditions.
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Bioavailability from Environmental Media. Antimony is poorly absorbed
 
following inhalation and oral exposure (Felicetti et al. 1979a, 1979b; Gerber
 
et al. 1982; Thomas et al. 1973). Dermal exposure to high levels of antimony
 
trioxide resulted in death in rabbits (Myers et al. 1978). The application
 
area was occluded, suggesting that at least some forms of antimony can be
 
absorbed through the skin. Although there is no information on the absorption
 
efficiency of antimony from environmental media in humans, there is evidence
 
in animals that it is absorbed. The vegetation and soils at sites near
 
antimony smelters are heavily contaminated with antimony. Elevated levels of
 
antimony in various tissues were observed in animals living near the smelter
 
(Ainsworth 1988). An animal study designed to measure the rate of absorption
 
of antimony from environmental media would be useful in assessing the
 
toxicological significance of levels of antimony in the air and soil near
 
hazardous waste sites.
 
Food Chain Bioaccumulation. Extensive studies at a smelter site
 
indicate that the uptake of antimony from soil in grass and subsequent
 
translocation in shoots is slight (Ainsworth 1988). At a polluted site, most
 
of the antimony on plants resulted from atmospheric deposition. These studies
 
additionally showed that there was no bioaccumulation of antimony in small
 
mammals compared with their food. Other studies on fish and aquatic organisms
 
indicate that the bioconcentration of antimony is low (Callahan et al. 1978;
 
EPA 1980; Maher 1986). Accordingly, there is little indication that antimony
 
would bioconcentrate in the food chain and in humans. It should be pointed
 
out that data on the biconcentration of antimony in fish and biomagnification
 
in higher trophic levels of animals is limited. Monitoring data on the levels
 
of antimony in plants and animals is minimal. A larger database of information
 
covering more sites and species is desirable. This would establish whether
 
antimony might accumulate in some species or in the presence of some forms of
 
antimony.
 
Exposure Levels in Environmental Media. Although some data on the
 
levels of antimony in ambient air are available, these data are not
 
representative and recent enough to estimate the current exposure levels to
 
antimony by the U.S. population via inhalation (Austin and Millward 1988;
 
Hopper and Barrie 1988; Johnson et al. 1984; Kowalczyk et al. 1982; Schroeder
 
et al. 1987; Wiersema et al. 1984). While the levels of antimony in water are
 
generally very low (Eckel and Jacob 1989), the data for ambient water are
 
marginally adequate; data for drinking water and groundwater are virtually
 
nonexistent. Similarly data regarding the levels of antimony in the various
 
food classes and diet are fragmentary (Cunningham 1987; Syengar et al. 1987;
 
Tanner and Freedman 1977). Reliable and recent monitoring data for antimony in
 
air, water, and foods are essential for estimating the extent of exposure from
 
each of these sources. While the levels of antimony in surface and groundwater
 
at hazardous waste sites are elevated above ambient levels (CLPSD 1989), the
 
elevation is not very great. Since it is not clear whether the levels reported
 
at waste sites are for dissolved antimony as are the ambient
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levels, the difference between antimony concentrations at waste sites and
 
ambient sites may be lower. Antimony concentrations in soil at some hazardous
 
waste sites are high (CLPSD 1989; Eckel and Langley 1988; View 1989), and
 
there is a potential of exposure from ingesting soil at these sites. The
 
leaching potential of these soils appears to be low (Ainsworth 1988; Foster
 
1989; King 1988; Trnovsky et al. 1988). The exposure potential from antimony
 
at these sites from antimony reentrained by wind also appears to be low
 
(Ainsworth 1988).
 
Exposure Levels in Humans. The levels of antimony in the hair, nails,
 
and breast milk of a sample of the U.S. population are known (Iyengar et al.
 
1982; Takagi et al. 1986, 1988). While the tissue levels of antimony in
 
Japanese people are available (Sumino et al. 1975), analogous levels for
 
Americans were not found. In particular, no reliable data regarding the levels
 
of this element in the blood and urine of unexposed U.S. residents are
 
available. Such data may be helpful in establishing the background exposure
 
levels of antimony. Levels of antimony in hair, nails, lung, blood, and urine
 
of some exposed workers are available, but the amount of data is small (Hewitt
 
1988; Katyama and Ishidi 1987; Ludersdorf et al. 1987). None of these data
 
refer to populations living around the hazardous waste sites containing
 
elevated levels of antimony. Such data may be significant in assessing the
 
exposure levels of this component of the population.
 
Exposure Registries. No exposure registries for antimony and its
 
compounds were located. Antimony and its compounds do not currently have a
 
subregistry established in the National Exposure Registry. They will be
 
considered in the future when chemical selection is made for subregistries to
 
be established. The information that is amassed in the National Exposure
 
Registry facilitates the epidemiological research needed to assess adverse
 
health outcomes that may be related to the exposure to the compound.
 
5.7.2 On-going Studies
 
Remedial investigations and feasibility studies conducted at the 52 NPL
 
sites known to be contaminated with antimony will add to the available
 
database on exposure levels in environmental media, exposure levels in humans,
 
and exposure registries, and will increase the current knowledge regarding the
 
transport and transformation of antimony in the environment. NIOSH is updating
 
its estimates of occupational exposure by including exposure to antimony and
 
its compounds in trade name chemicals (NIOSH 1989). No other ongoing
 
research studies pertaining to the environmental fate of antimony or to
 
occupational or general population exposures to antimony were identified.
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The purpose of this chapter is to describe the analytical methods that
 
are available for detecting and/or measuring and monitoring antimony in
 
environmental media and in biological samples. The intent is not to provide
 
an exhaustive list of analytical methods that could be used to detect and
 
quantify antimony. Rather, the intention is to identify well-established
 
methods that are used as the standard methods of analysis. Many of the
 
analytical methods used to detect antimony in environmental samples are the
 
methods approved by federal agencies such as EPA and the National Institute
 
for Occupational Safety and Health (NIOSH). Other methods presented in this
 
chapter are those that are approved by groups such as the Association of
 
Official Analytical Chemists (AOAC) and the American Public Health Association
 
ww - Additionally, analytical methods are included that refine previously
 
used methods to obtain lower detection limits, and/or to improve accuracy and
 
precision.
 
6.1 BIOLOGICAL MATERIALS
 
Methods for the analytical determination of antimony in biological
 
materials are basically the same as those used for the environmental samples
 
that are discussed below. The most commonly used methods determine the total
 
antimony content of the sample, not the particular antimony compound or
 
oxidation state that is present. Methodological differences are a function of
 
the level of antimony in the sample, digestion procedures required to
 
solubilize the sample, and the level of potentially interfering substances in
 
the type of sample. Antimony occurs at very low levels in biological samples.
 
The accurate determination of trace levels of antimony in these samples may
 
require special methods (e.g., neutron activation) that are both sensitive and
 
selective. Atomic absorption spectroscopy and inductively coupled plasmaatomic
 
emission spectroscopy, with or without preconcentration or separation
 
steps, are the most commonly employed methods. Atomic absorption has three
 
variants: direct aspiration into a flame, atomization in an electrically
 
heated carbon rod, or generation of stibine that is then passed into a heated
 
silica tube.
 
Instrumental neutron activation analysis (INAA), with or without
 
chemical separation, has very good sensitivity and selectivity for antimony,
 
and it has the advantage of being able to measure many elements
 
simultaneously. However, it is slow, costly, and requires special facilities.
 
INAA is favored for surveys where trace levels of many elements are to be
 
determined. It is often required for measuring antimony in tissues in which
 
the antimony level is very low. The neutron activation analysis of antimony
 
requires an exposure to neutron fluxes for 6 hours to 2 days. After the
 
exposure period, the samples are kept for several days before counting, This
 
allows the activity of short half-lived isotopes to decline, and thus improves
 
accuracy of the analysis (Iyengar et al. 1978). Nondestructive INCA can be
 
used to measure concentrations to levels somewhat below 1 ppm. Nondestructive
 
methods are not only advantageous because of reduced sample handling, but also
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because they are independent of the sample matrix and of the efficiency of the
 
digestion or extraction procedure. While this is generally adequate for
 
antimony determinations in hair and lung tissues, the antimony levels in blood
 
serum and kidney tissues are usually too low to measure without
 
preconcentration (Iyengar et al. 1978). Detection limits may be limited by
 
interferences from matrix elements such as sodium, potassium, phosphorus, and
 
bromine. Lower detection limits (approximately 0.006 ppm) can be obtained by
 
digestion and solvent extraction to eliminate these interferences (Mok and Wai
 
1988).
 
Analytical methods and detection limits for antimony in biological
 
materials are given in Table 6-1. Antimony contained in other biological
 
materials such as hair and nails can be determined by using the same
 
analytical techniques as for blood and tissue, but suitable procedures for
 
dissolving the sample matrix must be used (Takagi et al. 1986, 1988).
 
6.2 ENVIRONMENTAL SAMPLES
 
Analytical methods for antimony in environmental samples generally
 
determine the total antimony content of the sample; determining specific
 
antimony compounds is difficult. Some methods can be used to determine
 
antimony in different oxidation states, but these methods are only used in
 
special circumstances.
 
The most common methods used for environmental samples are atomic
 
absorption spectrometry (AAS) (either flame or graphite furnace) and
 
inductively coupled plasma-atomic emission spectroscopy (ICP-AES). Before the
 
widespread use of AAS, calorimetric methods were used for the determination of
 
antimony; the best known of these methods is the rhodamine B method (APHA
 
1972). The basis for the method is the formation of a pink complex when
 
pentavalent antimony reacts with rhodamine B in the presence of an excess of
 
chloride ions. The complex is extracted into an organic solvent and the
 
absorbance measured at 565 nm. Trivalent antimony must be oxidized to the
 
pentavalent state with nitric, sulfuric, and perchloric acids.
 
Water and waste water samples can be analyzed for antimony by EPA Test
 
Methods 220.1 (atomic absorption, direct aspiration), 220.2 (atomic
 
absorption, furnace technique), or 200.7 (inductively coupled plasma-atomic
 
emission spectroscopy) (EPA 1983b). These methods are suitable for
 
groundwater, surface water, and domestic and industrial effluents. In open
 
ocean water and in other water samples with a low antimony concentration, a
 
preconcentration and/or separation procedure involving coprecipitation,
 
chelation, selective adsorption, or hydride formation is required before
 
analysis (Andresen and Salbu 1982; Apte and Howard 1986; Maher 1986; Sturgeon
 
et al. 1985). The atomic absorption wavelength used for antimony is 217.6 nm.
 
In the presence of lead concentrations of the order of 1 g/L, however, a
 
spectral interference may occur at this resonance line, and the line at
 
231.1 nm should be used instead. When using direct aspiration, the spectral
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absorption of antimony is reduced when the concentration of acid increases.
 
Therefore, it is important to match the concentration of acid in standards and
 
samples (EPA 1983b). Background correction of nonspecific absorption is
 
advisable for some samples, such as those containing sulfuric acid (Ainsworth
 
1988). Analytical methods and detection limits for antimony in environmental
 
media are given in Table 6-2. If the determination of dissolved antimony is
 
required, samples should be filtered using a 0.45 µm membrane filter. 
Acid digestion to assure release of antimony from the sample matrix is a
 
crucial step in the analysis of environmental samples. Unless the particular
 
type of sample has been well studied, it is usually important to experiment
 
with different digestion procedures. For the release of antimony from soil,
 
hydrogen fluoride mixed with perchloric acid or another strong acid is
 
generally required. Aqua regia, however, has been found to be suitable. For
 
plant and animal tissue, a combination of sulfuric and nitric acids is most
 
satisfactory (Ainsworth 1988).
 
Antimony forms a volatile hydride under reducing conditions, and hydride
 
generation has been interfaced with different analytical procedures for
 
enhanced sensitivity and selectivity. The most popular reagent used for this
 
reduction is sodium borohydride (Andreae 1983). It is necessary to add KI to
 
the reaction medium to completely reduce Sb(II1). In atomic absorption,
 
increased sensitivity can be achieved by using hydride generation because the
 
efficiency of atomization is greater for stibine than for antimony solutions
 
introduced into the flame. Another advantage of hydride generation is that
 
separati.on is achieved from nonhydride-forming elements, thereby eliminating
 
interferences. Antimony reduction is pH dependent, possibly because neutral
 
and cationic species (but not anionic ones) are subject to reduction by
 
negatively charged borohydride ions. By exploiting the pH dependence of the
 
reduction, it is possible to separately determine Sb(III) and Sb(V) in natural
 
waters (Andreae 1983; Apte and Howard 1986). Other methods that distinguish
 
Sb(II1) from Sb(V) rely on selective extraction techniques in which Sb(II1) is
 
extracted into an organic solvent and analyzed. After analysis, Sb(V) is
 
reduced and extracted (Abbasi 1989; Mok and Wai 1987). When very high
 
sensitivity is required, such as that necessary for the analysis of antimony
 
in food, neutron activation analysis is often employed. X-ray fluorescence
 
(XRF) and anodic stripping voltammetry (ASV) are other analytical methods that
 
are frequently used (Costantini et al. 1985; Gillain and Brihaye 1985; Ives
 
et al. 1984; Johnson et al. 1984).
 
In the determination of trace metals, major concerns include
 
contamination and loss. Contamination can be introduced from impurities in
 
reagents and containers and from laboratory dust. Losses may also occur due
 
to adsorption of the analyte onto container walls. In the case of antimony, a
 
common source of loss is volatilization during acid digestion or ashing in an
 
AAS furnace.
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6.3 ADEQUACY OF THE DATABASE
 
Section 104(i)(5) of CERCLA as amended directs the Administrator of
 
ATSDR (in consultation with the Administrator of EPA and agencies and programs
 
of the Public Health Service) to assess whether adequate information on the
 
health effects of antimony is available. Where adequate information is not
 
available, ATSDR, in conjunction with the National Toxicology Program (NTP),
 
is required to assure the initiation of a program of research designed to
 
determine the health effects (and techniques for developing methods to
 
determine such health effects) of antimony.
 
The following categories of possible data needs have been identified by
 
a joint team of scientists from ATSDR, NTP, and EPA. They are defined as
 
substance-specific informational needs that, if met, would reduce or eliminate
 
the uncertainties of human health assessment. In the future, the identified
 
data needs will be evaluated and prioritized, and a substance-specific
 
research agenda will be proposed.
 
6.3.1 Data Needs
 
Methods for Determining Biomarkers of Exposure and Effect. Methods for
 
determining antimony in biological materials are well developed, and there are
 
methods available to most laboratories that are satisfactory for testing
 
biological samples that naturally contain high concentrations of antimony or
 
for occupational exposure testing (Anonymous 1977; NIOSH 1985). Since
 
antimony occurs at very low levels in many biological materials, methods such
 
as INAA that require special facilities must often be used to achieve adequate
 
sensitivity (Iyengar et al. 1978). Standardized methods are available from
 
NIOSH and other sources to measure antimony in blood, urine, and tissue (NIOSH
 
1985). Several authors have reported that antimony concentrations in hair,
 
nails, blood, or urine are elevated in exposed individuals; therefore,
 
antimony levels in these samples can be used as a biomarker for exposure to
 
antimony (Katayama and Ishidi 1987). Available analytical methods are capable
 
of determining the levels of antimony in these media in both normal and
 
occupationally exposed persons (Bakagi et al. 1986, 1988; Iyenger et al.
 
1988). Methods with sufficient sensitivity (e.g., INAA), however, are not
 
available in most laboratories.
 
No biomarkers that could be used to characterize effects of antimony
 
have been identified, Should subtle biochemical or physiological changes
 
unique to antimony be identified, methods to analyze for these changes could
 
possibly be developed if they don't already exist.
 
Methods for Determining Parent Compounds and Degradation Products in
 
Environmental Media. Methods for determining antimony in environmental media
 
are well developed and adequate. Standardized methods are available from EPA,
 
NIOSH, and other sources (APHA 1972; Cunningham 1987; DeDonker et al. 1983;
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EPA 1983a, 1986; NIOSH 1987). Since most analytical methods measure total
 
antimony, the methods for analyzing for the parent compound and degradation
 
product are identical.
 
6.3.2 On-going Studies
 
Analytical methods for antimony and antimony compounds are currently
 
being developed at EPA's Environmental Monitoring Systems Laboratory in
 
Cincinnati, Ohio (EPA 1989b). No on-going studies regarding new analytical
 
methods for measuring antimony in biological materials were located In the
 
available literature.
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7. REGULATIONS AND ADVISORIES
 
National and international guidelines and state regulations pertinent to
 
human exposure to antimony and compounds are summarized in Table 7-1.
 
Antimony compounds are regulated by the Clean Water Effluent Guidelines
 
for the following industrial point sources: nonferrous metal manufacturing,
 
steam electric, asbestos, timber products processing, mineral mining, paving
 
and roofing, paint formulating, ink formulating, gum and wood, carbon black,
 
and nonferrous metal forming (EPA 1988). Antimony compounds are also
 
regulated by the Clean Air Act.
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9. GLOSSARY
 
Acute Exposure -- Exposure to a chemical for a duration of 14 days or less, as
 
specified in the Toxicological Profiles.
 
Adsorption Coefficient (K
oc
) -- The ratio of the amount of a chemical adsorbed
 
per unit weight of organic carbon in the soil or sediment to the concentration
 
of the chemical in solution at equilibrium.
 
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or
 
soil (i.e., the solid phase) divided by the amount of chemical in the solution
 
phase, which is in equilibrium with the solid phase, at a fixed solid/solution
 
ratio. It is generally expressed in micrograms of chemical sorbed per gram of
 
soil or sediment.
 
Bioconcentration Factor (BCF) -- The quotient of the concentration of a
 
chemical in aquatic organisms at a specific time or during a discrete time
 
period of exposure divided by the concentration in the surrounding water at
 
the same time or during the same period.
 
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or group
 
of studies, that produces significant increases in the incidence of cancer (or
 
tumors) between the exposed population and its appropriate control.
 
Carcinogen -- A chemical capable of inducing cancer.
 
Ceiling Value -- A concentration of a substance that should not be exceeded,
 
even instantaneously.
 
Chronic Exposure -- Exposure to a chemical for 365 days or more, as specified
 
in the Toxicological Profiles.
 
Developmental Toxicity -- The occurrence of adverse effects on the developing
 
organism that may result from exposure to a chemical prior to conception
 
(either parent), during prenatal development, or postnatally to the time of
 
sexual maturation. Adverse developmental effects may be detected at any point
 
in the life span of the organism.
 
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a
 
result of prenatal exposure to a chemical; the distinguishing feature between
 
the two terms is the stage of development during which the insult occurred.
 
The terms, as used here, include malformations and variations, altered growth,
 
and in utero death.
 
EPA Health Advisory -- An estimate of acceptable drinking water levels for a
 
chemical substance based on health effects information. A health advisory is
 
not a legally enforceable federal standard, but serves as technical guidance
 
to assist federal, state, and local officials.
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Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental
 
concentration of a contaminant from which one could escape within 30 min
 
without any escape-impairing symptoms or irreversible health effects.
 
Intermediate Exposure -- Exposure to a chemical for a duration of 15-364 days
 
as specified in the Toxicological Profiles.
 
Immunologic Toxicity -- The occurrence of adverse effects on the immune system
 
that may result from exposure to environmental agents such as chemicals.
 
In Vitro -- Isolated from the living organism and artificially maintained, as
 
in a test tube.
 
In Vivo -- Occurring within the living organism.
 
Lethal Concentration (LC ) -- The lowest concentration of a chemical in
(Lo) Lo

air which has been reported to have caused death in humans or animals.
 
Lethal Concentration (LC ) -- A calculated concentration of a chemical in
(50) 50

air to which exposure for a specific length of time is expected to cause death
 
in 50% of a defined experimental animal population.
 
Lethal Dose (LD ) -- The lowest dose of a chemical introduced by a route
(Lo) Lo

other than inhalation that is expected to have caused death in humans or
 
animals.
 
Lethal Dose (LD ) -- The dose of a chemical which has been calculated to
(50) 50

cause death in 50% of a defined experimental animal population.
 
Lethal Time (LT ) -- A calculated period of time within which a specific
(50) 50

concentration of a chemical is expected to cause death in 50% of a defined
 
experimental animal population.
 
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical in
 
a study, or group of studies, that produces statistically or biologically
 
significant increases in frequency or severity of adverse effects between the
 
exposed population and its appropriate control.
 
Malformations -- Permanent structural changes that may adversely affect
 
survival, development, or function.
 
Minimal Risk Level -- An estimate of daily human exposure to a chemical that
 
is likely to be without an appreciable risk of deleterious effects
 
(noncancerous) over a specified duration of exposure.
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Mutagen -- A substance that causes mutations. A mutation is a change in the
 
genetic material in a body cell. Mutations can lead to birth defects,
 
miscarriages, or cancer.
 
Neurotoxicity -- The occurrence of adverse effects on the nervous system
 
following exposure to chemical.
 
No-Observed-Adverse-Effect Level (NOAEL) -- The dose of chemical at which
 
there were no statistically or biologically significant increases in frequency
 
or severity of adverse effects seen between the exposed population and its
 
appropriate control. Effects may be produced at this dose, but they are not
 
considered to be adverse.
 
Octanol-Water Partition Coefficient (KOW) -- The equilibrium ratio of the
 
concentrations of a chemical in n-octanol and water, in dilute solution.
 
Permissible Exposure Limit (PEL) -- An allowable exposure level in workplace
 
air averaged over an 8-hour shift.
 
q1* -- The upper-bound estimate of the low-dose slope of the dose-response
 
curve as determined by the multistage procedure. me ql* can be used to
 
calculate an estimate of carcinogenic potency, the incremental excess cancer
 
risk per unit of exposure (usually µg/L for water, mg/kg/day for food, and 
µg/m3 for air). 
Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps an
 
order of magnitude) of the daily exposure of the human population to a
 
potential hazard that is likely to be without risk of deleterious effects
 
during a lifetime. The RfD is operationally derived from the NOAEL (from
 
animal and human studies) by a consistent application of uncertainty factors
 
that reflect various types of data used to estimate RfDs and an additional
 
modifying factor, which is based on a professional judgment of the entire
 
database on the chemical. The RfDs are not applicable to nonthreshold effects
 
such as cancer.
 
Reportable Quantity (RQ) -- The quantity of a hazardous substance that is
 
considered reportable under CERCLA. Reportable quantities are (1) 1 lb or
 
greater or (2) for selected substances, an amount established by regulation
 
either under CERCLA or under Sect. 311 of the Clean Water Act. Quantities are
 
measured over a 24-hour period.
 
Reproductive Toxicity -- The occurrence of adverse effects on the reproductive
 
system that may result from exposure to a chemical. The toxicity may be
 
directed to the reproductive organs and/or the related endocrine system. The
 
manifestation of such toxicity may be noted as alterations in sexual behavior,
 
fertility, pregnancy outcomes, or modifications in other functions that are
 
dependent on the integrity of this system.
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9. GLOSSARY
 
Short-Term Exposure Limit (STEL) -- The maximum concentration to which workers
 
can be exposed for up to 15 min continually. No more than four excursions are
 
allowed per day, and there must be at least 60 min between exposure periods.
 
The daily TLV-TWA may not be exceeded.
 
Target Organ Toxicity -- This term covers a broad range of adverse effects on
 
target organs or physiological systems (e.g., renal, cardiovascular) extending
 
from those arising through a single limited exposure to those assumed over a
 
lifetime of exposure to a chemical.
 
Teratogen -- A chemical that causes structural defects that affect the
 
development of an organism.
 
Threshold Limit Value (TLV) -- A concentration of a substance to which most
 
workers can be exposed without adverse effect. The TLV may be expressed as a
 
TWA, as a STEL, or as a CL.
 
Time-Weighted Average (TWA) -- An allowable exposure concentration averaged
 
over a normal 8-hour workday or 40-hour workweek.
 
Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route
 
other than inhalation, which is expected to cause a specific toxic effect in
 
50% of a defined experimental animal population.
 
Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD
 
from experimental data. UFs are intended to account for (1) the variation in
 
sensitivity among the members of the human population, (2) the uncertainty in
 
extrapolating animal data to the case of human, (3) the uncertainty in
 
extrapolating from data obtained in a study that is of less than lifetime
 
exposure, and (4) the uncertainty in using LCAEL data rather than NOAEL data.
 
Usually each of these factors is set equal to 10.
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USER'S GUIDE
 
Chapter 1
 
Public Health Statement
 
This chapter of the profile is a health effects summary written in
 
nontechnical language. Its intended audience is the general public especially
 
people living in the vicinity of a hazardous waste site or substance release.
 
If the Public Health Statement were removed from the rest of the document, it
 
would still communicate to the lay public essential information about the
 
substance. The major headings in the Public Health Statement are useful to
 
find specific topics of concern. The topics are written in a question and
 
answer format. The answer to each question includes a sentence that will
 
direct the reader to chapters in the profile that will provide more
 
information on the given topic.
 
Chapter 2
 
Tables and Figures for Levels of Significant Exposure (LSE)
 
Tables (2-1, 2-2, and 2-3) and figures (2-l and 2-2) are used to summarize
 
health effects by duration of exposure and endpoint and to illustrate
 
graphically levels of exposure associated with those effects. All entries in
 
these tables and figures represent studies that provide reliable, quantitative
 
estimates of No-Observed-Adverse-Effect Levels (NOAELs), Lowest-Observed­
Adverse-Effect Levels (NOAELs) for Less Serious and Serious health effects, or
 
Cancer Effect Levels (CELs). In addition, these tables and figures illustrate
 
differences in response by species, Minimal Risk Levels (MRLs) to humans for
 
noncancer end points, and EPA's estimated range associated with an upper-bound
 
individual lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. The LSE
 
tables and figures can be used for a quick review of the health effects and to
 
locate data for a specific exposure scenario. The LSE tables and figures
 
should always be used in conjunction with the text.
 
The legends presented below demonstrate the application of these tables and
 
figures. A representative example of LSE Table 2-l and Figure 2-1 are shown.
 
The numbers in the left column of the legends correspond to the numbers in the
 
example table and figure.
 
LEGEND
 
See LSE Table 2-l
 
(1). Route of Exposure One of the first considerations when reviewing the
 
toxicity of a substance using these tables and figures should be the
 
relevant and appropriate route of exposure. When sufficient data exist,
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three LSE tables and two LSE figures are presented in the document. The
 
three LSE tables present data on the three principal routes of exposure,
 
i.e., inhalation, oral, and dermal (LSE Table 2-1, 2-2, and 2-3,
 
respectively). LSE figures are limited to the inhalation (LSE Figure 2-l)
 
and oral (LSE Figure 2-2) routes.
 
(2). Exposure Duration Three exposure periods: acute (14 days or less); 
intermediate (15 to 364 days); and chronic (365 days or more) are 
presented within each route of exposure. In this example, an inhalation 
study of intermediate duration exposure is reported. 
(3). Health Effect The major categories of health effects included in 
LSE tables and figures are death, systemic, immunological, 
neurological, developmental, reproductive, and cancer. NOAELs and 
LOAELs can be reported in the tables and figures for all effects but 
cancer. Systemic effects are further defined in the "System" column of 
the LSE table. 
(4). Key to Figure Each key number in the LSE table links study information 
to one or more data points using the same key number in the 
corresponding LSE figure. In this example, the study represented by key 
number 18 has been used to define a NOAEL and a Less Serious LOAEL (also 
see the two "18r" data points in Figure 2-l). 
(5). Species The test species, whether animal or human, are identified in 
this column. 
(6). Exposure Frequency/Duration The duration of the study and the weekly and 
daily exposure regimen are provided in this column. This permits 
comparison of NOAELs and LOAELs from different studies. In this case 
(key number 18), rats were exposed to [substance x] via inhalation for 
13 weeks, 5 days per week, for 6 hours per day. 
(7). System This column further defines the systemic effects. These systems 
include: respiratory, cardiovascular, gastrointestinal, hematological, 
musculoskeletal, hepatic, renal, and dermal/ocular. "Other" refers to 
any systemic effect (e.g., a decrease in body weight) not covered in 
these systems. In the example of key number 18, one systemic effect 
(respiratory) was investigated in this study. 
(8). NOAEL A No-Observed-Adverse-Effect Level (NOAEL) is the highest exposure 
level at which no harmful effects were seen in the organ system studied. 
Key number 18 reports a NOAEL of 3 ppm for the respiratory system which 
was used to derive an intermediate exposure, inhalation MR.L of 0.005 
ppm (see footnote "cm). 
(9). LOAEL A Lowest-Observed-Adverse-Effect Level (LOAEL) is the lowest 
exposure level used in the study that caused a harmful health effect. 
LOAELS have been classified into "Less Serious" and "Serious" effects. 
These distinctions help readers identify the levels of exposure at which 
adverse health effects first appear and the gradation of effects with 
increasing dose. A brief description of the specific end point used to 
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quantify the adverse effect accompanies the LOAEL. The "Less Serious"
 
respiratory effect reported in key number 18 (hyperplasia) occurred at a
 
LOAEL of 10 ppm.
 
(10). Reference The complete reference citation is given in Chapter 8 of the
 
profile.
 
(11). CEL A Cancer Effect Level (CEL) is the lowest exposure level associated
 
with the onset of carcinogenesis in experimental or epidemiological
 
studies. GELS are always considered serious effects. The LSE tables and
 
figures do not contain NOAELs for cancer, but the text may report doses
 
which did not cause a measurable increase in cancer.
 
(12). Footnotes Explanations of abbreviations or reference notes for data in
 
the LSE tables are found in the footnotes. Footnote "c" indicates the
 
NOAEL of 3 ppm in key number 18 was used to derive an MRL of 0.005 @pm.
 
LEGEND
 
See LSE Figure 2-1
 
LSE figures graphically illustrate the data presented in the corresponding LSE
 
tables. Figures help the reader quickly compare health effects according to
 
exposure levels for particular exposure duration.
 
(13). Exposure Duration The same exposure periods appear as in the LSE table.
 
In this example, health effects observed within the intermediate and
 
chronic exposure periods are illustrated.
 
(14). Health Effect These are the categories of health effects for which
 
reliable quantitative data exist. The same health effects appear in the
 
LSE table.
 
(15). Levels of Exposure Exposure levels for each health effect in the LSE
 
tables are graphically displayed in the LSE figures. Exposure levels are
 
reported on the log scale "y" axis. Inhalation exposure is reported in
 
mg/m3 or ppm and oral exposure is reported in mg/kg/day.
 
(16). NOAEL In this example, 18r NOAEL is the critical end point for which an
 
intermediate inhalation exposure MRL is based. As you can see from the
 
LSE figure key, the open-circle symbol indicates a NOAEL for the test
 
species (rat). The key number 18 corresponds to the entry in the LSE
 
table. The dashed descending arrow indicates the extrapolation from the
 
exposure level of 3 ppm (see entry 18 in the Table) to the MRL of 0.005
 
ppm (see footnote "b" in the LSE table).
 
(17). CEL Key number 38r is one of three studies for which Cancer Effect
 
Levels (CELs) were derived. The diamond symbol refers to a CEL for the
 
test species (rat). The number 38 corresponds to the entry in the LSE
 
table.
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(18). Estimated Upper-Bound Human Cancer Risk Levels This is the range
 
associated with the upper-bound for lifetime cancer risk of 1 in 10,000
 
to 1 in 10,000,000. These risk levels are derived from EPA's Human
 
Health Assessment Group's upper-bound estimates of the slope of the
 
cancer dose response curve at low dose levels (q1*).
 
(19). Key to LSE Figure The Key explains the abbreviations and symbols used in
 
the figure.
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Chapter 2 (Section 2.4)
 
Relevance to Public Health
 
The Relevance to Public Health section provides a health effects summary based
 
on evaluations of existing toxicological, epidemiological, and toxicokinetic
 
information. This summary is designed to present interpretive, weight-of­
evidence discussions for human health end points by addressing the
 
following questions.
 
1. 	 What effects are known to occur in humans?
 
2. 	 What effects observed in animals are likely to be of concern to
 
humans?
 
3. 	 What exposure conditions are likely to be of concern to humans,
 
especially around hazardous waste sites?
 
The section discusses health effects by end point. Human data are presented
 
first, then animal data. Both are organized by route of exposure (inhalation,
 
oral, and dermal) and by duration (acute, intermediate, and chronic). In vitro
 
data and data from parenteral routes (intramuscular, intravenous,
 
subcutaneous, etc.) are also considered in this section. If data are located
 
in the scientific literature, a table of genotoxicity information is included.
 
The carcinogenic potential of the profiled substance is qualitatively
 
evaluated, when appropriate, using existingtoxicokinetic, genotoxic, and
 
carcinogenic data. ATSDR does not currently assess cancer potency or perform
 
cancer risk assessments. MRLs for noncancer end points if derived, and the end
 
points from which they were derived are indicated and discussed in the
 
appropriate section(s).
 
Limitations to existing scientific literature that prevent a satisfactory
 
evaluation of the relevance to public health are identified in the
 
Identification of Data Needs section.
 
Interpretation of Minimal Risk Levels
 
Where sufficient toxicologic information was available, MRLs were derived.
 
MRLs are specific for route (inhalation or oral) and duration (acute,
 
intermediate, or chronic) of exposure. Ideally, MRLs can be derived from all
 
six exposure scenarios (e.g., Inhalation - acute, -intermediate, -chronic;
 
Oral - acute, -intermediate, - chronic). These MRLs are not meant to support
 
regulatory action,but to aquainthealth professionals with exposure levels at
 
which adverse health effects are not expected to occur in humans. They should
 
help physicians and public health officials determine the safety of a
 
community living near a substance emission, given the concentration of a
 
contaminant in air or the estimated daily dose received via food or water.
 
MRLs are based largely on toxicological studies in animals and on reports of
 
human occupational exposure.
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MRL users should be familiar with the toxicological information on which the
 
number is based. Section 2.4, "Relevance to Public Health," contains basic
 
information known about the substance. Other sections such as 2.6,
 
"Interactions with Other Chemicals" and 2.7, "Populations that are Unusually
 
Susceptible" provide important supplemental information.
 
MRL users should also understand the MRL derivation methodology. MRLs are
 
derived using a modified version of the risk assessment methodology used by
 
the Environmental Protection Agency (EPA) (Barnes and Dourson, 1988; EPA
 
1989a) to derive reference doses (RfDs) for lifetime exposure.
 
To derive an MRL, ATSDR generally selects the end point which, in its best
 
judgement, represents the most sensitive human health effect for a given
 
exposure route and duration. ATSDR cannot make this judgement or derive an MRL
 
unless information (quantitative or qualitative) is available for all
 
potential effects (e.g., systemic, neurological, and developmental). In order
 
to compare NOAELs and LOAELs for specific end points, all inhalation exposure
 
levels are adjusted for 24hr exposures and all intermittent exposures for
 
inhalation and oral routes of intermediate and chronic duration are adjusted
 
for continuos exposure (i.e., 7 days/week). If the information and reliable
 
quantitative data on the chosen end point are available, ATSDR derives an MRL
 
using the most sensitive species (when information from multiple species is
 
available) with the highest NOAEL that does not exceed any adverse effect
 
levels. The NOAEL is the most suitable end point for deriving an MRL. When a
 
NOAEL is not available, a Less Serious LOAEL can be used to derive an MRL, and
 
an uncertainty factor (UF) of 10 is employed. MRLs are not derived from
 
Serious LOAELs. Additional uncertainty factors of 10 each are used for human
 
variability to protect sensitive subpopulations (people who are most
 
susceptible to the health effects caused by the substance) and for
 
interspecies variability (extrapolation from animals to humans). In deriving
 
an MRL, these individual uncertainty factors are multiplied together. The
 
product is then divided into the adjusted inhalation concentration or oral
 
dosage selected from the study. Uncertainty factors used in developing a
 
substance-specific MRL are provided in the footnotes of the LSE Tables.
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ACRONYMS, ABBREVIATIONS, AND SYMBOLS
 
ACGIH	 American Conference of Governmental Industrial Hygienists
 
ADME	 Absorption, Distribution, Metabolism, and Excretion
 
ATSDR	 Agency for Toxic Substances and Disease Registry
 
BCF	 bioconcentration factor
 
BSC	 Board of Scientific Counselors
 
CDC	 Centers for Disease Control
 
CEL	 Cancer Effect Level
 
CERCLA	 Comprehensive Environmental Response, Compensation, and
 
Liability Act
 
CFR	 Code of Federal Regulations
 
CLP	 Contract Laboratory Program
 
cm	 centimeter
 
CNS	 central nervous system
 
DHEW	 Department of Health, Education, and Welfare
 
DHHS	 Department of Health and Human Services
 
DGL	 Department of Labor
 
ECG	 electrocardiogram
 
EEG	 electroencephalogram
 
EPA	 Environmental Protection Agency
 
EKG	 see ECG
 
FAO	 Food and Agricultural Organization of the United Nations
 
FEMA	 Federal Emergency Management Agency
 
FIFRA	 Federal Insecticide, Fungicide, and Rodenticide Act
 
f1	 first generation
 
fpm	 feet per minute
 
ft	 foot
 
FR	 Federal Register
 
G	 gram
 
GC 	chromatography
 
Ha	 hectare
 
HPLC	 high performance liquid chromatography
 
hr	 hour
 
IDLH	 Immediately Dangerous to Life and Health
 
IARC	 International Agency for Research on Cancer
 
ILO	 International Labor Organization
 
in	 inch
 
Kd	 distribution ratio (soil/water)
 
Kg	 kilogram
 
K
oc	 
organic carbon partition coefficient
 
K
ow	 
octanol-water partition coefficient
 
L	 liter
 
LC	 liquid chromatography
 
LCLo	 lethal concentration low
 
LC50	 lethal concentration 50 percent kill
 
lethal dose low
LDLo
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LD50 lethal dose 50 percent kill 
LOAEL lowest-observed-adverse-effect level 
LSE Levels of Significant Exposure 
m meter 
M molar 
mg milligram 
min minute 
mL milliliter 
mm millimeters 
mmo1 millimole 
mppcf millions of particles per cubic foot 
MRL Minimal Risk Level 
MS mass spectrometry 
NIEHS National Institute of Environmental Health Sciences 
NIOSH National Institute for Occupational Safety and Health 
NIOSHTIC NIOSH's Computerized Information Retrieval System 
nm nanometer 
nM nanomolar 
NHANES National Health and Nutrition Examination Survey 
nmol nanomole 
NOAEL no-observed-adverse-effect level 
NOES National Occupational Exposure Survey 
NOHS National Occupational Hazard Survey 
NPL National Priorities List 
NRC National Research Council 
NTIS National Technical Information Service 
NTP National Toxicology Program 
OSHA Occupational Safety and Health Administration 
PEL permissible exposure limit 
pg picogram 
pmo1 picogram 
PHS Public Health Service 
PMR proportional mortality ratio 
ppb parts per billion 
ppm parts per million 
ppt parts per trillion 
REL recommended exposure limit 
RfD Reference Dose 
RTECS Registry of Toxic Effects of Chemical Substances 
sec seconds 
SCE sister chromatid exchange 
SIC Standard Industrial Classification 
SMR standard mortality ratio 
STEL short-term exposure limit 
STORET STORAGE and RETRIEVAL 
TLV threshold limit value 
TSCA Toxic Substance Control Act 
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TRI Toxics Release Inventory
 
TWA time-weighted average
 
U.S. United States
 
UF uncertainty factor
 
WHO World Health Organization
 
> greater than 
≥ greater than or equal to 
= equal to 
< less than 
≤ less than or equal to 
5 percent 
α alpha 
β beta 
δ delta 
γ gamma 
µm micron 
µg microgram 
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PEER REVIEW
 
A peer review panel was assembled for antimony. The panel
 
consisted of the following members: Dr. William Buck, University of
 
Illinois, Urbana, Illinois; Dr. George Cherian, University of Western
 
Ontario, London, Ontario, Canada; Dr. Ernest Foulkes, University of
 
Cincinnati, Cincinnati, Ohio; Dr. Derek Hodgson, University of
 
Wyoming, Laramie, Wyoming; and Dr. Maryce Jacobs, American Institute
 
for Cancer Research, Washington, DC. These experts collectively have
 
knowledge of antimony's physical and chemical properties
 
,toxicokinetics, key health end points, mechanisms of action, human
 
and animal exposure, and quantification of risk to humans. All
 
reviewers were selected in conformity with the conditions for peer
 
review specified in the Comprehensive Environmental Response,
 
Compensation, and Liability Act of 1986, Section 104.
 
Scientists from the Agency for Toxic Substances and Disease
 
Registry (ATSDR) have reviewed the peer reviewers comments and
 
determined which comments will be included in the profile. A listing
 
of the peer reviewers comments not incorporated in the profile, with a
 
brief explanation of the rationale for their exclusion, exists as part
 
of the administrative record for this compound. A list of databases
 
reviewed and a list of unpublished documents cited are also included
 
in the administrative record.
 
The citation of the peer review panel should not be understood to
 
imply its approval of the profile's final content. The responsibility
 
for the content of this profile lies with the ATSDR.
 
